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ABSTRACT 
 
 The unique ability of allyl and crotyl silane reagents to act as competent 
nucleophiles as well as electron-rich dienophiles prompted an investigation into utilizing 
allyl and crotyl silanes in reactions with ortho-quinone methides (oQMs). In the presence 
of anhydrous FeCl3 and 2,6-lutidine, reaction of allyltrimethylsilane and the oQM 
intermediate generated from 2-(hydroxy(phenyl)methyl) phenol was found to produce 
both the cycloaddition and 1,4-addition product in 92% combined overall yield. This 
method was successfully extended to a stereoselective reaction between an 
enantioenriched (S,E)-crotyl silane and a variety of oQMs generated from electronically 
diverse ortho-hydroxybenzyl alcohol precursors. Both the chiral chroman and crotylation 
products were isolated in ratios reflective of the electronic nature of the parent oQM with 
overall combined yields of up to 96% and >99:1 er. A titanium tetrachloride-mediated 
ring-opening and elimination sequence was subsequently developed to provide direct 
  ix 
access to the crotylation products, containing a unique vicinal tertiary carbon stereocenter 
bond construction, in good yields and enantioselectivities. 
 An  enantioselective cyclopropanation of di- and tri-substituted allenylsilanes was 
investigated to expand the relatively limited scope of asymmetric allene cyclopropanation 
reactions and to provide access to functionalized, chiral alkylidenecyclopropanes (ACPs). 
In the presence of 2 mol% of the Ru(S-Pheox) catalyst, 1,1-di-substituted allenylsilanes 
reacted with the metal carbenoid generated from benzyl diazoacetate ester to give the 
corresponding ACP products in up to 85% yield and 99:1 er. Increasing the catalyst 
loading to 10 mol% enabled the first reported asymmetric cyclopropanation of chiral, tri-
substituted allenylsilanes, which gave optimal yields for the (R)-allenylsilanes over the 
corresponding (S)-isomers. A proposed mechanistic model was devised to rationalize the 
observed double stereodifferentiation event in the asymmetric cyclopropanation, which 
predicted the (R)-allenylsilanes and (S)-pheox ligand to be a matched pair. The reactivity 
of the densely functionalized ACP products was tested and led to the preparation of an 
unexpected 3-oxabicyclo[3.1.0]hexan-2-one product via iodolactonization. 
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CHAPTER ONE. Enantioselective Reactions of Crotyl Silane with ortho-Quinone 
Methide Intermediates 
 
Introduction 
 ortho-Quinone methides (oQMs) are important reactive intermediates that have 
found wide usage in organic synthesis and are involved in many biological processes.
1
 
The generated parent oQM consists of a 1,3-cyclohexadiene core in conjugation with a 
carbonyl and an exocyclic double bond. This highly polarized structure renders oQMs 
highly susceptible to react in 1,4-additions with nucleophiles, inverse-electron demand 
cycloaddition reactions with appropriate dienophiles, and 6π-oxa-electrocyclizations 
which offer three thermodynamically driven pathways toward rearomatization (Figure 
1.1).
2
 In light of the transient nature of these reactive intermediates, significant efforts 
have been made toward selective reactions of oQMs. Many methods have been 
developed over the past decades to selectively control their initial formation, including 
Figure 1.1 ortho-Quinone methide general modes of reactivity 
 
  
2 
through thermolytic, photolytic, oxidative, and acid- or base-promoted elimination 
processes, which have enabled the development of the oQM as a versatile synthetic 
intermediate.
3
 In particular, since the first report of an asymmetric reaction using an oQM 
by Pettus in 2004, significant advances have been made toward utilizing oQM 
intermediates in the context of asymmetric synthesis.
4
 A brief survey of the most recent 
advances will be dicussed. 
 With the advancement of asymmetric methods employing oQMs, considerable 
attention has been devoted to utilizing these versatile intermediates in natural product 
synthesis to rapidly introduce stereochemical complexity via cycloaddition processes.
5
 In 
addition to developing methods to construct biologically relevant chiral chroman 
scaffolds through asymmetric [4+2]-cycloadditions of oQM intermediates, we were 
similarly interested in the application of oQMs in acyclic, stereocontrolled 1,4-addition 
reactions. In particular, a potential crotylation reaction pathway could provide access to a 
unique vicinal tertiary carbon stereocenter bond construction, which is found in a variety 
of natural products and associated derivatives possessing potential therapeutic relevance 
(Figure 1.2).
6-9
 
Figure 1.2 Natural products and analogues containing vicinal tertiary carbon 
stereocenters 
 
  
3 
Background 
 ortho-Quinone methides have garnered significant attention within the literature, 
especially as methods continue to be developed to selectively generate, react, and study 
oQM intermediates in-situ.
10
 The following background sections will provide context for 
the modulation of oQM generation and reactivity by substituent effects, recent literature 
utilizing oQMs in stereocontrolled [4+2]-cycloaddition and 1,4-addition reactions, 
alternative methods to access vicinal tertiary carbon stereocenter bond constructions, and 
precedent for reactions of allyl silane reagents with oQM intermediates. 
 
Substituent Effects on the Formation and Reactivity of ortho-Quinone Methides 
 Studies from the Rokita laboratory in 2006 provided the first general, systematic 
study aimed to understand and potentially exploit the seemingly general behavioral trends 
exhibited among various substituted oQM precursors.
11
 Specifically, the studies 
examined the effect of substituents on the generation and reactivity of oQM 
intermediates. To further extend and generalize their initial studies focused on 
deoxynucleoside adduct stability and their oQM precursors, a series of N-morpholino-
adducts SR-1 were generated to probe the effect of electron-donating and -withdrawing 
substituents on the formation of the corresponding oQM SR-2 (Figure 1.3). The relative 
stability of oQM precursors SR-1 was monitored by the formation of the corresponding 
benzyl alcohols SR-3 via reaction of the generated oQM intermediate with water as a 
nucleophile. Electron-poor adducts (SR-1a and SR-1b) exhibited significantly longer half 
lives relative to the more electron-rich adducts (SR-1d and SR-1e), indicating that  
  
4 
Figure 1.3 Substituent effects on the rate of formation of ortho-quinone methides 
 
formation of an oQM intermediate is greatly suppressed when electron-withdrawing 
substituents are present on the phenol ring, while electron-donating substituents promote 
the facile formation of oQMs.  
 The effect of the substituents on the reactivity of oQMs with various nucleophiles 
was then probed by utilizing flash photolysis to generate the oQM intermediate from a 
series of substituted quaternary ammonium salt precursors SR-4 (Table 1.1). oQM 
consumption was monitored at its λ-max in aqueous solutions containing the oQM 
precursors in solutions of just water, morpholine, and 2-mercaptoethanol each as 
nucleophiles and the corresponding rates of reaction were determined to be second order. 
It was observed that for all three nucleophiles, the presence of increasingly stronger 
electron-withdrawing groups (from SR-4c to SR-4f) decreased the lifetime of the 
observed oQM intermediates (SR-5c to SR-5f) relative to electron-donating groups (SR-
4a) and therefore strongly promoted nucleophilic addition.  
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Table 1.1 Substituent effects on the rate of reaction of oQMs with nucleophiles 
 
 
 From these experiments, it was concluded that the general trends in the formation 
and subsequent reactivity of oQMs were consistent with the electronic nature of the oQM 
intermediate. Namely, electron-donating groups promoted initial formation of the oQM, 
but discouraged subsequent reactivity towards nucleophilic addition. Conversely, 
electron-withdrawing groups greatly suppressed initial oQM formation, but once the 
oQM intermediate is formed, were shown to facilitate the subsequent addition of 
nucleophiles. These general principles provide the basis for our understanding of oQM 
reactivity and helped guide the first part of our work in examining the substrate scope of 
the reaction between various substituted ortho-hydroxybenzyl alcohols, used as ortho-
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quinone methide precursors, and our nucleophilic (S,E)-crotyl silane (see Scope of the 
[4+2]-Cycloaddition and 1,4-Addition of oQMs by (S,E)-Silane subsection). 
 
Recent Enantioselective [4+2]-Cycloadditions of ortho-Quinone Methides 
 The prominence of ortho-quinone methides utilized in asymmetric 
transformations has been the subject of several reviews.
2, 12, 13
 Since the more recent 
detailed reviews in 2015, there have been several reports of asymmetric [4+2]- 
cycloadditions involving ortho-quinone methide intermediates leading to enantioenriched 
materials. 
 In 2016, the Shi laboratory developed the first use of o-hydroxylstyrenes FS-1 as 
versatile oQM precursors in enantioselective cycloaddition reactions with azlactones FS-
2 to yield highly substituted dihydrocoumarins FS-5 in moderate to excellent yields and 
good enantiomeric ratios (Figure 1.4).
14
 Interestingly, the transformation employed a 
novel synergistic catalyst system that employed a chiral Brønsted phosphoric acid FS-3  
Figure 1.4 Enantioselective [4+2]-cycloaddition of azlactones to o-hydroxylstrene-
derived oQM intermediates 
 
and a chiral Brønsted base, guanidine FS-4, which despite potential compatibility issues, 
were shown to cooperatively catalyze the asymmetric cycloaddition between a wide 
variety of electron-rich and electron-poor phenyl-substituted substrates. Control 
  
7 
experiments to confirm the synergistic relationship between the two chiral catalysts were 
carried out to probe the ability of each catalyst to perform independently as well as with 
an achiral catalyst partner, which all showed diminished yields and enantioselectivities. A  
Figure 1.5 Proposed transtion state for enantioselective [4+2]-cycloaddition using 
two chiral cooperative catalysts 
 
proposed transition state model was devised in which chiral phosphoric acid FS-3 and 
chiral guanidine FS-4 coordinate via a hydrogen-bonding interaction to simultaneously 
activate oQM intermediate FS-6 and enolize the azlactone to FS-7 (Figure 1.5).  The 
highly ordered complex then guides the stereocontrolled cycloaddition process to give 
tricyclic intermediate FS-8, which upon subsequent ring-opening, yields 
dihydrocoumarins FS-5. Substrates bearing aliphatic substituents at the R
2
 and R
3
 
positions of FS-2 failed to afford cycloaddition product, presumably due to the inability 
to stabilize the proposed enolized azlactone intermediate FS-7. 
 The Liu and Li laboratories in 2017 discovered an unexpected enantioselective 
[4+2]-cycloaddition of ortho-quinone methides generated from 2-(tosylmethyl) naphthols 
or sesamols CL-1 and electron-poor allenic esters CL-2 to give 4-substituted chromans 
CL-4 in good to excellent yields and high enantioselectivities utilizing the chiral  
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Figure 1.6 Enantioselective [4+2]-cycloaddition of allenic esters to o-quinone 
methide intermediates 
 
cinchonine-derived catalyst CL-3 (Figure 1.6).
15
 The initial aim of their work was 
focused on developing a kinetic resolution of the simpler phenol analogues of CL-1 with 
allenic esters, but in attempting to expand the reaction scope to the bicyclic napthol 
derivatives, [4+2]-cycloaddition products were isolated instead, which was attributed to 
the increased stability of the generated oQM intermediates. Excellent enantioselectivities 
were achieved and rationalized in a proposed transition state in which the oQM 
approaches the zwitterionic intermediate CL-5 opposite the face of the quinuclidine 
framework and ether stereocenter (Figure 1.7). Substitution at the benzylic position (R) 
with phenyl groups containing electron-donating and electron-withdrawing substituents 
were well tolerated under the reaction conditions, while a substrate bearing a propyl 
group yielded only a moderate yield of 43% and required a higher catalyst loading and 
longer reaction time. 
 
Figure 1.7 Proposed catalytic cycle for enantioselective [4+2]-cycloaddition of 
naphthol/sesamol-derived oQMs 
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 In an effort to access more simplified chroman scaffolds JS-4, the Sun laboratory 
developed an enantioselective [4+2]-cycloaddition of oQMs using vinyl sulfides JS-2 
(Figure 1.8, Eq. 1).
16
 ortho-Hydroxybenzyl alcohols JS-1 containing a variety of aryl, 
alkenyl, and alkynyl groups at the benzylic position (R
2
) were subjected to the chiral 
BINOL-derived phosphoric acid, generating the corresponding oQMs in-situ. The 
resulting coordination of the chiral catalyst (JS-3) to the intermediate oQM via a 
hydrogen-bonding interaction was proposed to direct the facial approach of the vinyl 
sulfide dienophile, providing the enantioenriched chromans JS-4 in good to excellent  
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Figure 1.8 Enantioselective [4+2]-cycloaddition of oQMs and vinyl sulfides 
 
yields and moderate to high ee. To demonstrate the utility of the installed thiol group, JS-
4a was oxidized to the sulfonyl JS-5, which was subsequently converted to the reduced  
chroman JS-6, the 4H-chromene JS-7, and the alkylated 2,4-trans-chroman JS-8 in good 
yields with retention of the ee obtained from the original cycloaddition process (Figure 
1.8, Eq. 2).  
 The List laboratory reported the first catalytic asymmetric intramolecular [4+2]-
cycloaddition of in-situ generated ortho-quinone methides in 2017 (Figure 1.9).
17
 By  
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Figure 1.9 Enantioselective intramolecular [4+2]-cycloaddition of in-situ generated 
oQMs 
 
utilizing dienyl alcohols BL-2 in reaction with salicylaldehyde derivatives BL-1, the 
extended conjugation of the dienyl precusor was shown to help stabilize the requisite 
oQM intermediate BL-5 and was crucial for high reactivity and selectivity. The reaction 
afforded excellent enantiomeric ratios with the chiral imidodiphosphoric acid BL-3, 
which contained a confined chiral pocket that was proposed to guide the highly 
stereoselective intramolecular cycloaddition. A wide-range of diversely functionalized 
furanochromanes BL-4 were obtained, including electron-rich, electron-poor, and 
sterically demanding substituents on the phenol ring. In addition, the distal linear alkene 
moiety (R
3
) could be replaced with a cyclohexene or phenyl ring to give tetracyclic 
scaffolds in 81% and 83% yield, respectively. By extending the chain length of BL-2 by 
an extra carbon (n = 2), a pyranochromane scaffold was also accessed and isolated as the 
sole product in 75% yield and an excellent 98:2 er. To provide evidence to support a 
concerted cycloaddition mechanism, dienyl alcohol BL-2G possessing a (Z)-olefin 
geometry at the C-3 and C-4 positions was reacted with BL-1a and produced a mixture of  
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Figure 1.10 Cycloaddition of a (Z)-dienyl alcohol 
 
two main diastereomers BL-4G and BL-4G' that both retained the cis-relative 
configuration of the starting alkene (Figure 1.10). 
 Building off of the List laboratory's intramolecular strategy, the Yan laboratory in 
2017 reported an enantioselective, intramolecular [4+2]-cycloaddition of in-situ 
generated vinylidene ortho-quinone methides HY-4 (Figure 1.11).
18
 By employing  
Figure 1.11: Enantioselective intramolecular [4+2]-cycloaddition of in-situ 
generated vinylidene oQMs 
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substrates HY-1 which possessed a substituted 2-ethynylphenol moiety and an electron-
rich benzofuran, [5-6-5] tricyclic derivatives HY-3 containing vicinal quaternary and 
tertiary stereocenters were obtained in good to excellent yields with >99:1% ee and >20:1 
dr. A chiral catalyst screen of various cinchona alkaloids and cinchona-alkaloid-derived 
thioureas revealed that the hydrogen-bonding abilities of the thiourea-containing catalysts 
were crucial in order to achieve optimal enantioselectivities. Thiourea HY-2 was found to 
be the most effective and selective catalyst for this transformation, providing an excellent 
yield of 98%, enantioselectivity of >99% ee, and diastereoselectivity of >20:1 dr for the 
model system (R
1
= R
2
 = R
3
 = H). Subsequent deuterium labeling studies revealed that the 
hydroxyl group of HY-1 was the source of the hydrogen atom at the C-3 position of the 
1H-indene, indicating a proton exchange and tautomerization event to generate the 
intermediate vinylidene ortho-quinone methide HY-4.   Evaluation of the substrate scope 
showed that substitution with electron-donating groups at the R
1
 position, aryl bromide 
groups at at the R
2
 and R
3
 positions, as well as quinolyl-derived substrates were all 
tolerated under the reaction conditions and obtained with 99% or greater ee. Evaluation 
of a series of simpler benzofuran derivatives, in contrast to the naphthyl-furans, allowed 
access to the corresponding heptacyclic products in good yields (66-71%) and 
enantioselectivities (91-97% ee). 
 Following their original report detailing the total synthesis of (+)-psiguadial B  
utilizing an intramolecular O-arylation strategy to construct the chroman core, the 
Reisman laboratory published an alternative approach in 2018 employing a [4+2]- 
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Figure 1.12 Retrosynthetic analysis for the total synthesis of (+)-psiguadial B 
 
cycloaddition between an in-situ generated oQM from the phloroglucinol derived SER-3 
and the vinyl ether generated from ketal SER-2 (Figure 1.12).
19, 20
 Upon heating in 
toluene, simultaneous extrusion of methanol provided a 1:1 mixture of enol ether SER-4 
and dehydration of SER-3 provided the requisite oQM intermediate SER-5 (Figure 1.13, 
Eq. 1). Unfortunately, a complex mixture of diastereomers was isolated in which four 
major products were determined (SER-6 to SER-9), but only SER-6 and SER-7 
possessed the desired cis-ring fusion at C-8/C-9 and anti relationship at C-9/C-1'. 
Additionally, these two diastereomers were isolated in a near 1:1 ratio, indicating that the 
inherent chirality of SER-4 exerted minimal control over the facial selectivity of the 
cycloaddition. Drawing inspiration from the Evans laboratory's use of Cu(II)-Box 
catalysts SER-10 in enantioselective hetero-Diels-Alder reactions, the aminoquinoline 
group of SER-2/SER-4 was envisioned to analogously serve as a bidentate ligand to 
form a Cu complex and direct the facial selectivity of the cycloaddition process (Figure 
1.13, Eq. 2).
21
 Unfortunately, the undesired diastereomers SER-8 and SER-9 
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predominated and the oQM approach to construct the desired chroman core of (+)-
psiguadial B was ultimately abandoned. 
Figure 1.13 [4+2]-cycloaddition of in-situ generated oQM in the total synthesis of 
(+)-psiguadial B 
 
 
Recent Enantioselective 1,4-Addition Reactions of ortho-Quinone Methides 
 In addition to the recent developments for utilizing ortho-quinone methides in 
stereocontrolled, inverse electron-demand Diels Alder reactions, significant 
advancements have been made in employing these versatile intermediates in asymmetric 
1,4-addition processes.  
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 For instance, the Schaus laboratory reported the first example of an asymmetric, 
multicomponent reaction (MCR) utilizing ortho-quinone methides in 2015 (Figure 
1.14).
22
 The use of electron-rich phenols SES-1 was crucial to encourage the proposed 
rate-limiting Friedel-Crafts hydroxyalkylation of aromatic aldehydes SES-2, which was 
ultimately promoted by the isopropyl boronate ester SES-3. After screening a variety of 
chiral diol and BINOL-derived chiral catalysts, 3,3'-(S)-Br2-BINOL (SES-4) was 
identified to give optimal yields and enantioselectivities for addition products SES-5.  
Aldehydes bearing electron-rich and halide-substituted aromatic rings were well-tolerated 
and gave high enantioselectivity (95:5 er for 4-methoxy and 4-bromobenzaldehyde),  
Figure 1.14 Enantioselective multicomponent reaction of ortho-quinone methides 
 
while the electron-poor 4-trifluoromethyl benzaldehyde showed a slight decrease in 
selectivity with a 91:9 er. Additionally, a wide variety of styrenyl and aryl boronates 
bearing both aromatic and aliphatic functionality proved to be effective under the reaction 
conditions, enabling a platform for further diversification. 
 Mechanistic experiments were performed following the isolation of chroman 
product SES-6 when utilizing the electron-rich styrenyl boronate SES-3b at elevated 
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temperature (Figure 1.15, Eq. 1). An electron-neutral styrenyl boronate ester was 
subsequently subjected to the same reaction conditions catalyzed by 3,3'-(S)-I2-BINOL 
SES-7 and showed a diminished conversion rate to the chroman product, which indicated  
Figure 1.15 Enantioselective multicomponent reaction of oQMs for chromans 
 
that an electron-rich boronate was needed to facilitate a proposed protonation to give 
intermediate SES-11 for the cyclization process to occur. To confirm a potential two-step 
process to the chroman products via the enantioenriched 1,4-addition products, product 
SES-10v (81:19 er) was isolated and subjected to the reaction conditions for chroman 
formation. Gratifyingly, the chroman product was isolated in a 90:10 er, which indicated 
that a step-wise process occurred with enhanced selectivity during the cyclization event 
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to give chroman products SES-6 (Figure 1.15, Eq. 2). It was reasoned that the initial 
enantioselectivity for the 1,4-addition process occurs during the dissociation of boronate 
complex SES-9 and subsequent rapid ligand exchange generates SES-10, which was 
consistent with previous studies conducted by their laboratory in which enantioselective 
addititions of boronates to oQMs occured at low temperatures.
23
 
 Following their previous work utilizing alcohols as nucleophiles in asymmetric 
additions to oQM intermediates in 2015, the Sun laboratory sought to further extend the 
use of heteroatom nucleophiles to the corresponding thiols ZL-2 (Figure 1.16).
24, 25
 
Inspired by a previous report utilizing tritylthiol ZL-2 in asymmetric additions to oQMs 
catalyzed by a chiral bifunctional base catalyst system, the Sun laboratory aimed to 
Figure 1.16 Enantioselective additions of oQMs by thiols 
 
develop a complementary transformation utilizing chiral Brønsted acid catalysis.
26
 
Reaction conditions were developed utilizing ortho-hydroxybenzyl alcohols ZL-1, which 
reacted with the sterically demanding tritylthiol ZL-2 to give thiol-substituted 
diarylmethane products ZL-4 in moderate-to-excellent yields. The highest 
enantioselectivity (92:8) was achieved with the biaryl, 4-bromo substitued phenol (ZL-1 
with R
1
= 4-bromo, R
2
= Ph), while substitution with a propargyl group at the benzylic 
position (ZL-1 with R
1 
= H, R
2 
= propargyl) yielded a modest 83:17 er. Experiments were 
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also conducted with benzylmercapatan and thiophenol, which both gave products with 
diminished enantioselectivities (52:48 and 62:38 er, respectively) and illustrated the 
importance of the relative size of the nucleophilic thiol to the stereoselectivity of the 
transformation. 
 In 2017, the Lan and Zhou laboratories reported an enantioselective α-addition of 
oQM intermediates with deconjugated butenolides YZ-2 (Figure 1.17, Eq1).
27
 To expand 
upon the limited examples of this highly specific substrate system, an asymmetric α- 
addition between oQMs derived from 2-(1-tosylalkyl)naphthols YZ-1 and ,λ-
unsaturated butenolides YZ-2 was developed. Under basic conditions utilizing the chiral  
Figure 1.17 Enantioselective additions of oQMs by deconjugated butenolides 
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squaramide catalyst YZ-3, initial α-addition of the oQM intermediate YZ-5 by dienolate 
YZ-6 occured to give the two contiguous tertiary stereocenters of the product 
intermediate YZ-7 and was followed by a transesterification event to provide the 
corresponding 3,4-dihydrocoumarins YZ-4 in generally high yields and ee (Figure 1.17, 
Eq. 2). Tosylnaphthols containing electron-rich and poor aryl groups at the benzylic R
1
 
position gave excellent yields with methyl substituted (R
2
) butenolides, while the use of 
the corresponding 2-(phenyl(tosyl)methyl)phenol gave a diminished yield due to the 
decreased stabilization of the requisite oQM. To help rationalize the unique α-selectivity 
over γ-selectivity for the addition, DFT calculations were conducted on the transition 
states for each reaction pathway, which revealed that the distortion energy that resulted 
from the interaction between dienolate YZ-6 and the electrophilic oQM YZ-5 was 
ultimately responsible for the observed regioselectivity. 
 The Schneider laboratory exploited chiral phosphoric acid catalysts (CS-5 and 
CS-6) in enantioselective additions of oQMs in a number of publications in 2015 and 
earlier, which included the preparation of stereodefined polycyclic 4-aryl-4H-chromenes  
CS-1, acetamidotetrahydroxanthenes CS-2, 7-alkynyl-12a-acetamido-substituted  
Figure 1.18 Enantioselective additions of oQMs for polycyclic scaffolds 
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benzoxanthenes CS-3, and diarylindolylmethanes CS-4 (Figure 1.18).
28-31
 In an effort to 
diversify the modes of asymmetric induction and activation of oQMs in enantioselective 
addition reactions, several recent reports over the past few years from the Schneider 
laboratory detailed the development of new chiral catalyst systems and conditions to 
generate the oQM in-situ.  
 In 2016, the Schneider group developed a transition-metal and chiral phosphoric 
acid co-catalyzed enantioselective addition of oQMs using diazoesters (Figure 1.19, Eq. 
1).
32
 Chiral phosphoric acid CS-9 in combination with [Rh2(OAc)4] were shown to 
cooperatively promote the in-situ formation and reaction between oxonium ylides (II)  
Figure 1.19 Enantioselective additions of oQMs by oxonium ylides 
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and oQM (III) intermediates to generate the densely functionalized chroman products 
CS-10 in generally high enantioselectivity and good yield (Figure 1.19, Eq. 2). Two 
cooperative catalytic cycles were proposed in which initial formation of the oQM 
generates an equivalent of water, which can trap the metal carbenoid intermediate (I) to 
generate the oxonium ylide intermediate (II). Coordination of the chiral phosphoric acid 
to both the oQM and oxonium ylide guides the subsequent conjugate addition via a 
highly ordered transition state to deliver the intermediate product (IV), which could 
undergo hemiacetalization to the chroman product (CS-10). 
 The following year, the Schneider laboratory reported an oxidative approach to 
generate oQMs in-situ to enable reactions of very electron-rich ortho-hydroxy benzhydryl 
alcohols.
33
 Sesamol and methoxy substituted phenols CS-11 were reacted with  
Figure 1.20 Enantioselective additions of oQMs generated by catalytic aerobic 
oxidation 
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nucleophilic acetyl acetone derivatives CS-12 (or H-L) to generate the corresponding 
electron-rich 4H-chromenes CS-13 in moderate to good yields under an aerobic 
atmosphere (Figure 1.20, Eq. 1). Mechanistic studies revealed that the chosen 
dibenzolylmethane (dbm) ligands of the manganese (III) precatalyst exchange with 
acetylacetone substrates CS-12 (H-L), generating the active MnL3 catalyst species which 
catalyzes the aerobic oxidation of CS-11 to oQM intermediate CS-14 (Figure 1.20, Eq. 
2). In the presence of chiral phosphoric acid CS-5 (H-P*), ligand exchange also 
generated the chiral manganese complex (MnL2P*) that ultimately controlled the 
enantioselective 1,4-addition to the oQM. 
 In the Schneider laboratory's continued pursuit to develop novel catalyst systems 
to promote the formation and asymmetric additions of oQMs, they recently reported in 
2018 on the successful use of a palladium(II)-aqua complex in a cooperative Brønsted 
acid/base catalyzed process.
34
 In the presence of the chiral Pd-complex CS-17, oQM 
intermediates derived from o-hydroxybenzyl alcohols CS-15 underwent enantioselective 
additions by cyclic -keto esters CS-16 to give the densely functionalized chroman 
hetereocycles CS-18 in good-to-high yields and excellent ee (Figure 1.21, Eq. 1). 
Notably, several substrates containing a 4-methoxy aryl ring (R
2
) were obtained in 
quantitative yield and 99% ee. Mechanistically, the authors reasoned that the unique 
properties of the palladium catalyst allowed for a dual role in which the generation of 
water from the palladium complex could enolize CS-16 and also generate triflic acid to 
promote the formation of oQM intermediate CS-20 (Figure 1.21, Eq. 2). Subsequent 
enantioselective addition by intermediate CS-19 and hemiacetalization would furnish 
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Figure 1.21 Enantioselective additions of oQMs catalyzed by a Pd(II)-aqua complex 
 
chroman product CS-18. 
 To extend the scope of potential carbon based nucleophiles beyond ketones and 
esters, the Schneider laboratory developed the use of aryl acetaldehydes in asymmetric 
additions to oQMs in 2018.
35
 Catalyzed by the chiral phosphoric acid CS-5, simultaneous 
dehydration of CS-21 to generate the corresponding oQM intermediate and enolization of 
CS-22 results in the enantioselective formation of two contiguous aryl stereocenters. 
Subsequent hemiacetal formation from the diarylchromanol and oxidation with PCC gave 
the cis-3,4-dihydrocoumarins CS-24 in moderate to good yields and er. Additionally, the 
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Figure 1.22 Enantioselective additions of oQMs by aryl acetaldehydes 
 
corresponding trans-3,4-dihydrocoumerins were readily accessible through an 
epimerization of the cis-products with DBU at 40 C. 
 
Methods to Access Vicinal Tertiary Carbon Stereocenters 
 During the initial stages of our studies, we became particularly interested in the 
application of oQMs in acyclic, stereocontrolled 1,4-addition reactions. Ultimately, a 
crotylation reaction of oQM intermediates was envisioned to provide direct access to a 
unique vicinal tertiary carbon stereocenter bond construction. The following background 
subsection will address issues and previous methods to access contiguous tertiary carbon 
stereocenters stereoseletively.   
 The efficient stereoselective construction of contiguous carbon stereocenters 
remains an important and continually developing field with applications in natural 
product synthesis.
36
 One particular challenge in the enantioselective construction of 
vicinal tertiary carbon stereocenters is the potential epimerization of the newly formed 
tertiary stereocenter under the given reaction conditions.
37
 This section will provide an 
overview of the general approaches to access vicinal tertiary carbon stereocenters 
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asymmetrically, which include enantioselective allylic alkylations, Claisen 
rearrangements, and conjugate addition reactions. 
 A commonly employed method to construct vicinal tertiary centers 
enantioselectively has been through the use of asymmetric allylic alkylation reactions, 
which are an important and versatile class of transformations due to the number of 
mechanisms which achieve enantiodiscrimination and the wide range of bond types that 
can be accessed.
38
  
Figure 1.23 Transition metal-catalyzed allylic alkylation with hard vs. soft 
nucleophiles 
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 In particular, carbonyl-based nucleophiles have been successfully utilized in a 
number of different asymmetric allylic alkylation reactions with a variety of transition 
metal catalysts. The prevalence of these soft nucleophiles in stereocontrolled transition 
metal-catalyzed allylic alkylations stems from their ability to uniquely engage the metal-
allyl complex.
39
 In comparison to hard nucleophiles that attach directly to the metal 
center and undergo subsequent reductive elimination with the allyl fragment to generate 
the alkylated product (Figure 1.23, Eq. 1), reactions with soft nucleophiles typically  
occur outside the coordination sphere of the metal catalyst (Figure 1.23, Eq. 2). By the 
careful selection of chiral ligand and allyl fragment in coordination with the metal center, 
high levels of enantiofacial discrimination have been achieved when utilizing soft 
nucleophiles. 
 -Diketone nucleophiles represent an important class of stabilized carbo-
nucleophilic substrates employed in allylic alkylations and continue to find new 
applications since the Trost laboratory's seminal publication over four decades ago.
40
 
Recently in 2015, the Kanbayashi and Onitsuka laboratory reported an asymmetric allylic  
Figure 1.24 Stereoselective allylic alkylation of b-diketones 
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alkylation of allylic chlorides KO-1 with -diketones KO-2 catalyzed by 
cyclopentadienyl-ruthenium complex KO-3 (Figure 1.24).
41
 An initial screen of various 
inorganic bases revealed that use of NaHCO3 was crucial to achieve appreciable levels of 
dr and high levels of ee for the vicinal tertiary stereocenters of alkylated products KO-4. 
To provide insight into NaHCO3's role in the achieved stereoselectivity, KO-4a was 
stirred in THF in the presence of various bases (DBU, K2CO3, and NaHCO3) and 
epimerization of the product was observed in all cases except when using NaHCO3. 
Studies to determine potential substituent effects of the nucleophile were conducted on a 
series of -diketones containing a phenyl group at the R2 position and various alkyl 
groups substituted at the R
3
 position. Linear alkyl groups at the R
3
 position were shown 
to give relatively high diastereoselectivities (7:1 for ethyl and 5:1 for n-butyl), while 
substitution with sterically demanding substituents surprisingly led to a relative decrease 
in dr (3:1 for t-butyl and 4:1 for isopropyl), illustrating the subtle effects substituent size 
can have on stereoselectivity.  
 The Braun laboratory in 2000 was the first to demonstrate that non-stabilized 
ketone enolates could also be utilized in asymmetric transition metal-catalyzed allylic 
alkylations in their preparation of alkylated products MB-7 and MB-9 containing vicinal 
tertiary carbon stereocenters (Figure 1.25).
42
  Preliminary experiments focused on  
optimizing the diastereoselectivity of the allylic alkylation of cyclohexanone MB-1 with 
racemic acetate MB-3 catalyzed by the in-situ generated achiral palladium-phosphane 
ligand MB-6 complex. After screening a variety of amine bases with differing counter-
ions to generate the initial cyclic (E)-enolate MB-2, magnesium chloride isopropylamine  
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Figure 1.25 Stereoselective allylic alkylation of non-stabilized ketone enolates 
 
was found to greatly increase the dr (97:3 ratio of syn:anti) over the corresponding 
lithium and potassium bases. Interestingly, while acyclic ketone MB-7 also generated an 
(E)-enolate intermediate (MB-8), the obtained product favored the opposite relative 
stereochemistry, which the authors suggest could possibly be due to a difference in 
operating transition states (closed versus open) between the cyclic versus acyclic enolate. 
Asymmetric induction was also achieved for both ketone substrates by employing chiral 
BINAP-ligand MB-6, which furnished the respective alkylation products in excellent ee 
for the cyclic product MB-7 and good ee for the acyclic MB-9. 
 The Hou laboratory later expanded the scope of non-stabilized ketone enolates to 
acyclic ketones XH-1 in asymmetric allylic alkylations with aryl methyl carbonates XH-
2 to generate products XH-4 bearing vicinal tertiary carbon stereocenters (Figure 1.26).
43
  
After a preliminary screen of copper and lithium based halide additives in various organic 
solvents, the combination of LiCl and DME with LiHMDS was found to dramatically 
increase the regioselectivity for product XH-4 over XH-5 (>98:2), which was attributed  
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Figure 1.26 Stereoselective allylic alkylation of non-stabilized ketone enolates 
to their ability to influence carbanion de-aggregation.
44
 Good to excellent dr and high ee 
was achieved for all substrates utilizing the ferrocene-derived ligand XH-3, including 
both aromatic and cyclohexyl-substituted (R
1
) ketones as well as electronically diverse 
aromatic groups on the allyl carbonate.  
 Enamine nucleophiles have also been successfully employed in a variety of 
asymmetric allylic alkylation reactions to generate vicinal tertiary carbon stereocenters. 
The Zhang laboratory's brief initial report in 2007 investigated the use of the preformed 
enamine 1-(cyclohex-1-en-1-yl)pyrrolidine in an asymmetric allylic alkylation with 
racemic 1,3-diphenyl-2-propenyl acetate WZ-2  utilizing a chiral palladium-ferrocenyl 
WZ-3 complex.
45
 Encouraged by the high yield (94%) and enantioselectivity (99% ee) 
obtained for product WZ-4 (n= 2), followup studies in 2012 aimed to generate the 
enamine nucleophiles in-situ from the corresponding ketones WZ-1 (Figure 1.27, Eq. 
1).
46
 Indeed, when cyclohexanone WZ-1 (n =2) was reacted with allyl acetate WZ-2 in 
the presence of an equivalent of pyrrolidine, product WZ-4 (n= 2) was obtained in 
comparable yield and enantioselectivity. It was noted that the reaction of in-situ 
generated enamines necessitated the use of higher polarity solvents (DMSO and DMF) to 
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achieve any conversion for the alkylation reaction. Initial experiments with aldehydes 
WZ-5 showed no conversion under the optimized reaction conditions, but after a brief 
ligand screen, the palladium-ruthenocene WZ-6 complex was found to catalyze the 
Figure 1.27 Stereoselective allylic alkylation of enamines 
 
allylic alkylation to give aldehyde products WZ-7 in good yield and enantioselectivity 
(Figure 1.27, Eq. 2). 
 In 2014, the Carreira laboratory further exploited the use of in-situ generated 
enamines in stereoselective allylic alkylation reactions by developing a versatile dual 
iridium and amine catalyst system (Figure 1.28, Eq. 1).
47
 By choosing the proper 
combination of the (R) or (S) chiral iridium catalyst ligand ((R)-L or (S)-L) and the (R) or 
(S) chiral amine catalyst ((R)-A or (S)-A), all four possible stereoisomers of alkylation 
products EC-3 could be accessed from the same set of aldehydes EC-1 and allylic  
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Figure 1.28 Stereoselective allylic alkylation of linear aldehydes 
 
alcohols EC-2 (Figure 1.28, Eq. 1). For example, in the reaction of hexanal EC-1a and 
phenyl vinyl carbinol EC-2a, the combination of [Ir/(S)-L] and (R)-A catalysts gave 
alkylated product (S,R)-(EC-3a), while the enantiomer (R,S)-(EC-3a) was obtained in 
comparable yield by a simple switch to the [Ir/(R)-L] and (S)-A catalysts (Figure 1.28, 
Eq. 2). Analogously, both syn products were also obtained by the corresponding 
appropriate pairings of the two chiral catalysts. Careful screening of potential acid 
promoters for the stereoselective process revealed that dimethylhydrogen phosphate was 
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crucial in order to minimize deleterious background reactions and potential 
epimerization. Remarkably, all substrates tested with a given catalyst combination 
produced alkylated products EC-3 with excellent enantioselectivity (>99% ee) and in 
good yield.  
 Asymmetric Claisen rearrangements have also been an important class of 
transformations in the stereoselective construction of contiguous teritary carbon 
stereocenters. The Corey laboratory reported the first enantioselective Claisen 
rearrangement of achiral allylic esters in 1991 utilizing chiral bromoborane reagent EJC-
2 (Figure 1.29).
48
 By a simple switch in base and solvent combination, both (Z)- enolates 
EJC-3 and (E)-enolates EJC-5 could be accessed to subsequently give the stereodefined 
erythro-products EJC-4 and threo-products EJC-6, respectively. In general, good 
diastereoselectivities were observed under both reaction conditions consistent with the 
respective geometry of the boron enolate, except in the case of the (E)-boron enolates  
Figure 1.29 Enantioselective Claisen rearrangement using stoichiometric chiral 
bromoborane 
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derived from phenylacetic acid (R1,R2 = Ph; 23:77 dr) and α-(phenylthio)acetic acid (R1 = 
SPh, R2 =Me; 39:61 dr). Although reactios required extended reaction times, excellent 
enantioselectivity (>97% ee) was achieved for a majority of the substrates examined. 
 An initial report by the Hiersmann group in 2001 detailed a diastereoselective 
Claisen rearrangement of 2-alkoxycarbonyl-substituted vinyl ethers MH-1 catalyzed by 
the achiral Lewis acids Cu(OTf)2 and Yb(OTf)3 (Figure 1.30, Eq. 1). Interestingly, 
substrates with a (Z)-geometry of the alkene allyl moiety reliably gave high 
diastereoselectivity for the syn-products MH-2, while the corresponding (E)-configured 
allyl substrates gave a correspondingly lower selectivity for the anti-products. This 
critical influence of the allyl ether olefin geometry on the observed diastereoselectivity 
was rationalized by chair-transition states in which the favored (Z,Z)-MH-1 coordinates  
Figure 1.30 Diastereoselective Claisen rearrangements using Cu(OTf)2 and 
Yb(OTf)3 
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to the metal catalyst and generates an ion-pair in which the R
1
 and n-propyl substituents 
are antiperiplanar to one another (Figure 1.30, Eq. 2). Subsequent addition of the vinyl 
ether would then produce the favored syn-product in a step-wise fashion. Conversely, a 
disfavorable synclinal arrangement occurs in the corresponding transition state of the ion-
pair generated from (Z,E)-MH-1, which could equilibrate to the more favorable 
antiperiplanar orientation and lead to erosion of the anti-diastereoselectivity for the 
vicinal tertiary carbon stereocenters. 
 Building on the aforementioned observations, the Hiersmann laboratory reported 
the first catalytic enantioselective Claisen rearrangement by employing chiral [Cu(II)box] 
catalysts MH-4, 5, or 6 (Figure 1.31, Eq. 1 and Eq. 2).
49, 50
 By the appropriate 
combination of vinyl ether olefin geometry of MH-3 and chirality of the catalyst 
employed, both enantiomers of MH-8 could be accessed in quantitative yield and good to 
excellent er for most substrates (Figure 1.31, Eq. 1). Reaction of the allyl vinyl ethers 
MH-9, which possessed mono-subsitution on both alkenes, provided access to all 
possible stereoisomers of MH-10 in quantitative yields and good stereoselectivity (Figure 
1.31, Eq. 2). 
 In a followup report in 2004, the Hiersmann laboratory aimed to broaden the 
substrate scope and improve the stereoselectivity of the chiral [Cu(Box)]-catalyzed 
Claisen rearrangement (Figure 1.31, Eq. 3).
51
 Substitution with various silyl and benzyl 
ether functionalities were generally well tolerated, though the sterically demanding 
triphenylsilane in several cases necessitated the use of the more strongly Lewis acidic and 
less sterically demanding catalyst MH-7. Addition of 4 Å molecular sieves to the reaction 
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mixture dramatically increased the stereoselectivity of the process and gave excellent 
enantioselectivity for a majority of the substrates tested. In accordance with observations 
from their original diastereoseletive study, the reaction of substrates with a (Z,E)-alkene 
Figure 1.31 Catalytic, enantioselective Claisen rearrangements using chiral 
[Cu(box)] 
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configuration ((Z,E)-MH-11) led to diminished diastereoselectivity for anti-MH-12 
products (only 63:37 syn:anti achieved) relative to the corresponding selectivity of the 
(Z,Z)-MH-11 substrates for the corresponding syn-MH-12 products (almost 99:1 syn:anti 
selectvitiy achieved). 
 In contrast to early transition metal catalyst systems which relied on coodination 
of the Lewis acidic metal to the oxygen of the vinyl ether to promote asymmetric Claisen 
rearrangements, the Mikami group sought to develop a palladium-based catalyst which  
Figure 1.32 Catalytic, enantioselective Claisen rearrangement using palladium 
catalyst 
 
 
 
could instead engage the soft carbon-carbon alkene bonds of precursors KM-1 (Figure 
1.32).
52
 A brief catalyst and ligand screen revealed that the neutral, in-situ generated (R)-
DABNTf-Pd complex catalyzed the rearrangement of KM-1 in good yield and 
stereoselectivity for the anti-product KM-2 posessing contiguous tertiary carbon 
stereocenters. However, attempts to improve the stereoselectivity of the process by 
lowering the temperature resulted in negligible increases in dr and ee at the expense of 
yield. The authors proposed a boat transition state KM-3 in which bidentate coordination 
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of the chiral palladium catalyst to the two alkene moieties gives rise to the observed anti-
stereoselectivity. 
 Most recently in 2010, the Nelson laboratory reported the catalytic, asymmetric 
Claisen rearrangement utilizing a cooperative transition metal-Lewis acid cocatalyst 
system dervied from ruthenium (Figure 1.33).
53
 Using the chiral Ru(II) complex derived 
from [(CpRu(CH3CN)3]PF6 and chiral picolinamide ligand SN-2 in combination with the 
Lewis acid cocatalyst triphenyl phosphite to assist the oxidative insertion event, 
appreciable conversion was observed for the [3,3]-SN-3 and undesired [1,3]-SN-4  
Figure 1.33 Catalytic, enantioselective Claisen rearrangement using ruthenium 
catalyst 
 
products. The addition of molecular sieves resulted in an unexpected increase in the 
stereoselectivity of the reaction, while an added amount of acetonitrile increased product 
yield by a proposed disruption of potential product inhibition by the ruthenium catalyst. 
Excellent stereoselectivities were achieved for all (E,E)-substrates obtained, providing 
the anti-SN-3 products with diastereomeric ratios up to 25:1 and up to 99% ee. However, 
when reacting the corresponding (Z,E)- and (E,Z)-SN-1 isomers, a significant drop in 
both the regioselectivity and the stereoseletivity for the syn-SN-3 products was observed. 
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 Enantioselective conjugate additions have also been utilized successfully in the 
stereoselective construction of contiguous tertiary carbon stereocenters. The Xu and 
Yuan laboratory reported an asymmetric Michael addition of arylacetyl phosphonate 
esters WY-1 to nitroalkenes WY-2 catalyzed by the quinine-derived thiourea catalyst 
WY-3 (Figure 1.34).
54
 After the initial stereoselective addition of the enol phosphonate to  
Figure 1.34 Enantioselective Michael addition to nitroalkenes 
 
the nitroalkene, treatment with ethanol and DBU furnished the α-substituted esters WY-4 
in generally excellent dr (up to >99:1) and ee (up to 94% ee). While nitroalkene 
substrates bearing either electron-rich or electron-poor aryl substitutents (R) were 
generally well tolerated, the corresponding alkyl substituted olefins showed no reactivity. 
A transition state model for the addition was proposed in which simultaneous enolization 
of the acetylphosphonate by the quinine moiety and activation of both substrates via 
multiple hydrogen-bond interactions furnishes the attack to the Si-face of the alkene. 
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 The Hu laboratory in 2014 reported the first asymmetric propargylic alkylation of 
propargyl acetates XPH-1 by acyclic ketone enamines XPH-2 through a copper- 
Figure 1.35 Enantioselective propargylic alkylations of propargyl acetates 
 
allenylidene intermediate to access vicinal tertiary carbon stereocenters containing 
propargyl substituents (Figure 1.35, Eq. 1).
55
 An initial screen of various copper salts 
revealed that Cu(OTf)2, in combination with the sterically demanding tridentate (S)-
P,N,N-ligand XPH-3, catalyzed the reaction of 1-phenylprop-2-yn-1-yl acetate (R
1
 = Ph) 
and (E)-4-(1-phenylprop-1-en-1-yl)morpholine (R
2
 = Ph, R
3
 = Me) in excellent yield 
(94%) and stereoselectivity (>99% ee, >95:5 dr). Reactions with propargylic esters XPH-
1 and enamines XPH-2 bearing a variety of aryl substituents (the R
1
 and R
2
 positions, 
respectively) gave generally high yields and enantioselectivity, while the corresponding 
alkyl substitution led to diminished yield and stereoselectivity. This methodology was  
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also successfully extended to the corresponding cyclic enamines XPH-6, which 
necessitated the use of copper acetate monohydrate and the less sterically demanding 
ligand XPH-6 to achieve appreciable chemoselectivity for alkylation products XPH-8 
(Figure 1.35, Eq. 2).
56
 
 
Previous Reactions of Allyl Silane with ortho-Quinone Methide Intermediates 
 Allyl silanes remain important and versatile reagents in a variety of 
transformations due to the unique reactivity of the olefin imparted by the adjacent silicon 
group. The intrinsic electronic properties of the silicon group help to stabilize -
carbocations and enable the high selectivity of reactions utilizing allyl silanes, which the 
Panek laboratory and others have aimed to exploit.
57
 In light of this selective reactivity, 
allyl silane reagents should serve as complementary reaction partners with reactive ortho-
quinone methide intermediates, though only a few examples have been reported to date. 
 The Hall laboratory demonstrated the use of allyl silane reagents as nucleophiles 
in a reaction with the oQM intermediate generated from an aryldioxaborin ortho-quinone 
methide precursor (Figure 1.36).
58
 The 2-aryl-1,3,2-aryldioxaborin DH-1 was accessed  
Figure 1.36 Example of 1,4-addition of oQM by allyl-TMS 
 
  
42 
through their devised three-component condensation of 3,5-bis(trifluoromethyl)phenyl 
boronic acid, phenol, and hexanal catalyzed by ZrCl4 under mild conditions. Subjection 
of the isolable DH-1 to Lewis acidic conditions generates the requisite oQM 
intermediate, which in the presence of 4 equivalents of allyltrimethylsilane gave the 1,4-
addition product DH-2 in good yield. 
 Allyltrimethylsilane has also been utilized as a competent dienophile in inverse 
electron-demand Diels-Alder (IEDDA) reactions with oQMs. In 2016, the Wang and 
Xiao laboratory reported the CSA-catalyzed reaction of various unactivated dienes with 
in-situ generated oQMs. ortho-Hydroxybenzyl alcohols JX-1 and allyltrimethylsilane 
were subjected to the reaction conditions, successfully yielding the silyl-substituted 
chroman product JX-2 in 51 % yield with a 3:1 dr (Figure 1.37).
59
 
Figure 1.37 Example of IEDDA reaction of oQM and allyl-TMS 
 
 Recent work by the Sajiki laboratory demonstrated the potential for allyl silane to 
utilize both of the aforementioned oQM reaction pathways with the corresponding ortho-
naphthoquinone (oNQM) system derived from 1,4-epoxy-1,4-dihydronaphthalenes 
(Figure 1.38).
60
 Use of the symmetric 1,4-bis(siloxymethyl) substrate HS-1 enabled the 
proposed reaction sequence in which an initial cycloaddition between oNQM 
intermediate HS-3 and allyl-TMS is followed by formation of a p-naphthoquinone 
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methide intermediate HS-6 that undergoes nucleophilic attack by a second equivalent of 
allyl-TMS to furnish dihydronapthopyran product HS-2.  
Figure 1.38 Reaction of o-naphthoquinone methides with allyl-TMS 
 
  
 In this context, we postulated that the unique dual reactivity exhibited by allyl-
TMS could be further exploited in reactions with the corresponding oQM systems and 
ultimately be extended to an asymmetric variant utilizing chiral silane reagents. In 
addition the possbility of two distinct reaction pathways provided the potential 
opportunity to explore what effects the substuition on the oQM precursor would have on 
product formation, which to the best of our knowledge, has only been systematically 
studied by the Rokita laboratory.
11
 Herein, we report an enantioselective FeCl3-promoted 
cycloaddtion and 1,4-addition reaction between a chiral crotyl silane and in-situ 
generated oQMs to access stereodefined benzopyran and 1,4-addition products.  
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Results and Discussion 
Optimization of the [4+2]-Cycloaddition and 1,4-Addition 
 During the preliminary steps of this investigation, initial reaction conditions were 
inspired by the work reported by the Schaus laboratory in which Fe(III) chloride salts 
were utilized to promote the in-situ formation and reaction of oQM intermediates.
61, 62
 
The readily-prepared o-hydroxybenzyl alcohols 1.1 were used as the oQM precursors for 
our studies (Figure 1.39). 
Figure 1.39 Proposed FeCl3-promoted formation of oQMs from o-hydroxybenzyl 
alcohols 
 
 We initiated the study by evaluating the reactivity of the ortho-quinone methide 
generated from 2-(hydroxy(phenyl)methyl) phenol (1.1a) with allyltrimethyl silane 
(Table 1.2). Using anhydrous FeCl3 (0.8 equiv) in the presence of 2,6-lutidine (0.4 equiv) 
in CHCl3 at an initial concentration of 0.5 M yielded only the 1,4-addition, or allylation, 
product in 42% yield as the free phenol 1.3a and 22% as the silylated phenol 1.3b, but no 
cycloaddition product 1.2 was observed (Table 1.2, Entry 1). The reaction concentration 
was lowered to 0.25 M, which resulted in a slight increase in overall yield of the 
allylation products to 78% (Table 1.2, Entry 2). Upon lowering the concentration further 
to 0.1 M, both the cycloaddition and allylation products were isolated in a near 1:1 ratio, 
while shortening the reaction time at the same concentration only modestly increased the  
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Table 1.2 [4+2]-Cycloaddition and 1,4-addition of oQM by allyl-TMS optimization 
 
cycloaddition product yield (Table 1.2, Entries 3 and 4). Gratifyingly, running the 
reaction at 0.05 M increased the overall yield to 92% for products 1.2 and 1.3a after 18 
hours, while a comparable yield was obtained upon shortening the reaction to 1 hour and 
proved to be the most efficient reaction condition (Table 1.2, Entries 5 and 6). 
 We next sought to extend the FeCl3-promoted reaction to the enantioenriched 
(S,E)-silane 1.4 (Table 1.3). Studies were initiated using the optimized reaction condition 
for allyl-TMS, which afforded both the cycloaddition product 1.5a in 51% yield as a 
  
46 
single diastereomer and the crotylation product 1.5b  in 16% yield with 8:1 dr (Table 1.3, 
Entry 1). Cooling the reaction to 0 C gave a noticeably cleaner reaction and an increase 
in overall yield to 71% (Table 1.3, Entry 2). It was noted that the omission of 2,6-lutidine 
resulted in a lower yield and observed baseline byproduct impurities, indicating the  
Table 1.3 [4+2]-Cycloaddition and 1,4-addition of oQM by (S,E)-silane optimization 
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importance of the base for a clean reaction profile (Table 1.3, Entry 4). Subsequent 
attempts to increase the concentration (Table 1.3, Entry 3) and lower the FeCl3 and 2,6-
lutidine loading (Table 1.3, Entries 5-7) at 0 C all led to decreases in overall yield. Thus, 
the optimized condition run at 0 C with 0.8 equivalents of FeCl3 and 0.4 equivalents of 
2,6-lutidine at a concentration of 0.05 M was carried forward to explore the substrate 
scope of the reaction. 
 
Scope of the [4+2]-Cycloaddition and 1,4-Addition of oQMs by (S,E)-Silane 
 A variety of diols containing electron-rich and electron-deficient substituents 
were evaluated and found to be tolerated under the reaction conditions (Figure 1.40). 
Diols bearing electron-donating groups at the meta-position to the oQM methylene (1.1b, 
1.1c) gave comparable overall yields of 78% for the methyl-substituted 1.5b/1.6b 
products and 70% for the methoxy-substituted 1.5c/1.6c products relative to the yields for 
the corresponding products of 1.1a. Interestingly however for substrate 1.1c, it was noted 
that the relative ratio of cycloaddition to crotylation product increased to 10:1, 
respectively, compared to the 5:1 ratio observed for products 1.5a/1.6a and 1.5b/1.6b. 
This observation is consistent with a decrease in the electrophilicity and reactivity of a 
more electron-rich oQM toward nucleophilic addition.
11
 
 Conversely, the strongly electron-withdrawing trifluoro-diol 1.1h favored the 
crotylation over the cycloaddition product (ratio of 1.5h:1.6h = 1:1.3) with comparable 
overall yield. The Lewis basic nitro-substituted diol 1.1i also favored the crotylation  
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Figure 1.40 Scope of [4+2]-cycloaddition and 1,4-addition of oQMs by (S,E)-silane 
 
 
product (ratio of 1.3g:1.4g = 1:5), but necessitated an increased amount of FeCl3 (2.5 
equiv) and 2,6-lutidine (1.25 equiv) to achieve appreciable conversion. Interestingly, the 
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nitro-substituted diol was the only substrate that generated a detectable amount of a 
cycloaddition minor diastereomer product (ratio of 8:1 major to minor), presumably due 
to a competing endo transition state which could be stabilized by secondary orbtial 
overlap interactions with the nitro group (see Proposed Transition State for 
Cycloaddition subsection). Notably, substitution with a halide onto the phenol ring of the 
diphenyl diol substrates (1.1d-f) gave excellent overall yields of up to 96% for the fluoro-
substituted products 1.5f/1.6f with product ratios slightly favoring the cycloaddition 
product.  
 Substitution on the R
2
 aryl ring with a chloro-group at the meta- and para- 
positions (1.1k and 1.1l, respectively) was also well tolerated and gave excellent overall 
yields. However, replacement of the stabilizing R
2
 aryl ring with methyl (1i) dramatically 
lowered the yield obtained due to the decreased stability of the corresponding oQM 
intermediate. Gratifyingly, the addition of the stabilizing bromo-substituent within the 
phenol ring (1.1j) yielded the R
2
-methyl substituted products 1.5j/1.6j in 94% overall 
yield. Interestingly, both R
2
 methyl-substituted crotylation products (1.6j and 1.6i) 
favored the syn-product, which was attributed to the decreased ability of the methyl group 
to dictate the relative orientation of the silane 1.4 within the antiperiplanar transition state 
(see Proposed Transition State for Crotylation subsection also for determination of 
relative stereochemistry). Unfortunately, attempts to extend the substrate scope to the 
dimethyl-substituted 2,(2-hydroxypropan-2-yl)phenol 1.1m yielded none of the desired 
cycloaddition (1.5m) or crotylation (1.6m) products (Figure 1.41). Instead, the 
dimerization product 1.5o was isolated in 83% yield, which was presumed to originate 
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Figure 1.41 Reaction of 2,(2-hydroxypropan-2-yl)phenol with (S,E)-silane 
 
 
from the reaction between oQM intermediate 1.1m-1 and the dehydrated intermediate 
1.1m-2.
63
 
 
 Origin of the Crotylation Product: A Hypothesis 
 Given the possibility that the crotylation products could have arisen from the in-
situ ring-opening of the pyran and concomitant silane elimination (ring-opening reaction) 
of the generated cycloaddition products, the cycloaddition product 1.5a was isolated and 
resubjected to the corresponding reaction conditions at 0 C, at room temperature, as well 
as with an added equivalent of H2O that would have been generated during the formation 
of the oQM intermediate (Figure 1.42, Eqs. 1 and 2). Conversion to the ring-opened (i.e. 
crotylation) product 1.6a was not observed under any of the reaction conditions, which 
indicated the existence of two potentially distinct mechanistic pathways to afford 
products 1.5 and 1.6. 
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Figure 1.42 Resubjection of 1.5a to reaction conditions 
 
 
Ring-Opening Reagent Screen 
 An experimental study was carried out to further probe possible access to the 
crotylation products from the corresponding cycloaddition products. The methyl-
substitued benzopyran 1.5b was isolated and conditions were screened to promote a 
concomitant ring-opening and silicon elimination to access ring-opened product 1.6a 
(Table 1.4). Use of the fluoride ion source TBAF while stirring at room temperature in 
THF gave incomplete conversion even at stoichiometric amounts (Table 1.4, Entries 1 
and 2). Interestingly, a significant portion of the product obtained was the 
thermodynamically favored α,-unsaturated isomer of 1.6b (1:7 and 1:5 ratio of 1.6b-
,γ:1.6b-α,, respectively), which presumably arose from the isomerization of ,γ-
unsaturated 1.6b under the basic reaction conditions. Other fluoride sources such as 
ammonium and cesium fluoride (Table 1.4, Entries 3 and 4) as well as the Lewis acid  
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Table 1.4 Ring-opening of cycloaddition product 1.5b 
 
 
BF3OEt2 (Table 1.4, Entries 5 and 6) gave no reaction while stirring at room 
temperature. The observed lack of reactivity suggested that more forcing conditions were 
necessary to promote the ring-opening and silane elimination reactions. Gratifyingly, 
after switching the solvent to DCE and refluxing the reaction overnight in the presence of 
a stoichiometric amount of BF3OEt2 (15 equiv), ring-opened product 1.6b-,γ was 
isolated in 70% yield (Table 1.4, Entry 7).  The major ring-opened product isolated from 
this reaction matched exactly with the major product obtained from the FeCl3-promoted 
process, which implied an anti-relative configuration of the two vicinal stereocenters of 
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1.6b-,γ (see Characterization Data for FeCl3 and Ring-Opening Reaction Products 
subsection).  Additionally, a new minor product was isolated and identified as the (Z)-
isomer of 1.6b-,γ, which was proposed to form through a potential E1 elimination of the 
silane moiety (see Origin of (Z)-isomer subsection). When utilizing the stronger Lewis 
acid TiCl4, an optimal yield of 75% with a 3:1 mixture of E:Z isomers was achieved after 
stirring for only 3 hours at room temperature (Table 1.4, Entry 8). 
 With the optimized reaction conditions in hand, we then sought to extend the ring-
opening-reaction to utilize the crude product mixture obtained from the FeCl3-promoted 
reactions of 1.1 and 1.4. Fortunately, when subjecting the crude product mixture obtained 
from the reaction of 1.1a and 1.4 to the TiCl4-mediated ring-opening reaction conditions, 
1.6a was obtained in 61% yield over two steps (Figure 1.43). Good overall yields were 
obtained for substrates bearing electron-donating substituents (1.1b and 1.1c) and 
demonstrated a unique approach to formally access 1,4-addition products despite the 
tendency for an electron-rich parent oQM to discourage nucleophilic addition. Substrates 
with halide substituents in the diphenyl diol series (1.1d, 1.1e, and 1.1f) performed well 
under the crude ring-opening conditions, in accordance with the high overall yields  
observed in the initial FeCl3-promoted reactions. While the electron-poor nitro-
substituted diol 1.1g gave a good overall yield, reaction of the trifluoromethyl-substituted 
1.1h unfortunately resulted in a complex mixture of byproducts. After consulting the 
literature, it was proposed that the observed reactivity issue could be due to the potential 
incompatibility of the TiCl4 promoter and the trifluoromethyl-tolyl moiety, which may 
undergo a defluorination side reaction.
64
 Reaction of R
2 
methyl-substituted substrates (1i  
  
54 
Figure 1.43 Scope of TiCl4-mediated crude ring-opening reaction 
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and 1j) also demonstrated the importance of the initial FeCl3-promoted reaction for the 
success of the subsequent ring-opening process and provided a method to selectively 
access vicinal methyl tertiary stereocenters. Crotylation products containing two aryl 
halide moieties (1.6k and 1.6l) were isolated in excellent yields and were envisioned to 
enable future elaboration of the crotylation products in a divergent fashion. 
 
Proposed Transition State for Cycloaddition and Modeling Studies 
 The stereochemical outcome of the [4+2]-cycloaddition between the in-situ 
generated o-quinone methide from diol 1.1 and (S,E)-silane 1.4 was rationalized by 
considering the four proposed transition states (Figure 1.44). For all cases, the preferred 
conformation of 1.4 positions the carbon bearing the silicon stereocenter such that the 
smallest group (H) orients into a position that minimizes the eclipsing interaction with the 
adjacent alkene and should result in an anti addition of the (S,E)-crotyl silane.
65
 It was 
also expected that the (E)-alkene geometry of the silane should be preserved in the 
product if the transformation occured in a concerted fashion.  Both exo transition state 
models (TS 1 and TS 2) and endo transition state models (TS 3 and TS 4) were 
considered. 
 Based on the steric constraints of the sterically demanding dimethylphenyl silane 
moiety and a presumed concerted cycloaddition reaction, it was expected that an exo 
transition state (TS 1 and TS 2) would be favored with retention of the (E)-alkene 
geometry, giving rise to a cis-trans relative bond construction of the pyran ring of 1.5. 
Indeed, coupling constant values between the benzylic proton on the carbon bearing the  
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Figure 1.44 Proposed transition states for the [4+2]-cycloaddition leading to 
benzopyran 1.5 
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R
2
 stereocenter (H8) and the adjacent proton on the carbon bearing the methyl 
stereocenter (H6) indicated a cis bond construction for all cycloaddition products 1.5 (J = 
4.8 to 5.4 Hz). In addition, coupling constant values observed between proton H6 and the 
adjacent anomeric proton (H5) indicated a trans relationship for all cycloaddition 
products 1.5 (J = 9.0 to 10.0 Hz), which supported the notion of a concerted 
cycloaddition with retention of the silane starting material (E)-olefin geometry. 
 To provide further evidence that the observed coupling constants were consistent 
with a cis-trans configuration of the pyran ring of 1.5, DFT optimizations (B3LYP/6-
31g**) were performed on cycloadduct 1.5c (R
1 
= OMe) to determine the lowest energy 
conformers for each of the proposed diastereomers (Figure 1.45). From the lowest-energy 
optimized conformers, the dihedral angles were measured between protons H8 and H6 and 
used to approximate the corresponding coupling constants (Table 1.5). The lowest energy 
conformers for diastereomers 1.5c and 1.5c-1 showed dihedral angles of absolute value 
47 and 46, respectively, which would give approximate coupling constants within 4 to 
6 Hz. Gratifyingly, the experimentally observed JH8/H6 value of 5.3 Hz for 1.5c, which 
corroborates a cis relative bond configuration, was in agreement with the predicted 
values. Conversely, the lowest energy conformer for diastereomers 1.5c-2 and 1.5c-3 
showed corresponding dihedral angles with absolute values 171 and 170, respectively, 
and would indicate far larger coupling constants in the 12 to 13 Hz range. The dihedral 
angles were then measured between protons H6 and H5 for each diastereomer. As 
expected, the lowest energy conformers for all four diastereomers showed dihedral angles 
with absolute value in the 170 to 175 range, which predicted coupling constants in the 
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Figure 1.45 Lowest-Energy Optimized Conformer for Diastereomers 1.5c, 1.5c-1, 
1.5c-2, and 1.5c-3 
 
 
 
Table 1.5 Predicted Dihedral Angle between H8/H6 and H6/H5 with J Values for each 
Energy-Optimized Conformer vs. Observed J values for 1.5c 
Conformer 
(Modeled) 
Predicted 
Dihedral Angle 
H8/H6 
JH8/H6 (Hz) 
Predicted 
Dihedral Angle 
H6/H5 
JH6/H5 (Hz) 
1.5c -47 4 to 6 -170 12 to 13 
1.5c-1 46 4 to 6 170 12 to 13 
1.5c-2 171 12 to 13 171 12 to 13 
1.5c-3 -170 12 to 13 -175 12 to 13 
Observed for 
1.5c 
n/a 5.3 n/a 10.4 
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12 to 13 Hz range and is in the vicinity of the relatively large 10.4 Hz  JH6/H5 value 
observed for 1.5c.  
 Unfortunately, crystal growth attempts were unsuccessful and thus the absolute 
configuration of the cycloaddition product was unable to be determined. However, based 
on the well-established anti mode of addition of enantioenriched crotyl silanes to 
electrophiles, addition to the oQM was predicted to occur such that the (S,E)-silane 
approaches via the top face of the oQM (TS 1), favoring diastereomer 1.5 over 1.5.1.
65
 
 
Proposed Transition State for Crotylation and Cyclization Study 
 The stereochemical outcome of the crotylation reaction between the in-situ 
generated oQM from diol 1.1 and (S,E)-silane 1.4 was rationalized by considering the 
proposed transition state (Figure 1.46). The antiperiplanar addition of the (S,E)-silane 
minimizes the interaction between the terminal methyl group of the silane reagent and the 
R
2
 group of the oQM, resulting in the favored anti-stereochemistry for all substrates 
except for products 1.6i and 1.6j.
65
 The observed syn selectivity for these two substrates  
was attributed to the decrease in size of the methyl group, which induced less steric bias 
compared to the larger aryl substituents. 
Figure 1.46 Proposed Transition State for the Crotylation for 1.6 
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 In order to confirm the anti relative stereochemistry of the majority of products 
1.6 obtained from the FeCl3-promoted crotylation reaction, the chloro-substituted 
crotylation product 1.6e was isolated and cyclized through a two step sequence (Figure 
1.47). Initial epoxidation with mCPBA gave the isolated epoxide 1.7 in 58% yield, which 
was subsequently cyclized under basic conditions to afford benzopyran 1.8 in 43% yield 
and 5:1 dr. Fortunately, the observed coupling constant between H8 and H6 of 5.3 Hz for 
1.8 matched that of the corresponding chloro-substituted cycloaddition product 1.5e, thus 
supporting the assignment of the anti relative configuration of crotylation product 1.6e.  
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Figure 1.47 Cyclization of 1.6e to confirm relative stereochemistry 
 
 In addition, further evidence of an anti-relative configuration was previously 
alluded to in the ring-opening reaction discussion section. The 
1
H NMR spectra of the 
major products obtained for the ring-opened crotylation products 1.6 were found to 
exactly match the spectra obtained for the major crotylation products of the FeCl3-
promoted reaction (except for R
2
 = Me substrates 1.6i and 1.6j). Therefore, given that a 
cis-relative configuration existed between the [4+2]-cycloaddition products' benzylic 
proton (H8) and the adjacent proton on the carbon bearing the methyl stereocenter (H6), 
an anti-relative configuration was expected for the major crotylation products of the ring-
opening reaction. 
 
Proposed Origin of (Z)-isomer from Ring-opening Reaction 
 As previously mentioned during the ring-opening studies, a new minor (Z)- 
isomer was observed for the isolated ring-opened crotylation products 1.6. To ensure that 
the minor (Z)-isomer did not originate from a potential isomerization of the initially 
generated crotylation product from the FeCl3 promoted reaction, 1.6d was isolated as the 
(E)-isomer and subjected to the TiCl4 promoted ring-opening conditions (Figure 1.48, Eq. 
1). Fortunately, the recovered product showed no evidence of isomerization and retained 
the original 30:1 dr. In a second experiment to test other potential isomerization  
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Figure 1.48 Resubject crotylation product to ring-opening conditions 
 
 
pathways, 1.6d was isolated from the crude ring-opening reaction between 1.1d and 
silane 1.4 as a mixture of 4:1 (E):(Z)-isomers and resubjected to the ring-opening 
conditions (Figure 1.48, Eq. 2).  Erosion of the original isomeric ratio was not observed, 
which provided further evidence that the minor (Z)-isomer originated from the ring-
opening of the cycloaddition product. 
 On the basis of these experiments, two competing mechanistic pathways were 
proposed to account for the observed mixture of (E) and (Z)-products 1.6 from the ring-
opening reaction (Figure 1.49). By considering the lowest-energy optimized conformer of 
cycloaddition product 1.5c from the previous modeling studies, the generation of the (E)-
isomer of 1.5c was proposed to occur if the ring-opening and silane elimination process 
occurred via an E2-type elimination. Rotation of the indicated carbon bond would align  
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Figure 1.49 Proposed mechanisms for the ring-opening reaction 
 
 
the carbon-silicon bond anti relative to the carbon-oxygen bond of the pyran ring, 
facilitating elimination to provide the favored (E)-olefin geometry. However, if the ring-
opening and silane elimination occurred through a presumed E1-type elimination, 
formation of the (Z)-isomer would be possible. An additional observation to support a 
potential E1-type process was the observed differences in the obtained (Z):(E) product 
ratios during the ring-opening optimization study, where the stronger Ti(IV) Lewis acid 
produced a higher ratio of the (Z):(E)-isomer than the BF3OEt2-mediated reaction (1:3 
and 1:21, respectively). 
 
Selected Chiral HPLC Study 
 To confirm that the cycloaddition and crotylation products were obtained with an 
anticipated complete transfer of chirality from the starting enantioenriched (S,E)-silane 
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1.4 ( >95% ee), a series of selected substrates were analyzed by chiral HPLC (Figure 
1.50).
66
 Unfortunately, the enantiomers of cycloaddition products 1.5 did not separate on  
Figure 1.50 Chiral HPLC study of selected substrates 
 
any of the tested chiral columns, necessitating the reduction to alcohols 1.9. As expected, 
all substrates tested gave enantiomeric ratios consistent with the starting enantiopurity of 
1.4. Additionally, crotylation products 1.6a-c from both the FeCl3 and ring-opening 
reactions were analyzed by chiral HPLC and showed >99:1 er. 
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Conclusion 
 In conclusion, we have successfully developed a highly stereoselective 
cycloaddition and crotylation reaction of in-situ generated ortho-quinone methides with 
an enantioenriched chiral (S,E)-crotyl silane reagent in the presence of the readily 
available promoter FeCl3. This methodology was applied to a wide variety of 
electronically diverse aryl-substituted ortho-hydroxybenzyl alcohols and gave good-to-
excellent overall yields for both the cycloaddition and crotylation product. The substrate 
scope could also be extended to include benzylic-methyl substitution, though additional 
stabilization through bromo-substitution of the phenol ring was needed to achieve 
appreciable overall yield. Ultimately, the relative ratio of cycloaddition to crotylation 
product for the substrates tested showed a tendency for electron-poor substrates to 
encourage the crotylation over the cycloaddition process, while the converse was true for 
their electron-rich counterparts, and was consistent with earlier studies conducted by the 
Rokita laboratory.
11
  
 Through resubjection of the cycloaddition product to the FeCl3-promoted reaction 
conditions, we determined that the isolated crotylation products did not arise from the 
ring-opening of the generated cycloaddition products under the reaction conditions. This 
result indicated the presence of two distinct reaction pathways in which the (S,E)-silane 
was proposed to guide both the highly selective cycloaddition reaction through an anti 
addition to the ortho-quinone intermediate via an exo transition state as well as the 
crotylation reaction through an antiperiplanar, open transition state. 
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 A TiCl4-mediated ring-opening reaction sequence was subsequently developed 
that utilized the crude product mixture from the FeCl3-promoted reaction to provide 
selective access to the crotylation products. Consistent with the overall yields obtained 
from the corresponding initial FeCl3-promoted reactions, good to excellent yields were 
obtained for the ring-opened crotylation products containing vicinal tertiary carbon 
stereocenters, illustrating a new facile method to selectively access these stereochemical 
motifs. 
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Experimental 
General Information 
All 
1
H and 
13
C NMR spectra were taken in CDCl3 and C6D6 at 400 or 500 MHz (as 
indicated, respectively) using a Varian 500 MHz VNMR spectrometer at ambient 
temperature. Chemical shifts are reported as major diastereomer and/or alkene isomer, 
unless otherwise noted, in parts per million using the solvent internal standard 
(chloroform: 7.26 for 
1
H NMR and 
13
C NMR 77.2 ppm, benzene: 7.16 ppm for 
1
H 
NMR). Data are reported as follows: chemical shift, multiplicity (s = singlet, d = doublet, 
t = triplet, q = quartet, m = multiplet, br = broad), coupling constant, integration. Infrared 
resonance spectra were recorded on a Nexus 670 FT-IR spectrometer. Optical rotations 
were recorded on a Rudolph Autopol II digital polarimeter at 25 C and 589 nm and 
reported as follows:     
  (concentration in g/100 mL of CH2Cl2). High resolution mass-
spectra were obtained on a Waters Q-TOF Mass Spectrometer at Boston University 
Chemical Instrumentation Center (CIC). A Chiralpak AD-H (Chiral Technologies Inc., 
150 x 4.60 mm I.D.) column was used for enantiomeric ratio determination. All reactions 
were carried out in oven or flame-dried glassware under argon atmosphere, unless 
otherwise noted. Dichloromethane, diethyl ether, toluene, and tetrahydrofuran were 
obtained from a dry solvent system (alumina) and used without further drying. 
Anhydrous chloroform stabilized with amylenes was purchased from Sigma Aldrich and 
was used without further purification. Allyltrimethyl silane was purchased from Gelest 
and used without further purification. Anhydrous FeCl3 was purchased from Sigma 
Aldrich and used without further purification. 2,6-lutidine was distilled over AlCl3 and 
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stored over 4 Å molecular sieves. All other reagents were purchased from Sigma Aldrich, 
Alfa Aesar, Gelest, and Oakwood and used as supplied. Unless otherwise noted, reactions 
were magnetically stirred and monitored by thin layer chromatography with Macherey 
Nagel Polygram 0.20 mm silica gel 60 Å plates. Flash chromatography was performed 
using ZEOprep 60 ECO 32-63 μm ZEOCHEM silica gel 
 
Preparation of Starting Materials 
A) Preparation of (S,E)-silane 
 
Methyl (S,E)-3-(dimethyl(phenyl)silyl)hex-4-enoate (1.4): 
Prepared according to the procedure by Panek, et. al.
66
 
 
B) General procedure for preparation of diols from salicylaldehyde derivatives 
 
To a solution of salicylaldehyde (1 mL, 10 mmol, 1 equiv) in Et2O (50 mL) at 0 °C was 
added a solution of phenylmagnesium bromide in Et2O (30 mmol, 3 equiv) dropwise. The 
reaction was then removed from ice and stirred for 2 hours at rt and monitored by TLC in 
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5:1 Hexanes:EtOAc. Upon completion, the reaction was then quenched at 0 °C with 
saturated aqueous NH4Cl solution. It was then extracted with Et2O (3 x 25 mL) and the 
combined organic layers were washed with brine, dried over MgSO4, filtered, and 
concentrated. Purification by silica gel chromatography yielded the product as an off-
white solid. The diols were stored under argon in a -70 C freezer. 
 
The general procedure was utilized to prepare diols 1a-1f and 1h-1j from the 
corresponding salicylaldehyde derivative in accordance with reported literature.
67, 68,69, 70, 
61, 71 
 
4-bromo-2-((4-chlorophenyl)(hydroxy)methyl)phenol (1.1k): 
Prepared by the General Procedure for the Preparation of Diols using 
5-bromosalicyclaldehyde (1.0004 g, 4.97 mmol, 1 equiv) and 4-
chlorophenylmagnesium bromide solution (39.80 mmol, 8 equiv) for 
3 hours at rt. Purification by silica gel chromatography (15:1 to 5:1 
Hexanes:EtOAc) yielded product 1.1k as a white solid (1.2105 g, 
78% yield). 
1
H NMR (500 MHz, CDCl3): δ7.72 (br s, 1H), 7.36-7.27 (overlap, 5H), 7.00 (d, J = 2.4 
Hz, 1H),  6.76 (d, J = 8.6 Hz, 1H), 5.92 (s, 1H), 3.10 (d, J = 16.6 Hz, 1H); 
13
C NMR 
(125 MHz, CDCl3): δ154.5, 139.7, 134.5, 132.4, 130.7, 129.2, 128.5, 128.3, 126.9, 119.3, 
112.2, 75.7; IR (thin film, cm
-1) νmax: 3315, 1579, 1483, 1417, 1362, 1271, 1237, 1166, 
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1109, 1091, 1013, 886, 816, 765, 722, 661, 625; HRMS (m/z): [M-H]
-
 calculated for 
C13H10BrClO2 310.9474, found 310.9462; Melting Point: 101 - 105 C. 
 
4-bromo-2-((3-chlorophenyl)(hydroxy)methyl)phenol (1.1l): 
Prepared by the General Procedure for the Preparation of Diols 
using 5-bromosalicyclaldehyde (3.0153 g, 15 mmol, 1 equiv) and 3-
chlorophenylmagnesium bromide solution (120 mmol, 8 equiv) for 
6 hours at rt. Purification by silica gel chromatography (15:1 to 10:1 
to 5:1 Hexanes:EtOAc) yielded product 1.1l as a white solid (1.9651 g, 42% yield). 
1
H NMR (500 MHz, CDCl3): δ7.59 (br s, 1H), 7.39 (s, 1H), 7.32-7.29 (overlap, 3H), 7.23 
(m, 1H), 7.03 (d, J = 2.4 Hz), 6.78 (d, J = 8.6 Hz, 1H), 5.92 (d, J = 2.4 Hz, 1H), 2.98 (br 
s, 1H); 
13
C NMR (125 MHz, CDCl3): δ154.5, 143.3, 134.9, 132.5, 130.8, 130.3, 128.8, 
128.3, 127.0, 125.0, 119.4, 112.3, 75.7; IR (thin film, cm
-1) νmax: 3304, 1596, 1575, 1483, 
1416, 1363, 1271, 1236, 1191, 1166, 1109, 1079, 1017, 882, 816, 786, 761, 692, 622; 
HRMS (m/z): [M-H]
-
 calculated for C13H10BrClO2 310.9474, found 310.9474; Melting 
Point: 70 - 77 C. 
 
C) Procedure for the preparation of the R = NO2 diol
72
 
 
2-(hydroxy(phenyl)methyl)-4-nitrophenol (1.1g): 
  
71 
The ketone precursor to 1g was prepared according to the procedure by Xu, B.; et. al. To 
a solution of the ketone precursor (0.519 g, 2.14 mmol, 1 equiv) in EtOH (21 mL) was 
added NaBH4 (0.081 g, 0.21 mmol, 0.1 equiv) at rt. The reaction was stirred at rt for 1 h 
and monitored by TLC in 3:1 Hexanes:Et2O. Upon completion, the EtOH was removed 
by rotary evaporation and the residue was redissolved in water and Et2O. The reaction 
was then quenched with saturated aqueous NH4Cl solution. It was then extracted with 
Et2O (3 x 25 mL) and the combined organic layers were washed with brine, dried over 
MgSO4, filtered, and concentrated. Purification by silica gel chromatography (3:1 to 1:1 
Hexanes:EtOAc) yielded 1.1g (0.3888g, 1.59 mmol, 74% yield) as a white solid. 
 
1
H NMR (500 MHz, CDCl3): δ9.11 (s, 1H), 8.10 (dd, J = 9.0, 2.7 Hz, 1H), 7.79 (d, J = 
2.7 Hz, 1H), 7.44-7.35 (overlap, 5H), 6.98 (d, J = 9.0 Hz, 1H), 6.11 (d, J = 2.0 Hz, 1H), 
2.98 (d, J = 2.6 Hz, 1H); 
13
C NMR (125 MHz, CDCl3): δ161.8, 140.7, 129.4, 129.3, 
126.3, 127.0, 126.6, 125.6, 124.7, 118.1; IR (thin film, cm
-1) νmax: 3290, 2925, 1619, 
1591, 1522, 1492, 1336, 1285, 1086, 1017, 943, 914, 840, 752, 699, 639, 602; HRMS 
(m/z): [M-H]
-
 calculated for C13H11NO4 244.0610, found 244.0606; Melting Point: 114 - 
118 C. 
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General Procedure for FeCl3/2,6-Lutidine-Promoted Cycloaddition + 1,4-Addition 
Reaction of Diols 1.1 with Chiral Crotyl Silane 1.4 
 
To a solution of 1.1 (0.25 mmol) and 1.4 (0.131 g, 0.50 mmol, 2 equiv) in anhydrous 
CHCl3 (5 mL) at 0 C was added anhydrous FeCl3 (0.8 equiv) and 2,6-lutidine (0.4 
equiv) for all substrates except for NO2-diol 1.1g, which required 2.5 equiv of FeCl3 and 
1.25 equiv of 2,6-lutidine. The reaction was stirred for 1 or 3 h and monitored by TLC in 
5:1 or 3:1 Hexanes:EtOAc. Upon completion, the reaction was quenched with saturated 
aqueous NaHCO3 solution. It was then extracted with EtOAc (3 x 25 mL) and the 
combined organic layers were washed with brine, dried over MgSO4, filtered, and 
concentrated. Purification by silica gel chromatography yielded products 1.5 and 1.6. 
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General Procedure for the TiCl4-promoted Ring-Opening/Silicon Elimination Reaction 
of the Crude Product Mixture of 1.5 and 1.6 
 
 
The General Procedure for FeCl3/2,6-Lutidine-Promoted Cycloaddition + 1,4-Addition 
of Diols 1.1 with Chiral Crotyl Silane 1.4 was followed to produce the crude product 
mixture of 1.5 and 1.6. To the crude product mixture of 1.5 and 1.6 (original SM diol = 
0.25 mmol, 1 equiv) at 0 C was added a solution of TiCl4 in DCM (1.0 M, 0.75 mL, 0.75 
mmol, 3 equiv). The reaction was warmed to rt, stirred for 3 hours at rt, and monitored by 
TLC in 5:1 Hexanes:EtOAc. Upon completion, the reaction was then quenched at 0°C 
with saturated aqueous NH4Cl solution. It was then extracted with DCM (3 x 25 mL) and 
the combined organic layers were washed with brine, dried over MgSO4, filtered, and 
concentrated. Purification by silica gel chromatography yielded product 1.6.  
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Characterization Data for FeCl3 and Ring-Opening Reaction Products 
General Notes:  
1) The crotylation product 1.6 was obtained separately from the two General Procedures:  
a. General Procedure for the FeCl3/2,6-Lutidine-Promoted Cycloaddition + 1,4-Addition 
of Diols 1.1 with Chiral Crotyl Silane 1.4 
b.  General Procedure for the TiCl4-promoted Ring-Opening/Silicon Elimination of the 
Crude Product Mixture of 1.5 and 1.6.  
 
2) To illustrate that the major products of 1.6 obtained from both General Procedures 
were the same for all substrates except for 1.5i/1.6i and 1.5j/1.6j, a series of selected 
substrates (1.6a, 1.6d, and 1.6e) was fully analyzed for the products obtained from both 
the FeCl3/2,6-Lutidine-Promoted reaction (data labeled "FeCl3") as well as the TiCl4-
promoted Ring-Opening/Silicon Elimination reaction (data labeled "Ring-Opening "). 
The spectral data provided for these substrates are of:  
A) the mixture of major/minor product of 1.6 obtained from the FeCl3 reaction 
B) the mixture of major/minor product of 1.6 obtained from the Ring-Opening reaction 
C) the isolated major product of 1.6 from the Ring-Opening  reaction 
D) the isolated minor product of 1.6 from the Ring-Opening reaction.  
Unfortunately, the FeCl3 reaction major and minor products of 1.6 were inseparable by 
chromatography, but their alkene peaks for substrates 1.6d and 1.6e from the FeCl3 
reaction were resolved when using C6D6 for the 
1
H NMR of the mixture of FeCl3 reaction 
major/minor of 1.6d and 1.6e. 
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3) For all other derivatives of 1.6, spectral data provided are from the Ring-Opening 
reaction. 
 
4) 
1
H NMR spectra of 1.6 were also taken in C6D6 in order to resolve alkene coupling 
constants. This allowed for the tentative assignments of the major product for both the 
FeCl3 and Ring-Opening reaction ((E)-anti isomer), the minor product for the FeCl3 
reaction ((E)-syn isomer), and the minor product for the Ring-Opening reaction ((Z)-anti 
isomer) for all substrates except for the R
2
 = Me products 1.5i/1.6i and 1.5j/1.6j in which 
the FeCl3 reaction major products were determined to be the (E)-syn isomer over the (E)-
anti isomer. 
 
5) For 1.1e, both general procedures were run at a 1.0 mmol scale. 
 
Methyl (S)-3-(dimethyl(phenyl)silyl)-3-((2R,3R,4R)-3-methyl-4-phenylchroman-2-
yl)propanoate (1.5a): 
Prepared by the General Procedure for FeCl3/2,6-Lutidine-
Promoted reaction. Purification by silica gel 
chromatography (80:1 to 50:1 to 7:1 Pet Ether:EtOAc) 
afforded 1.5a as a clear oil (65.0 mg, 59% yield) and single 
diastereomer.     
   = -195.2 (c = 1.0, CH2Cl2). 
1
H NMR (500 MHz, CDCl3): δ7.57-
7.55 (overlap, 2H), 7.39-7.32 (overlap, 3H), 7.16-7.12 (overlap, 4H), 6.90-6.85 (overlap, 
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2H), 6.79-6.76 (overlap, 3H), 4.06 (dd, J = 9.9, 2.7 Hz, 1H), 3.96 (d, J = 5.3 Hz, 1H), 
3.53 (s, 3H), 2.60 (dd, J = 15.9, 5.0 Hz, 1H), 2.47 (dd, J = 15.9, 8.1 Hz, 1H), 2.25 (m, 
1H), 1.67 (ddd, J = 7.9, 5.0, 2.7 Hz, 1H), 0.70 (d, J = 7.0 Hz, 3H), 0.49 (s, 3H), 0.42 (s, 
3H); 
13
C NMR (125 MHz, CDCl3): 174.7, 153.6, 142.2, 137.8, 134.3, 130.4, 130.3, 
129.1, 127.8, 127.8, 127.8, 126.3, 124.9, 120.3, 116.3, 76.5, 51.7, 46.8, 32.4, 29.3, 24.4, 
14.8, -3.0, -3.1; IR (thin film, cm
-1) νmax: 2953, 1735, 1586, 1485, 1456, 1427, 1245, 
1223, 1120, 1017, 973, 837, 815, 774, 753, 701; HRMS (m/z): [M+H]
+
 calculated for 
C28H32O3Si 445.2199, found 445.2213; Melting Point: 129 - 137 C. 
 
 
Methyl (5S,6R,E)-6-(2-hydroxyphenyl)-5-methyl-6-phenylhex-3-enoate (1.6a): 
Prepared by the General Procedure for FeCl3/2,6-
Lutidine-Promoted reaction. Purification  by silica gel 
chromatography (80:1 to 50:1 to 7:1 Pet Ether:EtOAc) 
afforded 1.6a as a yellow residue (9.1 mg, 12% yield) 
with er >99:1 and dr 22:1. Also prepared and analyzed by the General Procedure for the 
TiCl4-promoted Ring-Opening/Silicon Elimination reaction. Purification by silica gel 
chromatography (7:1 Hexanes:EtOAc) afforded 1.6a as a white solid (47.6 mg, 61% 
yield) with er >99:1, E:Z ratio: 3:1, and dr 16:1.     
   = +10.8 (c = 1.0, CH2Cl2). 
A) Mixture of major/minor product of 1.6a obtained from the FeCl3 reaction: 
1
H NMR (500 MHz, CDCl3): δ7.32 (dd, J = 7.7, 1.5 Hz, 1H), 7.25-7.21 (overlap, 4H), 
7.12 (m, 1H), 7.05 (td, J = 7.9, 1.6 Hz, 1H), 6.91 (td, J = 7.5, 1.1 Hz, 1H), 6.70 (dd, J = 
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8.0, 1.1 Hz, 1H), 5.46-5.39 (overlap, 2H), 4.68 (br s, 1H), 4.07 (d, J = 10.5 Hz, 1H), 3.60 
(s, 3H), 3.11 (m, 1H), 2.93-2.84 (overlap, 2H), 1.03 (d, J = 6.6 Hz, 3H); 
1
H NMR (500 
MHz, C6D6): δ7.30-7.28 (overlap, 2H), 7.21 (dd, J = 7.6, 1.7 Hz, 1H), 7.13-7.10 (overlap, 
2H), 6.97 (m, 1H), 6.88 (td, J = 7.7, 1.7 Hz, 1H), 6.81 (td, J = 7.5, 1.3 Hz, 1H), 6.16 (dd, 
J = 7.9, 1.3 Hz, 1H), 5.52 (dtd, J = 15.1, 6.8, 1.0 Hz, 1H), 5.36 (ddt, J = 15.5, 7.6, 1.4 Hz, 
1H), 4.21 (d, J = 10.7 Hz, 1H), 3.99 (br s, 1H), 3.24 (s, 3H), 3.02 (m, 1H), 2.71-2.61 
(overlap, 2H), 1.04 (d, J = 6.6 Hz, 3H); 
13
C NMR (125 MHz, CDCl3): 172.5, 153.4, 
143.4, 138.9, 130.4, 128,9, 128.6, 128.3, 127.2, 126.2,  121.6, 121.2, 116.1, 51.8, 50.4, 
39.8, 38.1, 29.9, 19.4 
 
B) Mixture of major/minor product of 1.6a obtained from the Ring-Opening reaction: 
1
H NMR (500 MHz, CDCl3): δ7.32 (dd, J = 7.7, 1.6 Hz, 1H), 7.28-7.19 (overlap, 4H), 
7.12 (m, 1H), 7.05 (td, J = 7.7, 1.6 Hz, 1H), 6.91 (td, J = 7.6, 1.2 Hz, 1H), 6.70 (dd, J = 
8.0, 1.2 Hz, 1H), 5.47-5.40 (overlap, 2H), 4.84 (br s, 1H), 4.08 (d, J = 10.5 Hz, 1H), 3.60 
(s, 3H), 3.11 (m, 1H), 2.93-2.85 (overlap, 2H), 1.03 (d, J = 6.6 Hz, 3H); 
13
C NMR (125 
MHz, CDCl3): 172.7, 153.4, 139.0, 130.4, 128.9, 128.6, 128.3, 127.2, 126.1, 121.5, 
121.0, 116.0, 51.9, 50.4, 39.8, 38.1, 19.4; IR (thin film, cm
-1) νmax: 3409, 2954, 1712, 
1598, 1497, 1454, 1438, 1406, 1333, 1267, 1212, 1167, 1114, 971, 813, 736, 699; 
HRMS (m/z): [M-H]
-
 calculated for C20H22O3 309.1491, found 309.1487. 
C) Isolated major product of 1.6a from the Ring-Opening reaction: 
1
H NMR (500 MHz, CDCl3): δ7.32 (dd, J = 7.7, 1.3 Hz, 1H), 7.27-7.20 (overlap, 4H), 
7.12 (m, 1H), 7.05 (td, J = 7.8, 1.5 Hz, 1H), 6.91 (td, J = 7.5, 1.0 Hz, 1H), 6.70 (dd, J = 
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8.0, 0.8 Hz, 1H), 5.48-5.40 (overlap, 2H), 4.92 (br s, 1H), 4.08 (d, J = 10.5 Hz, 1H), 3.60 
(s, 3H), 3.11 (m, 1H), 2.93-2.85 (overlap, 2H), 1.03 (d, J = 6.6 Hz, 3H); 
1
H NMR (500 
MHz, C6D6): δ7.32-7.30 (overlap, 2H), 7.21 (dd, J = 7.6, 1.5 Hz, 1H), 7.13-7.10 (overlap, 
2H), 6.97 (m, 1H), 6.89 (td, J = 7.7, 1.7 Hz, 1H), 6.81 (td, J = 7.5, 1.3 Hz, 1H), 6.22 (d, J 
= 7.9 Hz, 1H), 5.52 (dtd, J = 15.1, 6.8, 1.0 Hz, 1H), 5.37 (ddt, J = 15.5, 7.6, 1.4 Hz, 1H), 
4.30 (br s, 1H), 4.24 (d, J = 10.8 Hz, 1H), 3.23 (s, 3H), 3.03 (m, 1H), 2.70-2.60 (overlap, 
2H), 1.05 (d, J = 6.6 Hz, 3H). 
D) Isolated minor product of 1.6a from the Ring-Opening reaction: 
1
H NMR (500 MHz, CDCl3): δ7.37-7.34 (overlap, 2H), 7.24-7.18 (overlap, 3H), 7.11 (m, 
1H), 7.06 (td, J = 7.7, 1.6 Hz, 1H), 6.93 (td, J = 7.5, 1.3 Hz, 1H), 6.71 (dd, J = 8.0, 1.1 
Hz, 1H), 5.44-5.36 (overlap, 2H), 4.71 (br s, 1H), 4.08 (d, J = 10.5 Hz, 1H), 3.66 (s, 3H), 
3.34 (m, 1H), 3.08 (dd, J = 16.8, 6.2 Hz, 1H), 2.86 (dd, J = 16.8, 5.4 Hz, 1H), 1.00 (d, J 
= 6.6 Hz, 3H); 
1
H NMR (500 MHz, C6D6): δ7.30-7.28 (overlap, 2H), 7.21 (dd, J = 7.6, 
1.6 Hz, 1H), 7.10-7.07 (overlap, 2H), 6.96 (m, 1H), 6.90 (td, J = 7.9, 1.7 Hz, 1H), 6.83 
(td, J = 7.5, 1.3 Hz, 1H), 6.18 (dd, J = 7.9, 1.2 Hz, 1H), 5.47 (dtd, J = 10.9, 7.3, 0.9 Hz, 
1H), 5.33 (ddt, J = 11.4, 9.8, 1.7 Hz, 1H), 4.18 (d, J = 10.7 Hz, 1H), 4.10 (br s, 1H), 3.32 
(m, 1H), 3.29 (s, 3H), 2.97 (ddd, J = 16.7, 7.7, 1.7 Hz, 1H), 2.76 (ddd, J = 16.7, 6.8, 1.8 
Hz, 1H), 1.00 (d, J = 6.6 Hz, 3H). 
 
Methyl (S)-3-(dimethyl(phenyl)silyl)-3-((2R,3R,4R)-3,6-dimethyl-4-phenylchroman-
2-yl) propanoate (1.5b): 
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Prepared by the General Procedure for FeCl3/2,6-
Lutidine-Promoted reaction. Purification  by silica gel 
chromatography (80:1 to 50:1 to 7:1 Hexanes:EtOAc) 
afforded 1.5b as a white solid (73.7 mg, 64% yield) and 
single diastereomer.     
   = -167.2 (c = 1.0, CH2Cl2). 
1
H NMR (500 MHz, CDCl3): δ7.57-7.56 (overlap, 2H), 7.39-7.32 (overlap, 3H), 7.15-
7.13 (overlap, 3H), 6.95 (d, J = 7.0 Hz, 1H), 6.80-6.78 (overlap, 3H), 6.66 (s, 1H), 4.03 
(dd, J = 9.9, 2.2 Hz, 1H), 3.91 (d, J = 5.2 Hz, 1H), 3.53 (s, 3H), 2.60 (dd, J = 15.8, 4.9 
Hz, 1H), 2.47 (dd, J = 15.7, 8.0 Hz, 1H), 2.22 (m, 1H), 2.16 (s, 3H), 1.66 (ddd, J = 8.3, 
5.0, 2.8 Hz, 1H), 0.68 (d, J = 6.9 Hz, 3H), 0.49 (s, 3H), 0.41 (s, 3H); 
13
C NMR (125 
MHz, CDCl3): 174.7, 152.5, 142.4, 137.9, 134.3, 130.6, 130.3, 129.3, 129.1, 128.5, 
127.8, 127.8, 126.3, 124.5, 116.0, 76.3, 51.6, 46.8, 32.5, 29.9, 29.2, 24.4, 20.6, 14.8, -3.0, 
-3.5; IR (thin film, cm
-1) νmax: 2953, 1737, 1590, 1487, 1451, 1428, 1245, 1230, 1195, 
1174, 1131.51, 1078, 1019, 837, 814, 776, 737, 702; HRMS (m/z): [M+Na]
+
 calculated 
for C29H34O3Si 481.2175, found 481.2183; Melting Point: 108 - 110 C. 
 
Methyl (5S,6R,E)-6-(2-hydroxy-5-methylphenyl)-5-methyl-6-phenylhex-3-enoate 
(1.6b) 
Prepared by the General Procedure for FeCl3/2,6-
Lutidine-Promoted reaction. Purification  by silica gel 
chromatography (80:1 to 50:1 to 7:1 Hexanes) afforded 
1.6b as a yellow residue (11.6 mg, 14% yield) with dr 11:1. Also prepared by the General 
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procedure for the TiCl4-promoted Ring-Opening/Silicon Elimination reaction. 
Purification  by silica gel chromatography (7:1 Hexanes:EtOAc) afforded 1.6b as a white 
solid (60.8 mg, 75% yield) with  E:Z ratio 3:1 and dr >30:1.     
   = -36.0 (c = 1.0, 
CH2Cl2). 
1
H NMR (500 MHz, CDCl3): δ7.29-7.28 (overlap, 2H), 7.24-7.21 (overlap, 2H), 7.13-
7.10 (overlap, 2H), 6.83 (dd, J = 8.0, 1.6 Hz, 1H), 6.60 (d, J = 8.0 Hz, 1H), 5.48-5.42 
(overlap, 2H), 4.95 (br s, 1H), 4.06 (d, J = 10.8 Hz, 1H), 3.61 (s, 3H), 3.12 (m, 1H), 2.94-
2.85 (overlap, 2H), 2.27 (s, 3H), 1.03 (d, J = 6.6 Hz, 3H); 
1
H NMR (500 MHz, C6D6): 
δ7.35-7.35 (overlap, 2H), 7.14-7.11 (overlap, 3H), 6.97 (m, 1H), 6.70 (d, J = 8.1 Hz, 1H), 
6.18 (m, 1H), 5.55 (dtd, J = 15.6, 6.9, 0.9 Hz, 1H), 5.38 (ddt, J = 15.6, 7.8, 1.6 Hz, 1H), 
4.22 (d, J = 11.1 Hz, 1H), 4.01 (br s, 1H), 3.24 (s, 3H), 3.09 (m, 1H), 2.71-2.61 (overlap, 
2H), 2.12 (s, 3H), 1.08 (d, J = 6.6 Hz, 3H); 
13
C NMR (125 MHz, CDCl3): 172.8, 151.3, 
143.6, 139.1, 130.1, 130.0, 129.1, 128.9, 128.2, 127.6, 126.0, 121.4, 115.8, 51.9, 50.5, 
39.8, 38.1, 20.9, 19.5; IR (thin film, cm
-1) νmax: 3409, 2954, 1712, 1598, 1497, 1454, 
1438, 1406, 1333, 1267, 1212, 1167, 1114, 971, 813, 736, 699; HRMS (m/z): [M+Na]
+
 
calculated for C21H24O3 347.1623, found 347.1617; Melting Point: 98 - 102 C. 
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Methyl (S)-3-(dimethyl(phenyl)silyl)-3-((2R,3R,4R)-6-methoxy-3-methyl-4-
phenylchroman-2-yl)propanoate (1.5c) 
Prepared by the general procedure for FeCl3/2,6-
Lutidine-Promoted reaction. Purification  by silica gel 
chromatography (45:1 to 30:1 to 5:1 Hexanes:EtOAc) 
afforded 1.5c as a yellow solid (76.1 mg, 64% yield) 
and single diastereomer.     
   = -151.2 (c = 1.0, CH2Cl2). 
1
H NMR (500 MHz, CDCl3): δ7.56-7.55 (overlap, 2H), 7.39-7.32 (overlap, 3H), 7.14-
7.11 (overlap, 3H), 6.81 (d, J = 8.9 Hz, 1H), 6.79-6.77 (overlap, 2H), 6.73 (dd, J = 8.9, 
3.0 Hz, 1H), 6.37 (d, J = 2.9 Hz, 1H), 4.01 (dd, J = 9.8, 2.9 Hz, 1H), 3.91 (d, J = 5.3 Hz, 
1H), 3.64 (s, 3H), 3.53 (s, 3H), 2.59 (dd, J = 15.9, 4.9 Hz, 1H), 2.47 (dd, J = 15.9, 8.1 Hz, 
1H), 2.21 (m, 1H), 1.65 (ddd, J = 8.0, 4.8, 2.9 Hz, 1H), 0.68 (d, J = 6.9 Hz, 3H), 0.47 (s, 
3H), 0.40 (s, 3H); 
13
C NMR (125 MHz, CDCl3): 174.7, 153.3, 148.7, 142.1, 137.9, 
134.2, 130.2, 129.1, 127.8, 127.8, 126.4, 125.2, 116.9, 114.5, 76.3, 55.7, 51.6, 47.0, 32.5, 
29.3, 24.4, 14.8, -3.0,-3.5; IR (thin film, cm
-1) νmax: 2952, 1734, 1494, 1452, 1427, 1219, 
1198, 1174, 1142, 1114, 1080, 1039, 1019, 836, 813, 775, 736, 702; HRMS (m/z): 
[M+H]
+
 calculated for C29H34O4Si 475.2305, found 475.2323; Melting Point: 57 - 62 C. 
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Methyl (5S,6R,E)-6-(2-hydroxy-5-methoxyphenyl)-5-methyl-6-phenylhex-3-enoate 
(1.6c) 
Prepared by the general procedure for FeCl3/2,6-
Lutidine-Promoted reaction. Purification  by silica 
gel chromatography (45:1 to 30:1 to 5:1 
Hexanes:EtOAc) afforded 1.6c as a yellow residue (5.2 mg, 6% yield) with dr 3:1. 
Also prepared by the general procedure for the TiCl4-promoted Ring-Opening/Silicon 
Elimination reaction. Purification  by silica gel chromatography (7:1 Hexanes:EtOAc) 
afforded 1.6c as an orange solid (60.8 mg, 75% yield) with  E:Z ratio 3:1 and dr >30:1. 
    
   = -36.0 (c = 1.0, CH2Cl2). 
1
H NMR (500 MHz, CDCl3): δ7.25-7.20 (overlap, 4H), 7.12 (m, 1H), 6.89 (d, J = 3.0 
Hz, 1H), 6.65 (d, J = 8.7 Hz, 1H), 6.59 (dd, J = 8.7, 2.9 Hz, 1H), 5.46-5.39 (overlap, 2H), 
4.39 (br s, 1H), 4.04 (d, J = 10.4 Hz, 1H), 3.75 (s, 3H), 3.60 (s, 3H), 3.08 (m, 1H), 2.93-
2.83 (overlap, 2H), 1.04 (d, J = 6.6 Hz, 3H); 
1
H NMR (500 MHz, C6D6): δ7.32-7.30 
(overlap, 2H), 7.12-7.09 (overlap, 2H), 7.04 (d, J = 3.0 Hz, 1H), 6.97 (m, 1H), 6.46 (dd, J 
= 8.7, 3.0 Hz, 1H), 6.19 (d, J = 8.7 Hz, 1H), 5.50 (m, 1H), 5.34 (ddt, J = 15.6, 7.9, 1.4 
Hz, 1H), 4.21 (d, J = 8.7 Hz, 1H), 3.88 (br s, 1H), 3.35 (s, 3H), 3.23 (s, 3H), 3.02 (m, 
1H), 2.69-2.59 (overlap, 2H), 1.07 (d, J = 6.6 Hz, 3H); 
13
C NMR (125 MHz, CDCl3): 
172.7, 153.9, 147.5, 143.2, 138.8, 131.8, 128.9, 128.3, 126.2, 121.5,  116.6, 114.8, 111.4, 
55.8, 51.9, 50.5, 39.8, 38.1, 19.4; IR (thin film, cm
-1) νmax: 3411, 2955, 1713, 1599, 1505, 
1451, 1432, 1334, 1264, 1203, 1175, 1040, 972, 831, 803, 699; HRMS (m/z): [M+Na]
+
 
calculated for C21H24O4 363.1572, found 363.1557; Melting Point: 75 - 81 C. 
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Methyl (S)-3-((2R,3R,4R)-6-bromo-3-methyl-4-phenylchroman-2-yl)-3-
(dimethyl(phenyl)-silyl)propanoate (1.5d) 
Prepared by the general procedure for FeCl3/2,6-
Lutidine-Promoted reaction. Purification  by silica gel 
chromatography (80:1 to 50:1 to 7:1 Hexanes:EtOAc) 
afforded 1.5d as a white residue (71.2 mg, 55% yield) 
and single diastereomer.     
   = -115.8 (c = 1.0, CH2Cl2). 
1
H NMR (500 MHz, CDCl3): δ7.56-7.54 (overlap, 2H), 7.40-7.33 (overlap, 3H), 7.22 
(dd, J = 8.7, 2.4 Hz, 1H), 7.16-7.13 (overlap, 3H), 6.98 (d, J = 2.4 Hz, 1H), 6.77 (d, J = 
8.7 Hz, 1H), 6.74-6.72 (overlap, 2H), 4.03 (dd, J = 9.9, 2.8 Hz, 1H), 3.90 (d, J = 5.3 Hz, 
1H), 3.55 (s, 3H), 2.58 (dd, J = 15.9, 5.0 Hz, 1H), 2.45 (dd, J = 15.9, 8.0 Hz, 1H), 2.19 
(m, 1H), 1.65 (ddd, J = 7.9, 5.0, 2.9 Hz, 1H), 0.68 (d, J = 6.9 Hz, 3H), 0.49 (s, 3H), 0.41 
(s, 3H); 
13
C NMR (125 MHz, CDCl3): 174.5, 153.7, 141.6, 137.6, 134.2, 132.8, 130.8, 
130.2, 129.2, 127.9, 127.9, 127.0, 126.6, 118.2, 112.3 76.9, 51.7, 46.5, 32.3, 29.2, 24.4, 
14.7, -3.0, -3.6; IR (thin film, cm
-1) νmax: 2953, 1736, 1479, 1428, 1245, 1193, 1173, 
1128, 1116, 999, 947, 929, 838, 814, 776, 757, 701, 577; HRMS (m/z): [M+H]
+
 
calculated for C28H31BrO3Si 523.1304, found 523.1308. 
 
Methyl (5S,6R,E)-6-(5-bromo-2-hydroxyphenyl)-5-methyl-6-phenylhex-3-enoate 
(1.6d) 
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Prepared by the general procedure for FeCl3/2,6-
Lutidine-Promoted reaction. Purification  by silica gel 
chromatography (80:1 to 50:1 to 7:1 Hexanes:EtOAc) 
afforded 1.6d as a white solid (36.1 mg, 37% yield) 
with er >99:1 and dr 13:1. Also prepared by the general procedure for the TiCl4-promoted 
Ring-Opening/Silicon Elimination reaction. Purification  by silica gel chromatography 
(7:1 to 5:1 Hexanes:EtOAc) afforded 1.6d as a white solid (77.0 mg, 79% yield) with er 
>99:1, E:Z ratio 6:1, dr 14:1.     
   = -60.0 (c = 1.0, CH2Cl2). 
A) Mixture of major/minor product of 1.6d obtained from the FeCl3 reaction: 
1
H NMR (500 MHz, CDCl3): δ7.40 (d, J = 2.4 Hz, 1H), 7.26-7.23 (overlap, 4H), 7.16-
7.12 (overlap, 2H), 6.60 (d, J = 8.5 Hz, 1H), 5.48-5.27 (overlap, 2H), 5.16 (br s, 1H), 
4.04 (d, J = 10.6 Hz, 1H), 3.60 (s, 3H), 3.07 (m, 1H), 2.93-2.84 (overlap, 2H), 1.03 (d, J 
= 6.6 Hz, 3H); 
1
H NMR (500 MHz, C6D6): δ7.53 (d, J = 2.4 Hz, 1H), 7.18-7.17 (overlap, 
2H), 7.08-7.05 (overlap, 2H), 6.98-6.93 (overlap, 2H), 5.86 (m, 1H), 5.43 (dtd, J = 15.3, 
7.0, 1.0 Hz, 1H), 5.30 (minor product- br dd, J = 15.4, 7.7 Hz, 1H), 5.24 (br dd, J = 15.3, 
7.7 Hz, 1H), 4.22 (br s, 1H), 4.05 (d, J = 10.8 Hz, 1H), 3.22 (s, 3H), 2.84 (m, 1H), 2.64-
2.57 (overlap, 2H), 0.94 (d, J = 6.6 Hz, 3H); 
13
C NMR (125 MHz, CDCl3): 172.8, 152.7, 
142.6, 138.6, 132.9, 131.3, 130.0 , 128.9, 128.4, 126.4, 121.8, 117.8, 113.2, 52.0, 50.4, 
39.7, 38.1, 19.4 
B) Mixture of major/minor product of 1.6d obtained from the Ring-Opening reaction: 
1
H NMR (500 MHz, CDCl3): δ7.40 (d, J = 2.4 Hz, 1H), 7.25-7.22 (overlap, 4H), 7.16-
7.12 (overlap, 2H), 6.59 (d, J = 8.5 Hz, 1H), 5.47-5.39 (overlap, 2H), 5.16 (br s, 1H), 
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4.04 (d, J = 10.5 Hz, 1H), 3.60 (s, 3H), 3.06 (m, 1H), 2.90-2.85 (overlap, 2H), 1.03 (d, J 
= 6.6 Hz, 3H); 
13
C NMR (125 MHz, CDCl3): 172.9, 152.8, 142.7, 138.6, 132.9, 131.3, 
129.9, 128.8, 128.4, 126.4, 121.7, 117.7, 113.1, 52.0, 50.3, 39.7, 38.1, 19.4; IR (thin film, 
cm
-1) νmax: 3391, 2955, 1710, 1597, 1491, 1452, 1414, 1316, 1271, 1213, 1166, 1106, 97, 
812, 755, 731, 699; HRMS (m/z): [M+Na]
+
 calculated for C20H21BrO3 411.0572, found 
411.0573; Melting Point: 142 - 148 C. 
C) Isolated major product of 1.6d from the Ring-Opening reaction: 
1
H NMR (500 MHz, CDCl3): δ7.41 (d, J = 2.4 Hz, 1H), 7.25-7.23 (overlap, 4H), 7.16-
7.13 (overlap, 2H), 6.60 (d, J = 8.5 Hz, 1H), 5.47-5.38 (overlap, 2H), 4.71 (br s, 1H), 
4.02 (d, J = 10.5 Hz, 1H), 3.60 (s, 3H), 3.06 (m, 1H), 2.91-2.84 (overlap, 2H), 1.03 (d, J 
= 6.6 Hz, 3H); 
1
H NMR (500 MHz, C6D6): δ7.52 (d, J = 2.4 Hz, 1H), 7.17-7.15 (overlap, 
2H), 7.08-7.05 (overlap, 2H), 6.97-6.93 (overlap, 2H), 5.82 (d, J = 8.5 Hz, 1H), 5.43 (dtd, 
J = 15.1, 6.9, 1.0 Hz, 1H), 5.24 (ddt, d, J = 15.5, 7.7, 1.4 Hz, 1H), 4.03 (d, J = 10.8 Hz, 
1H), 4.01 (br s, 1H), 3.23 (s, 3H), 2.83 (m, 1H), 2.66-2.56 (overlap, 2H), 0.93 (d, J = 6.6 
Hz, 3H). 
D) Isolated minor product of 1.6d from the Ring-Opening reaction: 
1
H NMR (500 MHz, CDCl3): δ7.44 (d, J = 2.4 Hz, 1H), 7.24-7.21 (overlap, 4H), 7.17-
7.13 (overlap, 2H), 6.61 (d, J = 8.5 Hz, 1H), 5.41-5.35 (overlap, 2H), 4.73 (br s, 1H), 
4.04 (d, J = 10.3 Hz, 1H), 3.66 (s, 3H), 3.29 (m, 1H), 3.08 (dd, J = 16.9, 6.3 Hz, 1H), 
2.87 (dd, J = 16.7, 5.9 Hz, 1H), 1.00 (d, J = 6.6 Hz, 3H); 
1
H NMR (500 MHz, C6D6): 
δ7.60 (d, J = 2.4 Hz, 1H), 7.31 (s, 1H), 7.05-6.92 (overlap, 5H), 5.78 (d, J = 8.5 Hz, 1H), 
5.44 (dtd, J = 10.9, 7.2, 1.0 Hz, 1H), 5.21 (ddt, J = 11.3, 9.7, 1.8 Hz, 1H), 3.99 (d, J = 
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10.7 Hz, 1H), 3.84 (br s, 1H), 3.23 (s, 3H), 3.17 (m, 1H), 2.87 (ddd, J = 16.9, 7.7, 1.7 Hz, 
1H), 2.67 (ddd, J = 16.9, 6.8, 1.9 Hz, 1H), 1.00 (d, J = 6.7 Hz, 3H). 
 
 
Methyl (S)-3-((2R,3R,4R)-6-chloro-3-methyl-4-phenylchroman-2-yl)-3-
(dimethyl(phenyl)-silyl)propanoate (1.5e) 
Prepared by the general procedure for FeCl3/2,6-Lutidine-
Promoted reaction. Purification  by silica gel 
chromatography (80:1 to 50:1 to 7:1 Hexanes:EtOAc) 
afforded 1.5e as a white solid (74.8 mg, 63% yield) and 
single diastereomer.     
   = -146.8 (c = 1.0, CH2Cl2). 
- 1.0 mmol scale: The reaction was also run at a 1.0 mmol scale using 1e (0.2340 g, 1.0 
mmol, 1 equiv), 4 (0.524 g, 2.0 mmol, equiv), FeCl3 (0.1300 g, 0.8 mmol, 0.8 equiv) and 
2,6-lutidine (46.5 L, 0.4 mmol, 0.4 equiv) at 0 C for 3 h and afforded 1.5e as a white 
solid (286.3 mg, 60% yield) and single diastereomer. 
1
H NMR (500 MHz, CDCl3): δ7.55-7.53 (overlap, 2H), 7.40-7.32 (overlap, 3H), 7.22 
(dd, J = 8.7, 2.4 Hz, 1H), 7.16-7.11 (overlap, 3H), 7.08 (dd, J = 8.7, 2.6 Hz, 1H), 6.83-
6.80 (overlap, 2H), 6.73-6.71 (overlap, 2H), 4.03 (dd, J = 9.8, 2.8 Hz, 1H), 3.90 (d, J = 
5.3 Hz, 1H), 3.54 (s, 3H), 2.57 (dd, J = 15.9, 5.0 Hz, 1H), 2.46 (dd, J = 15.9, 8.0 Hz, 1H), 
2.19 (m, 1H), 1.66 (ddd, J = 8.0, 5.1, 2.9 Hz, 1H), 0.67 (d, J = 7.0 Hz, 3H), 0.48 (s, 3H), 
0.40 (s, 3H); 
13
C NMR (125 MHz, CDCl3): 174.5, 153.2, 141.4, 137.6, 134.2, 130.2, 
129.9, 129.2, 127.9, 127.9, 126.6, 126.4, 124.9, 117.7, 76.9, 51.7, 46.6, 32.3, 29.2, 24.4, 
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14.7, -3.0, -3.6; IR (thin film, cm
-1) νmax: 2951, 1736, 1481, 1428, 1246, 1198, 1174, 
1126, 1018, 998, 837, 815, 776, 736, 701, 644; HRMS (m/z): [M+H]
+
 calculated for 
C28H31ClO3Si 479.1809, found 479.1830; Melting Point: 105 - 109 C. 
 
 
Methyl (5S,6R,E)-6-(5-chloro-2-hydroxyphenyl)-5-methyl-6-phenylhex-3-enoate 
(1.6e) 
Prepared by the general procedure for FeCl3/2,6-
Lutidine-Promoted reaction. Purification  by silica gel 
chromatography (80:1 to 50:1 to 7:1 Hexanes:EtOAc) 
afforded 1.6e as a white solid (21.6 mg, 25% yield) 
with er >99:1 and dr 18:1. Also prepared by the general procedure for the TiCl4-promoted 
Ring-Opening/Silicon Elimination reaction. Purification  by silica gel chromatography 
(7:1 Hexanes:EtOAc) afforded 1.6e as a white solid (70.8 mg, 82% yield) with er >99:1, 
E:Z ratio 4:1, and dr 15:1.     
   = -43.0 (c = 1.0, CH2Cl2). 
1.0 mmol scale reactions: 
- FeCl3: The reaction was repeated at a 1.0 mmol scale using 1.1e (0.2340 g, 1.0 mmol, 1 
equiv), 4 (0.524 g, 2.0 mmol, equiv), FeCl3 (0.1300 g, 0.8 mmol, 0.8 equiv) and 2,6-
lutidine (46.5 L, 0.4 mmol, 0.4 equiv) at 0 C for 3 h and afforded 1.6e as a white solid 
(89.2 mg, 26% yield) with dr 15:1. 
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- Ring-opening: The reaction was repeated at a 1.0 mmol scale using 1.1e following the 
general procedure for the TiCl4-promoted Ring-Opening/Silicon Elimination reaction and 
afforded 1.6e as a white solid (270.1 mg, 79% yield) with E:Z ratio 6:1. 
 
A) Mixture of major/minor product of 1.6e obtained from the FeCl3 reaction: 
1
H NMR (500 MHz, CDCl3): δ7.40 (d, J = 2.5 Hz, 1H), 7.25-7.22 (overlap, 4H), 7.14 
(m, 1H), 6.99 (m, 1H), 6.64 (d, J = 8.5 Hz, 1H), 5.48-5.39 (overlap, 2H), 5.23 (br s, 1H), 
4.06 (d, J = 10.6 Hz, 1H), 3.60 (s, 3H), 3.07 (m, 1H), 2.93-2.84 (overlap, 2H), 1.03 (d, J 
= 6.6 Hz, 3H); 
1
H NMR (500 MHz, C6D6): δ7.39 (d, J = 2.5 Hz, 1H), 7.20-7.18 (overlap, 
2H), 7.09-7.06 (overlap, 2H), 6.95 (m, 1H), 6.84 (dd,  J = 8.5, 2.6 Hz, 1H), 5.97 (d, J = 
8.5 Hz, 1H), 5.44 (dtd, J = 15.0, 7.0, 1.0 Hz, 1H), 5.32 (minor product- ddt, J = 15.6, 7.9, 
1.4 Hz, 1H), 5.26 (ddt, J = 15.6, 7.7, 1.4 Hz, 1H), 4.38 (br s, 1H), 4.09 (d, J = 10.9 Hz, 
1H), 3.21 (s, 3H), 2.85 (m, 1H), 2.64-2.55 (overlap, 2H), 0.96 (d, J = 6.6 Hz, 3H); 
13
C 
NMR (125 MHz, CDCl3): 172.8, 152.2, 142.7, 138.6, 132.4, 128.9, 128.4, 127.0, 126.4, 
125.8, 121.8, 117.2, 52.0, 50.3, 39.7, 38.1, 19.4 
B) Mixture of major/minor product of 6e obtained from the Ring-Opening reaction: 
1
H NMR (500 MHz, CDCl3): δ7.27 (d, J = 2.5 Hz, 1H), 7.25-7.22 (overlap, 4H), 7.14 
(m, 1H), 6.99 (dd, J = 8.5, 2.6 Hz, 1H), 6.64 (d, J = 8.5 Hz, 1H), 5.48-5.38 (overlap, 2H), 
5.30 (br s, 1H), 4.06 (d, J = 10.6 Hz, 1H), 3.61 (s, 3H), 3.07 (m, 1H), 2.93-2.84 (overlap, 
2H), 1.03 (d, J = 6.6 Hz, 3H); 
13
C NMR (125 MHz, CDCl3): 172.9, 152.3, 142.7, 138.6, 
132.4, 128.8, 128.4, 127.0, 126.4, 125.7, 121.7, 117.2, 52.0, 50.3, 39.7, 38.1, 19.4; IR 
(thin film, cm
-1) νmax: 3388, 2955, 1711, 1598, 1494, 1438, 1417, 1316, 1271, 1214, 
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1166, 1112, 971, 813, 757, 732, 700, 654; HRMS (m/z): [M+Na]
+
 calculated for 
C20H21ClO3 367.1077, found 367.1090; Melting Point: 128 - 134 C. 
C) Isolated major product of 6e from the RO: 
1
H NMR (500 MHz, CDCl3): δ7.27 (d, J = 2.6 Hz, 1H), 7.25-7.22 (overlap, 4H), 7.14 
(m, 1H), 7.00 (dd, J = 8.5, 2.6 Hz, 1H), 6.64 (d, J = 8.5 Hz, 1H), 5.48-5.37 (overlap, 2H), 
4.81 (br s, 1H), 4.04 (d, J = 10.5 Hz, 1H), 3.60 (s, 3H), 3.06 (m, 1H), 2.93-2.84 (overlap, 
2H), 1.03 (d, J = 6.6 Hz, 3H); 
1
H NMR (500 MHz, C6D6): δ7.39 (d, J = 2.5 Hz, 1H), 
7.19-7.17 (overlap, 2H), 7.09-7.06 (overlap, 2H), 6.95 (m, 1H), 6.83 (dd, J = 8.5, 2.5 Hz, 
1H), 5.91 (m, 1H), 5.45 (br dt, J = 14.5, 7.1 Hz, 1H), 5.25 (br dd, J = 15.5, 7.7 Hz, 1H), 
4.21 (br s, 1H), 4.07 (d, J = 10.7 Hz, 1H), 3.23 (s, 3H), 2.84 (m, 1H), 2.66-2.56 (overlap, 
2H), 0.95 (d, J = 6.6 Hz, 3H). 
D) Isolated minor product of 6e from the Ring-Opening reaction: 
1
H NMR (500 MHz, CDCl3): δ7.30 (d, J = 2.5 Hz, 1H), 7.24-7.21 (overlap, 4H), 7.14 
(m, 1H), 7.02 (dd, J = 8.5, 2.5 Hz, 1H),  6.65 (d, J = 8.5 Hz, 1H), 5.41-5.37 (overlap, 
2H), 4.82 (br s, 1H), 4.05 (d, J = 10.5 Hz, 1H), 3.66 (s, 3H), 3.28 (m, 1H), 3.08 (dd, J = 
16.8, 6.2 Hz, 1H), 2.87 (dd, J = 16.7, 5.4 Hz, 1H), 1.00 (d, J = 6.5 Hz, 3H); 
1
H NMR 
(500 MHz, C6D6): δ7.42 (d, J = 2.5 Hz, 1H), 7.04-6.97 (overlap, 4H), 6.80 (dd, J = 8.5, 
2.6 Hz, 1H), 5.85 (d, J = 8.5 Hz, 1H), 5.44 (br dt, J = 10.9, 7.2 Hz, 1H), 5.19 (ddt, J = 
11.3, 9.2, 1.8 Hz, 1H), 4.09 (br s, 1H), 3.99 (d, J = 10.6 Hz, 1H), 3.24 (s, 3H), 3.13 (m, 
1H), 2.84 (ddd, J = 16.9, 7.7, 1.7 Hz, 1H), 2.63 (ddd, J = 16.9, 6.8, 1.9 Hz, 1H), 0.86 (d, J 
= 6.6 Hz, 3H). 
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Methyl (S)-3-(dimethyl(phenyl)silyl)-3-((2R,3R,4R)-6-fluoro-3-methyl-4-
phenylchroman-2-yl)propanoate (1.5f) 
Prepared by the general procedure for FeCl3/2,6-Lutidine-
Promoted reaction. Purification  by silica gel 
chromatography (80:1 to 50:1 to 7:1 to 5:1 
Hexanes:EtOAc) afforded 1.5f as a white residue (78.6 
mg, 69% yield) and single diastereomer.     
   = -189.0 (c = 1.0, CH2Cl2). 
1
H NMR (500 MHz, CDCl3): δ7.57-7.55 (overlap, 2H), 7.41-7.34 (overlap, 3H), 7.16-
7.12 (overlap, 3H), 6.87-6.80 (overlap, 2H), 6.75-6.74 (overlap, 2H), 6.56 (dd, J = 9.0, 
2.7 Hz, 1H), 4.03 (dd, J = 9.7, 2.7 Hz, 1H), 3.92 (d, J = 5.4 Hz, 1H), 3.55 (s, 3H), 2.60 
(dd, J = 15.9, 5.0 Hz, 1H), 2.48 (dd, J = 15.9, 8.0 Hz, 1H), 2.21 (m, 1H), 1.68 (m, 1H), 
0.69 (d, J = 7.0 Hz, 3H), 0.49 (s, 3H), 0.41 (s, 3H); 
13
C NMR (125 MHz, CDCl3): 174.6, 
156.8 (d, JC-F = 237.8 Hz) , 150.6, 141.6, 137.7, 134.2, 130.2, 129.2, 126.6, 125.8 (d, JC-F 
= 7.1 Hz), 117.2 (d, JC-F = 8.0 Hz), 116.1 (d, JC-F = 22.4 Hz), 114.8 (d, JC-F = 23.2 Hz), 
76.7, 51.7, 46.7, 32.3, 29.3, 24.4, 14.7, -3.0, -3.6; IR (thin film, cm
-1) νmax: 2952, 1734, 
1490, 1452, 1427, 1246, 1216, 1195, 1134, 1112, 1078, 1018, 998, 928, 865, 835, 812, 
796, 775, 736, 700; HRMS (m/z): [M+H]
+
 calculated for C28H31FO3Si 485.1924, found 
485.1902. 
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Methyl (5S,6R,E)-6-(5-fluoro-2-hydroxyphenyl)-5-methyl-6-phenylhex-3-enoate 
(1.6f) 
Prepared by the general procedure for FeCl3/2,6-
Lutidine-Promoted reaction. The reaction was run using 
FeCl3 (0.0324 g, 0.20 mmol, 0.8 equiv) and 2,6-lutidine 
(11.6 L, 0.10 mmol, 0.4 equiv) at 0 C for 3 h and 
monitored by TLC in 5:1 Hexanes:EtOAc. Purification  by silica gel chromatography 
(80:1 to 50:1 to 7:1 to 5:1 Hexanes:EtOAc) afforded 1.6f as a yellow solid (22.2 mg, 27% 
yield) with dr 6:1.Also prepared by the general procedure for the TiCl4-promoted Ring-
Opening/Silicon Elimination reaction. Purification  by silica gel chromatography (7:1 
Hexanes:EtOAc) afforded 1.6f as a white solid (64.4 mg, 79% yield) with  E:Z ratio 3:1 
and dr 8:1.     
   = 4.8 (c = 1.0, CH2Cl2). 
1
H NMR (500 MHz, CDCl3): δ7.25-7.24 (overlap, 3H), 7.14, (m, 1H), 7.03 (dd, J = 9.8, 
3.0 Hz), 1H), 6.73 (td, J = 8.1, 3.0 Hz, 1H), 6.65 (dd, J = 8.7, 4.8 Hz), 5.48-5.38 
(overlap, 2H), 5.00 (br s, 1H), 4.08 (d, J = 10.4 Hz, 1H), 3.60 (s, 3H), 3.04 (m, 1H), 2.93-
2.84 (overlap, 2H), 1.03 (d, J = 6.6 Hz, 3H); 
1
H NMR (500 MHz, C6D6): δ7.20-7.18 
(overlap, 2H), 7.10-7.06 (overlap, 4H), 6.96 (m, 1H), 6.54 (td, J = 8.0, 2.9 Hz, 1H), 5.96 
(m, 1H), 5.46 (m, 1H), 5.27, (br dd, J = 15.2, 7.5 Hz, 1H), 4.12 (d, J = 10.8 Hz, 1H), 4.02 
(br s, 1H), 3.23 (s, 3H), 2.83 (m, 1H), 2.67-2.57 (overlap, 2H), 0.97 (d, J = 6.6 Hz, 3H); 
13
C NMR (125 MHz, CDCl3): 172.8, 157.4 (d, JC-F = 237.7 Hz), 149.5, 142.7, 138.6, 
132.2, 128.8, 128.4, 126.4, 121.7, 116.8 (d, JC-F = 8.3 Hz), 115.0, 114.9, 113.4 (d, JC-F = 
23.1 Hz), 51.9, 50.2, 39.9, 38.1, 19.3; IR (thin film, cm
-1) νmax: 3413, 2958, 1713, 1601, 
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1506, 1437, 1336, 1259, 1175, 976, 810, 723, 700; HRMS (m/z): [M-H]
-
 calculated for 
C20H21FO3 327.1396, found 327.1386; Melting Point: 139 - 144 C. 
 
Methyl (S)-3-(dimethyl(phenyl)silyl)-3-((2R,3R,4R)-3-methyl-6-nitro-4-
phenylchroman-2-yl)propanoate (1.5g): 
Prepared by the general procedure for FeCl3/2,6-
Lutidine-Promoted reaction. Purification  by silica gel 
chromatography (25:1 to 20:1 to 3:1 Hexanes:EtOAc) 
afforded 1.5g as a clear oil (9.4 mg, 8% yield) with dr 
8:1.     
   = -168.8 (c = 0.5, CH2Cl2). 
1
H NMR (500 MHz, CDCl3): δ8.04 (dd, J = 9.1, 2.8 Hz, 1H), 7.83 (d, J = 2.7 Hz, 1H), 
7.54-7.52 (overlap, 2H), 7.41-7.33 (overlap, 3H), 7.19-7.12 (overlap, 3H), 6.92 (d, J = 9.1 
Hz, 1H), 6.68-6.66 (overlap, 2H), 4.12 (dd, J = 9.9, 2.8 Hz, 1H), 3.99 (d, J = 5.1 Hz, 1H), 
3.57 (s, 3H), 2.56 (dd, J = 15.9, 5.3 Hz, 1H), 2.46 (dd, J = 15.9, 7.6 Hz, 1H), 2.21 (m, 
1H), 1.70 (ddd, J = 7.9, 5.3, 2.8 Hz, 1H), 0.71 (d, J = 6.9 Hz, 3H), 0.49 (s, 3H), 0.40 (s, 
3H); 
13
C NMR (125 MHz, CDCl3): 174.3, 160.0, 141.3, 140.4, 137.2, 134.1, 130.0, 
129.4, 128.2, 128.0, 127.0, 126.8, 125.5, 124.1, 116.9, 78.5, 51.9, 48.5, 32.3, 29.2, 24.4, 
14.6, -3.0, -3.7; IR (thin film, cm
-1) νmax: 2922, 1754, 1585, 1517, 1485, 1453, 1337 
1247, 1174, 1101, 1017, 829, 815, 737, 701; HRMS (m/z): [M+H]
+
 calculated for 
C28H31NO5Si 490.2050, found 490.2047. 
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Methyl (5S,6R,E)-6-(2-hydroxy-5-nitrophenyl)-5-methyl-6-phenylhex-3-enoate 
(1.6g) 
Prepared by the general procedure for FeCl3/2,6-
Lutidine-Promoted reaction.Purification  by silica 
gel chromatography (25:1 to 20:1 to 3:1 Hexanes) 
afforded 1.6g as a yellow solid (43.3 mg, 49% yield) 
with dr 14:1. Also prepared by the general procedure for the TiCl4-promoted Ring-
Opening/Silicon Elimination reaction. Purification  by silica gel chromatography (7:1 
Hexanes:EtOAc) afforded 1.6g as a white solid (52.0 mg, 59% yield) with  E:Z ratio 15:1 
and dr 3:1.     
   = -72.4 (c = 0.5, CH2Cl2). 
1
H NMR (500 MHz, CDCl3): δ8.27 (d, J = 2.7 Hz, 1H), 7.98 (dd, J = 8.9, 2.7 Hz, 1H), 
7.30-7.24 (overlap, 4H), 6.83 (tt, J = 6.6, 1.5 Hz, 1H), 6.82 (d, J = 8.9 Hz, 1H), 5.51-5.40 
(overlap, 2H), 4.15 (d, J = 10.6 Hz, 1H), 3.62 (s, 3H), 3.16 (m, 1H), 2.95-2.87 (overlap, 
2H), 1.04 (d, J = 6.6 Hz, 3H); 
1
H NMR (500 MHz, C6D6): δ8.48 (d, J = 2.7 Hz, 1H), 7.80 
(dd, J = 8.8, 2.8 Hz, 1H), 7.19-7.04 (overlap, 5H), 6.00 (d, J = 8.8 Hz, 1H), 5.53 (dtd, J = 
15.2, 7.0, 1.0 Hz, 1H), 5.33 (ddt, J = 15.6, 7.0, 1.5 Hz, 1H), 4.17 (d, J = 10.8 Hz, 1H), 
3.34 (s, 3H), 2.99 (m, 1H), 2.76-2.66 (overlap, 2H), 1.00 (d, J = 6.6 Hz, 3H); 
13
C NMR 
(125 MHz, CDCl3): 173.2, 159.7, 142.0, 141.8, 138.3, 131.7, 128.8, 128.6, 126.7, 124.8, 
123.7, 122.0, 116.0, 52.1, 50.3, 39.7, 38.1, 19.3; IR (thin film, cm
-1) νmax: 3342, 2926, 
1708, 1589, 1522, 1495, 1452, 1436, 1338, 1282, 1215, 1163, 1076, 973, 833, 752, 700; 
HRMS (m/z): [M+Na]
+
 calculated for C20H21NO5 378.1317, found 378.1322; Melting 
Point: 155 - 160 C. 
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Methyl (S)-3-(dimethyl(phenyl)silyl)-3-((2R,3R,4R)-3-methyl-4-phenyl-6-
(trifluoromethyl)chroman-2-yl)propanoate (1.5h) 
Prepared by the general procedure for FeCl3/2,6-
Lutidine-Promoted reaction. Purification  by silica gel 
chromatography (80:1 to 50:1 to 7:1 to 5:1 
Hexanes:EtOAc) afforded 1.5h as a clear oil (44.9 mg, 
35% yield) and single diastereomer.     
   = -174.8 (c = 1.0, CH2Cl2). 
1
H NMR (400 MHz, CDCl3): δ7.56-7.54 (overlap, 2H), 7.41-7.33 (overlap, 4H), 7.17-
7.12 (overlap, 4H), 6.94 (d, J = 8.6 Hz, 1H), 6.74-6.72 (overlap, 2H), 4.10 (dd, J = 10.0, 
2.7 Hz, 1H), 3.97 (d, J = 5.2 Hz, 1H), 3.56 (s, 3H), 2.58 (dd, J = 15.9, 5.2 Hz, 1H), 2.47 
(dd, J = 15.9, 7.8 Hz, 1H), 2.22 (m, 1H), 1.69 (ddd, J = 7.8, 5.3, 2.7 Hz, 1H), 0.71 (d, J = 
7.0 Hz, 3H), 0.50 (s, 3H), 0.42 (s, 3H); 
13
C NMR (100 MHz, CDCl3): 174.4, 157.2 141.1, 
137.5, 134.2, 130.1, 129.3, 128.0, 128.0, 127.8 (q, JC-F = 3.8 Hz), 126.7, 125.2, 125.1 (q, 
JC-F = 3.7 Hz), 124.6 (q, JC-F = 269.6 Hz), 122.5 (q, JC-F = 32.6 Hz), 116.7, 77.4, 51.7, 
46.6, 32.3, 29.2, 24.4, 14.7, -3.0, -3.6; IR (thin film, cm
-1) νmax: 2954, 1735, 1621, 1591, 
1504, 1494, 1453, 1428, 1329, 1250, 1192, 1160, 1114, 1067, 1018, 904, 872, 826, 815, 
776, 735, 700; HRMS (m/z): [M+H]
+
 calculated for C29H31F3O3Si 513.2073, found 
513.2075. 
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Methyl (5S,6R,E)-6-(2-hydroxy-5-(trifluoromethyl)phenyl)-5-methyl-6-phenylhex-3-
enoate (1.6h) 
Prepared by the general procedure for FeCl3/2,6-
Lutidine-Promoted reaction. Purification  by silica gel 
chromatography (80:1 to 50:1 to 7:1 to 5:1 
Hexanes:EtOAc) afforded 1.6h as a white solid (43.6 
mg, 46% yield) with dr 15:1.     
   = -16.2 (c = 1.0, CH2Cl2). The general procedure for 
the TiCl4-promoted Ring-Opening/Silicon Elimination reaction was attempted, however 
no product was obtained from the reaction. Data analysis was conducted on the FeCl3 
product.  
1
H NMR (500 MHz, CDCl3): δ7.58 (d, J = 1.9 Hz, 1H), 7.30 (m, 1H), 7.27-7.22 
(overlap, 4H), 7.14 (overlap, 1H), 6.78 (d, J = 8.4 Hz, 1H), 5.81 (br s, 1H), 5.49-5.39 
(overlap, 2H), 4.11 (d, J = 10.5 Hz, 1H), 3.61 (s, 3H), 3.13 (m, 1H), 2.94-2.85 (overlap, 
2H), 1.02 (d, J = 6.6 Hz, 3H); 
1
H NMR (500 MHz, C6D6): δ7.72 (m, 1H), 7.20-7.18 
(overlap, 2H), 7.10-7.05 (overlap, 3H), 6.94 (m, 1H), 5.96 (m, 1H), 5.44 (m, 1H), 5.25 
(br dd, J = 15.5, 7.8 Hz, 1H), 4.57 (br s, 1H), 4.08 (d, J = 10.8 Hz, 1H), 3.23 (s, 3H), 2.91 
(m, 1H), 2.66-2.57 (overlap, 2H), 0.92 (d, J = 6.6 Hz, 3H); 
13
C NMR (125 MHz, CDCl3): 
173.0, 156.4 142.5, 138.5, 131.0, 128.9, 128.5, 126.5, 125.8 (q, JC-F = 3.8 Hz), 124.6 (q, 
JC-F = 3.8 Hz), 123.1 (q, JC-F = 32.6 Hz), 121.8, 116.0, 52.0, 50.4, 39.7, 38.1, 19.4; IR 
(thin film, cm
-1) νmax: 3386, 2958, 1714, 1615, 1495, 1440, 1327, 1282, 1161, 1116, 972, 
832, 701; HRMS (m/z): [M-H]
-
 calculated for C21H21F3O3 377.1365, found 377.1366; 
Melting Point: 110 - 118 C. 
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Methyl (S)-3-(dimethyl(phenyl)silyl)-3-((2R,3R,4S)-3,4-dimethylchroman-2-
yl)propanoate (1.5i) 
Prepared by the general procedure for FeCl3/2,6-Lutidine-
Promoted reaction. Purification  by silica gel chromatography 
(80:1 to 50:1 to 10:1 to 7:1 Pet Ether:EtOAc) afforded 1.5i as 
a white residue (11.2 mg, 12% yield) and single diastereomer. 
    
   = -32.0 (c = 0.2, CH2Cl2). 
1
H NMR (500 MHz, CDCl3): δ7.58-7.56 (overlap, 2H), 7.35-7.34 (overlap, 3H), 7.09-
7.02 (overlap, 2H), 6.82 (td, J = 7.4, 1.0 Hz, 1H), 6.73 (d, J = 8.3 Hz, 1H), 4.04 (dd, J = 
9.3, 3.0 Hz, 1H), 3.47 (s, 3H), 2.77 (qd, J = 7.2, 5.3 Hz, 1H), 2.57 (dd, J = 16.1, 5.1 Hz, 
1H), 2.41 (dd, J = 16.1, 7.6 Hz, 1H), 2.04 (dqd, J = 9.3, 7.0, 5.3 Hz, 1H), 1.81 (ddd, J = 
7.9, 5.2, 3.0 Hz, 1H), 1.03 (d, J = 7.2 Hz, 3H), 0.92 (d, J = 7.0 Hz, 3H), 0.44-0.43 
(overlap, 6H); 
13
C NMR (125 MHz, CDCl3): 174.7, 153.9, 137.9, 134.2, 129.2, 129.0, 
128.3, 127.8, 127.3, 120.0, 116.4, 76.6, 51.6, 34.1, 31.8, 29.9, 29.4, 24.7, 18.0, 14.1, -3.3, 
-3.4; IR (thin film, cm
-1) νmax: 2960, 2922, 2854, 1738, 1584, 1488, 1461, 1232, 1125, 
1111, 1036, 1005, 835, 815, 752, 735, 700; HRMS (m/z): [M+Na]
+
 calculated for 
C23H30O3Si 405.1862, found 405.1862. 
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Methyl (5S,6S,E)-6-(2-hydroxyphenyl)-5-methylhept-3-enoate (1.6i) 
Prepared by the general procedure for FeCl3/2,6-Lutidine-
Promoted reaction. Purification  by silica gel 
chromatography (80:1 to 50:1 to 10:1 to 7:1 Pet 
Ether:EtOAc) afforded 1.6i as a yellow residue (9.2 mg, 10% yield) and with dr 1:3. 
Also prepared by the general procedure for the TiCl4-promoted Ring-Opening/Silicon 
Elimination reaction. Purification  by silica gel chromatography (15:1 to 10:1 
Hexanes:EtOAc) afforded 1.6i as a white residue (60.8 mg, 75% yield) with  E:Z ratio 5:1 
and dr 2:1. The isolated product also contained a significant amount of the original FeCl3 
major product (E-syn) relative to the RO major product (ratio of 3 to 5, respectively). 
    
   = -22.0 (c = 0.1, CH2Cl2). Assignment of the disfavored diastereomer ((E)-anti 
isomer) obtained in the FeCl3 reaction the was done by analogy to 1.6j. 
1
H NMR (500 MHz, CDCl3): δ7.12 (m, 1H), 7.06 (m, 1H), 6.90 (td, J = 7.5, 1.1 Hz, 1H), 
6.74 (dd, = 7.9, 1.1 Hz, 1H), 5.56-5.44 (overlap, 2H), 4.82 (br s, 1H), 3.69 (s, 3H), 3.05 
(d, J = 5.8 Hz, 2H), 2.94 (m, 1H), 2.42 (m, 1H), 1.19 (d, J = 7.1 Hz, 3H), 0.88 (d, J = 6.8 
Hz, 3H); 
1
H NMR (500 MHz, C6D6): δ7.04 (m, 1H), 6.95 (td, J = 7.7, 1.6 Hz, 1H), 6.84 
(m, 1H), 6.30 (d, J = 7.8 Hz, 1H), 5.56 (dtd, J = 14.8, 7.0, 0.8 Hz, 1H), 5.34 (br dd, J = 
15.3, 8.6 Hz, 1H), 4.18 (br s, 1H), 3.30 (s, 3H), 2.99 (m, 1H), 2.83 (dd, J = 6.9, 1.2 Hz, 
2H), 2.40 (m, 1H), 1.21 (d, J = 7.1 Hz, 3H), 0.91 (d, J = 6.7 Hz, 3H); 
13
C NMR (125 
MHz, CDCl3): 172.8, 153.2, 139.4, 128.3, 126.8, 121.5, 121.0, 115.7, 52.0, 42.8, 38.1, 
38.0, 18.7, 18.6; IR (thin film, cm
-1) νmax: 3421, 2959, 2926, 1717, 1593, 1504, 1453, 
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1255, 1169, 977, 752; HRMS (m/z): [M+Na]
+
 calculated for C15H20O3 271.1310, found 
271.1316. 
 
Methyl (S)-3-((2R,3R,4S)-6-bromo-3,4-dimethylchroman-2-yl)-3-
(dimethyl(phenyl)silyl)propanoate (1.5j) 
Prepared by the general procedure for FeCl3/2,6-Lutidine-
Promoted reaction. Purification  by silica gel 
chromatography (80:1 to 50:1 to 7:1 Pet Ether:EtOAc) 
afforded 1.5j as a clear oil (46.4 mg, 41% yield) with dr 
8:1.     
   = -55.2 (c = 0.5, CH2Cl2). 
1
H NMR (500 MHz, CDCl3): δ7.56-7.54 (overlap, 2H), 7.36-7.34 (overlap, 3H), 7.16-
7.13 (overlap, 2H), 6.60 (d, J = 8.5 Hz, 1H), 4.01 (dd, J = 8.9, 3.5 Hz, 1H), 3.50 (s, 3H), 
2.74 (qd, J = 7.0, 4.8 Hz, 1H), 2.54 (dd, J = 16.1, 5.4 Hz, 1H), 2.41 (dd, J = 16.1, 7.2 Hz, 
1H), 1.99 (dqd, J = 8.9, 6.9, 4.8 Hz, 1H), 1.81 (ddd, J = 7.0, 5.4, 3.5 Hz, 1H), 1.00 (d, J = 
7.2 Hz, 3H), 0.90 (d, J = 6.9 Hz, 3H), 0.43 (s, 3H), 0.41 (s, 3H); 
13
C NMR (125 MHz, 
CDCl3): 174.5, 154.0, 137.7, 134.2, 131.5, 130.3, 130.1, 129.3, 127.9, 118.2, 112.0, 77.3, 
51.7, 33.7, 31.7, 29.6, 24.8, 17.7, 13.9, -3.3 -3.5; IR (thin film, cm
-1) νmax: 2963, 1736, 
1577, 1479, 1428, 1407, 1375, 1355, 1247, 1231, 1198, 1174, 1131, 1112, 999, 960, 837, 
814, 776, 734, 701; HRMS (m/z): [M+H]
+
 calculated for C23H29BrO3Si 461.1148, found 
461.1136. 
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Methyl (5S,6S,E)-6-(5-bromo-2-hydroxyphenyl)-5-methylhept-3-enoate (1.6j) 
Prepared by the general procedure for FeCl3/2,6-
Lutidine-Promoted reaction. Purification  by silica gel 
chromatography (80:1 to 50:1 to 7:1 Pet Ether:EtOAc) 
afforded 1.6j as a yellow residue (43.1 mg, 53% yield) 
with dr 2:3. Also prepared by the general procedure for the TiCl4-promoted Ring-
Opening/Silicon Elimination reaction. Purification  by silica gel chromatography (7:1 
Hexanes:EtOAc) afforded 1.6j as a yellow residue (66.2 mg, 81% yield) with E:Z ratio 
4:1 and dr 4:3. The isolated product also contained a significant amount of the original 
FeCl3 major product relative to the RO major product (ratio of 3 to 4, respectively).     
   
= -21.4 (c = 1.0, CH2Cl2).  
 To confirm that the (E)-anti isomer was the disfavored diastereomer obtained in 
the FeCl3 reaction, the corresponding [4+2] product 1.5j was isolated as a single 
diastereomer possessing a cis-benzylic and homobenzylic bond construction and then 
subjected to the TiCl4-promoted Ring-Opening/Silicon Elimination reaction conditions. 
The major product from this isolated Ring-Opening reaction, which contained an (E)-anti 
bond construction, was identical to the minor peaks of the FeCl3 product mixture.  
1
H NMR (500 MHz, CDCl3): δ7.18 (m, 1H), 7.12 (td, J = 8.7, 2.5 Hz, 1H), 6.65 (d, J = 
8.5 Hz, 1H), 5.72 (br s, 1H), 5.52-5.42 (overlap, 2H), 3.70 (s, 3H), 3.06 (d, J = 5.9 Hz, 
2H), 2.92 (m, 1H), 2.38 (m, 1H), 1.16 (d, J = 7.1 Hz, 3H), 0.87 (d, J = 6.7 Hz, 3H) 
1
H NMR (500 MHz, C6D6): δ7.29 (m, 1H), 7.05 (m, 1H), 6.05 (m, 1H), 5.47 (m, 1H), 
5.22 (br dd, J = 15.3, 8.6 Hz, 1H), 4.50 (br s, 1H), 3.31 (s, 3H), 2.96 (m, 1H), 2.79 (d, J = 
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6.9 Hz, 1H), 2.22 (m, 1H), 1.05 (d, J = 7.1 Hz, 1H), 0.80 (d, J = 6.7 Hz, 3H); 
13
C NMR 
(125 MHz, CDCl3): 173.4, 152.7, 139.1, 134.7, 131.0, 129.4, 121.5, 117.4, 112.9, 52.1, 
42.6, 38.0, 38.0, 18.6, 18.4; IR (thin film, cm
-1) νmax: 3407, 2965, 1714, 1493, 1438, 
1415, 1377, 1270, 1211, 1173, 1123.75, 1102, 1012, 975, 882, 812; HRMS (m/z): 
[M+Na]
+
 calculated for C15H19BrO3 349.0415, found 349.0427. 
 
Methyl (S)-3-((2R,3R,4R)-6-bromo-4-(4-chlorophenyl)-3-methylchroman-2-yl)-3- 
(dimethyl(phenyl)silyl)propanoate (1.5k) 
Prepared by the general procedure for FeCl3/2,6-
Lutidine-Promoted reaction. Purification  by silica gel 
chromatography (80:1 to 50:1 to 40:1 to 5:1 
Hexanes:EtOAc) afforded 1.5k as a white solid (81.1 
mg, 58% yield) and single diastereomer.     
   = -115.5 
(c = 2.0, CH2Cl2). 
1
H NMR (500 MHz, CDCl3): δ7.53-7.51 (overlap, 2H), 7.40 (m, 1H), 7.35-7.32 (overlap, 
2H), 7.22 (dd, J = 8.7, 2.5 Hz, 1H), 7.09-7.08 (overlap, 2H), 6.92 (d, J = 2.4 Hz, 1H), 
6.75 (d, J = 8.7 Hz, 1H), 6.60-6.59 (overlap, 2H), 3.91 (dd, J = 9.7, 3.0 Hz, 1H), 3.86 (d, 
J = 5.2 Hz, 1H), 3.56 (s, 3H), 2.56 (dd, J = 15.9, 5.1 Hz, 1H), 2.46 (dd, J = 15.9, 7.9 Hz, 
1H), 2.15 (m, 1H), 1.65 (ddd, J = 8.0, 5.2, 3.0 Hz, 1H), 0.66 (d, J = 7.0 Hz, 3H), 0.48 (s, 
3H), 0.38 (s, 3H); 
13
C NMR (125 MHz, CDCl3): 174.4, 153.6, 139.8, 137.5, 134.1, 
132.7, 132.5, 131.3, 131.0, 129.3, 128.1, 127.9, 126.4, 118.3, 112.4, 76.9, 51.7, 45.8, 
32.2, 29.2, 24.3, 14.6, -2.9, -3.9; IR (thin film, cm
-1) νmax: 2951 1735, 1489, 1478, 1427, 
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1403, 1246, 1173, 1128, 1112, 1093, 1014, 998, 836, 814, 773, 736, 701; HRMS (m/z): 
[M+H]
+
 calculated for C28H30BrClO3Si 557.0914, found 557.0902; Melting Point: 128 - 
130 C. 
 
 Methyl (5S,6R,E)-6-(5-bromo-2-hydroxyphenyl)-6-(4-chlorophenyl)-5-methylhex-3-
enoate (1.6k) 
Prepared by the general procedure for FeCl3/2,6-
Lutidine-Promoted reaction. Purification  by silica gel 
chromatography (80:1 to 50:1 to 40:1 to 7:1 Hexanes) 
afforded 1.6k as a yellow residue (35.2 mg, 33% yield) 
with dr 16:1.Also prepared by the general procedure for 
the TiCl4-promoted Ring-Opening/Silicon Elimination reaction. Purification  by silica gel 
chromatography (7:1 Hexanes:EtOAc) afforded 1.6k as a clear oil (82.0 mg, 78% yield) 
with  E:Z ratio 9:1 and dr 26:1.     
   = -62.8 (c = 1.0, CH2Cl2). 
1
H NMR (500 MHz, CDCl3): δ7.36 (d, J = 2.4 Hz, 1H), 7.20-7.17 (overlap, 4H), 7.14  
(dd, J = 8.5, 2.4 Hz, 1H), 6.61 (d, J = 8.5 Hz, 1H), 5.55 (br s, 1H), 5.45-5.35 (overlap, 
2H), 4.04 (d, J = 10.9 Hz, 1H), 3.61 (s, 3H), 3.02 (m, 1H), 2.94-2.85 (overlap, 2H), 1.01 
(d, J = 6.6 Hz, 1H); 
1
H NMR (500 MHz, C6D6): δ7.43 (d, J = 2.3 Hz, 1H), 7.04-7.02 
(overlap, 2H), 7.00 (m, 1H), 6.94-6.92 (overlap, 2H), 5.90 (m, 1H), 5.36 (m, 1H), 5.38 
(br dd, J = 15.7, 7.9 Hz, 1H), 4.56 (br s, 1H), 3.97 (d, J = 11.0 Hz, 1H), 3.24 (s, 3H), 2.72 
(m, 1H), 2.64-2.54 (overlap, 2H), 0.90 (d, J = 6.6 Hz, 1H); 
13
C NMR (125 MHz, CDCl3): 
173.1, 152.8, 141.5, 138.6, 132.4, 131.9, 131.1, 130.2, 130.1, 128.4, 121.9, 117.6, 113.0, 
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52.1, 49.7, 39.9, 38.1, 19.4; IR (thin film, cm
-1) νmax: 3404, 2953, 1711, 1490, 1438, 
1410, 1272, 1168, 1092, 1014, 974, 814; HRMS (m/z): [M+Na]
+
 calculated for 
C20H20BrClO3 445.0182, found 445.0183. 
 
Methyl (S)-3-((2R,3R,4R)-6-bromo-4-(3-chlorophenyl)-3-methylchroman-2-yl)-3- 
(dimethyl(phenyl)silyl)propanoate (1.5l) 
Prepared by the general procedure for FeCl3/2,6-Lutidine-
Promoted reaction. Purification  by silica gel 
chromatography (80:1 to 50:1 to 5:1 Hexanes:EtOAc) 
afforded 1.5j as a white residue (66.2 mg, 48% yield) and 
single diastereomer.     
   = -119.0 (c = 1.0, CH2Cl2). 
1
H NMR (500 MHz, CDCl3): δ7.53-7.52 (overlap, 2H), 7.40-7.33 (overlap, 3H),7.22 (dd, 
J = 8.7, 2.4 Hz, 1H), 7.14 (m, 1H), 7.04 (t, J = 7.8 Hz, 1H), 6.94 (d, J = 2.3 Hz, 1H), 
6.77-6.74 (overlap, 2H), 6.52 (d, J = 7.8 Hz, 1H), 3.98 (dd, J = 9.6, 3.2 Hz, 1H), 3.86 (d, 
J = 5.4 Hz, 1H), 3.55 (s, 3H), 2.56 (dd, J = 16.0, 5.2 Hz, 1H), 2.45 (dd, J = 16.0, 7.7 Hz, 
1H), 2.16 (m, 1H), 1.68 (ddd, J = 8.0, 5.1, 3.2 Hz, 1H), 0.68 (d, J = 7.0 Hz, 3H), 0.47 (s, 
3H), 0.38 (s, 3H); 
13
C NMR (125 MHz, CDCl3): 174.4, 153.6, 143.4, 137.5, 134.1, 
133.0, 132.7, 131.1, 130.1, 129.5, 129.2, 128.3, 127.0, 127.0, 126.1, 118.4, 112.4, 77.0, 
51.8, 46.1, 32.3, 29.3, 24.4, 14.8, -3.0, -3.8; IR (thin film, cm
-1) νmax: 2917, 1734, 1593, 
1570, 1478, 1428, 1407, 1244, 1195, 1173, 1128, 1114, 1018, 998, 948, 837, 813, 785, 
735, 699; HRMS (m/z): [M+H]
+
 calculated for C28H30BrClO3Si 557.0914, found 
557.0900. 
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Methyl (5S,6R,E)-6-(5-bromo-2-hydroxyphenyl)-6-(4-chlorophenyl)-5-methylhex-3-
enoate (1.6l) 
Prepared by the general procedure for FeCl3/2,6-
Lutidine-Promoted reaction. Purification  by silica gel 
chromatography (80:1 to 50:1 to 5:1 Hexanes) afforded 
1.6l as a yellow residue (41.0 mg, 39% yield) with dr 
15:1.Also prepared by the general procedure for the 
TiCl4-promoted Ring-Opening/Silicon Elimination reaction. Purification  by silica gel 
chromatography (7:1 Hexanes:EtOAc) afforded 1.6l as a yellow solid (84.0 mg, 80% 
yield) with  E:Z ratio 7:1 and dr 19:1.     
   = -53.9 (c = 2.0, CH2Cl2). 
1
H NMR (500 MHz, CDCl3): δ7.36 (d, J = 2.3 Hz, 1H), 7.19-7.09 (overlap, 5H), 6.62  
(d, J = 8.5 Hz, 1H), 6.07 (br s, 1H), 5.48-5.35 (overlap, 2H), 4.06 (d, J = 11.0 Hz, 1H), 
3.62 (s, 3H), 3.05 (m, 1H), 2.96-2.87 (overlap, 2H), 1.01 (d, J = 6.6 Hz, 1H); 
1
H NMR 
(500 MHz, C6D6): δ7.45-7.41 (overlap, 2H), 6.98 (m, 1H), 6.95-6.92 (overlap, 2H), 6.77 
(t, J = 7.9 Hz, 1H), 5.94 (d, J = 8.5 Hz, 1H), 6.37 (dtd, J = 15.4, 7.0, 1.1 Hz, 1H), 5.15 (br 
dd, J = 15.3, 7.8 Hz, 1H), 4.84 (br s, 1H), 3.99 (d, J = 11.1 Hz, 1H), 3.23 (s, 3H), 2.76 
(m, 1H), 2.62-2.53 (overlap, 2H), 0.90 (d, J = 6.6 Hz, 1H); 
13
C NMR (125 MHz, CDCl3): 
173.1, 152.7, 144.9, 138.3, 133.7, 131.9, 130.9, 129.9, 129.3, 128.8, 126.7, 126.1, 121.6, 
117.3, 112.7, 51.9, 49.8, 39.4, 37.8, 19.0; IR (thin film, cm
-1) νmax: 3374, 2954, 1711, 
1593, 1571 1493 1475, 1438, 1413, 1273, 1212, 1167, 1100, 972, 814, 779, 693; HRMS 
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(m/z): [M+Na]
+
 calculated for C20H20BrClO3 445.0182, found 445.0197; Melting Point: 
58 - 70 C. 
 
Cyclization Study of 1.6e 
 
 
Methyl 2-((2S,3R)-3-((1R,2R)-1-(5-chloro-2-hydroxyphenyl)-1-phenylpropan-2-
yl)oxiran-2-yl)acetate (1.7) 
To a solution of 1.6e (0.0150 g, 0.044 mmol, 1 equiv) in CH2Cl2 (0.8 mL) at 0 °C was 
added NaHCO3 (0.0073 g, 0.087 mmol, 2 equiv). The reaction mixture was stirred for 10 
min and a solution of meta-chloroperbenzoic acid (0.0093 g, 0.052, 1.2 equiv) in CH2Cl2 
(0.5 mL) was added. The reaction was then warmed to rt, stirred for 22 h, and monitored 
by TLC in 3:1 Hexanes:EtOAc. Upon completion, the reaction was quenched with 
saturated aqueous Na2S2O4 solution. It was then extracted with DCM (3 x 20 mL) and the 
combined organic layers were washed with brine, dried over MgSO4, filtered, and 
concentrated. Purification by silica gel chromatography (7:1 to 3:1 Hexanes:EtOAc) 
yielded 1.7 as a pale white residue (9.1 mg, 58% yield) with dr 3:1.      
   = -108.0 (c = 
0.2, CH2Cl2). 
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1
H NMR (500 MHz, CDCl3): δ7.29-7.26 (overlap, 5H), 7.18 (m, 1H), 7.03, (dd,  J = 8.5, 
2.5 Hz, 1H), 6.65 (d, J = 8.5 Hz, 1H), 5.13 (br s, 1H), 4.12 (d, J = 11.4 Hz, 1H), 3.62 (s, 
3H), 2.68 (ddd, J = 7.8, 3.3, 2.2 Hz, 1H), 2.49 (dd, J = 8.1, 2.2 Hz, 1H), 2.16 (m, 1H), 
2.00 (dd, J = 16.3, 3.3 Hz, 1H), 1.93 (dd, J = 16.3, 7.7 Hz, 1H), 109 (d, J = 6.5 Hz, 1H); 
13
C NMR (125 MHz, CDCl3): 170.9, 152.3, 142.3, 130.9, 128.8, 128.4, 127.9, 127.4, 
126.9, 126.0, 117.3, 110.2, 62.8, 56.0, 52.1, 48.8, 39.6, 37.3, 16.3; IR (thin film, cm
-1
) 
νmax: 3395, 2924, 1738, 1496, 1453, 1437, 1418, 1379, 1326, 1270, 1197, 1173 1115, 
891, 817, 758, 702, 654, 612; HRMS (m/z): [M+Na]
+
 calculated for C20H21ClO4 
383.1026, found 383.1013. 
 
Methyl (R)-3-((2R,3R,4R)-6-chloro-3-methyl-4-phenylchroman-2-yl)-3-
hydroxypropanoate (1.8) 
To a sealed tube was added 1.7 (30.8 mg, 0.086 mmol, 1 equiv), 4-
dimethylaminopyridine (0.0105 g, 0.086 mmol), and toluene (1 mL).  The mixture was 
heated to 85 °C, stirred for 37 h, and monitored by TLC in in 3:1 Hexanes:EtOAc. Upon 
completion, the reaction was quenched with saturated aqueous NH4Cl solution. It was 
then extracted with EtOAc (3 x 20 mL) and the combined organic layers were washed 
with brine, dried over MgSO4, filtered, and concentrated. Purification by silica gel 
chromatography (10:1 to 7:1 to 3:1 Hexanes:EtOAc) yielded 1.8 as a white residue (13.1 
mg mg, 43% yield) with dr 5:1.      
   = -59.0 (c = 0.2, CH2Cl2). 
1
H NMR (500 MHz, CDCl3): δ7.31-7.27 (overlap, 2H), 7.25 (m, 1H), 7.10 (dd, J = 8.8, 
2.6 Hz, 1H), 7.08-7.06 (overlap, 2H), 6.92 (d, J = 2.5 Hz, 1H), 6.86 (d, J = 8.8 Hz, 1H), 
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4.17 (m, 1H), 4.11 (dd, J = 8.6, 4.6 Hz, 1H), 4.07 (d, J = 5.3 Hz, 1H), 3.72 (s, 3H), 3.24 
(d, J = 6.7 Hz, 1H), 2.69 (dd, J = 16.3, 8.6 Hz, 1H), 2.63 (dd, J = 16.2, 3.4 Hz, 1H), 2.23 
(m, 1H), 0.82 (d, J = 7.1 Hz, 1H); 
13
C NMR (125 MHz, CDCl3): 173.3, 152.3, 140.7, 
130.3, 129.9, 128.3, 128.2, 127.1, 126.0, 125.5, 118.1, 78.9, 68.1, 52.1, 45.6, 36.0, 32.1, 
14.6; IR (thin film, cm
-1) νmax: 3457, 2924, 1736, 1482, 1438, 1412, 1298, 1245, 1194, 
1171, 1128, 1081, 1045, 996, 892, 818, 756, 704; HRMS (m/z): [M+Na]
+
 calculated for 
C20H21ClO4 383.1026, found 383.1026. 
 
 
General Procedure for the Reduction of Selected Products 1.5 for Chiral HPLC 
 
 
To a solution of 1.5a (0.1276 g, 0.29 mmol, 1 equiv) and in anhydrous Et2O (1.2 mL) at 0 
C was added LiAlH4 (0.0218 g, 0.58 mmol, 2 eq). The reaction was stirred for 30 min at 
0 C  and monitored by TLC in 5:1 Hexanes:EtOAc. Purification by silica gel 
chromatography (5:1 Hexanes:EtOAc) yielded 1.9a as a white solid. 
 
(S)-3-(dimethyl(phenyl)silyl)-3-((2R,3R,4R)-3-methyl-4-phenylchroman-2-
yl)propan-1-ol (1.9a) 
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Prepared by the general procedure for the Reduction of Selected 
Products 5. Purification  by silica gel chromatography (5:1 
Hexanes:EtOAc) afforded 1.9a as a white residue (110.5 mg, 
92% yield) with er 97:3.     
   = -161.3 (c = 0.3, CH2Cl2). 
1
H NMR (500 MHz, CDCl3): δ7.59-7.57 (overlap, 2H), 7.39-7.33 (overlap, 3H), 7.17-
7.14 (overlap, 4H), 6.93 (d, J = 8.2 Hz, 1H), 6.88 (d, J = 7.5 Hz, 1H), 6.83-6.76 (overlap, 
3H), 4.08 (dd, J = 10.3, 2.3 Hz, 1H), 3.98 (d, J = 5.3 Hz, 1H), 3.66 (ddd, J = 10.8, 7.6, 5.7 
Hz, 1H), 3.56 (dt, J = 10.7, 7.3 Hz, 1H), 2.38 (m, 1H), 1.97-1.83 (overlap, 2H), 1.35 (br 
s, 1H), 1.25 (m, 1H), 0.71 (d, J = 7.0 Hz, 3H), 0.49-0.48 (overlap, 6H); 
113
C NMR (125 
MHz, CDCl3): 154.8, 142.4, 139.0, 134.0, 130.5, 130.3, 129.1, 128.0, 127.8, 127.8, 
126.3, 125.2, 120.3, 116.3, 62.7, 47.1, 32.4, 27.7, 24.3, 14.9, -2.5, -2.8; IR (thin film, cm
-
1) νmax: 3360, 3026, 2927, 1586, 1485, 1456, 1427, 1318, 1245, 1121, 1036, 998, 835, 
811, 753, 700; HRMS (m/z): [M+Na]
+
 calculated for C27H32O2Si 439.2069, found 
439.2065 
 
(S)-3-((2R,3R,4R)-6-bromo-3-methyl-4-phenylchroman-2-yl)-
3(dimethyl(phenyl)silyl)propan-1-ol (1.9d) 
Prepared by the general procedure for the Reduction of 
Selected Products 5. Purification  by silica gel 
chromatography (5:1 Hexanes:EtOAc) afforded 1.9d as a 
clear oil (38.0 mg, 91% yield) with er >99:1.     
   = -146.8 (c = 1.0, CH2Cl2). 
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1
H NMR (500 MHz, CDCl3): δ7.56-7.54 (overlap, 2H), 7.40-7.32 (overlap, 3H), 7.23 (dt, 
J = 8.7, 1.9 Hz, 1H), 7.16-7.13 (overlap, 3H), 6.99 (t, J = 1.7 Hz, 1H), 6.80 (dd, J = 8.7, 
1.6 Hz, 1H), 6.76-6.75 (overlap, 2H), 4.03 (dd, J = 10.3, 1.2 Hz, 1H), 3.91 (d, J = 5.3 Hz, 
1H), 3.65 (ddd, J = 10.6, 7.7, 5.6 Hz, 1H), 3.55 (dt, J = 10.6, 7.3 Hz, 1H), 2.32 (m, 1H), 
1.94-1.80 (overlap, 2H), 1.36 (br s, 1H), 1.22 (m, 1H), 0.68 (d, J = 6.9 Hz, 3H), 0.47-0.46 
(overlap, 6H); 
13
C NMR (125 MHz, CDCl3): 153.9, 141.6, 138.7, 134.0, 132.9, 130.8, 
130.2, 129.1, 128.0, 127.9, 127.3, 126.6, 118.1, 112.2, 77.3, 62.6, 46.9, 32.2, 27.6, 24.1, 
14.8, -2.4, -2.9; IR (thin film, cm
-1) νmax: 3332, 3067, 2930, 1576, 1479, 1452, 1427 
1407, 1245, 1128, 1112, 1037, 997, 977, 897, 812, 768, 736, 701, 676; HRMS (m/z): 
[M+H]
+
 calculated for C27H31BrO2Si 495.1355, found 495.1361 
 
(S)-3-((2R,3R,4R)-6-chloro-3-methyl-4-phenylchroman-2-yl)-3-
(dimethyl(phenyl)silyl)propan-1-ol (1.9e) 
Prepared by the general procedure for the Reduction of 
Selected Products 5. Purification  by silica gel 
chromatography (5:1 Hexanes:EtOAc) afforded 1.9e as a 
clear oil (38.1 mg, 90% yield) with er >99:1.     
   = -
170.1 (c = 1.0, CH2Cl2). 
1
H NMR (500 MHz, CDCl3): δ7.55-7.54 (overlap, 2H), 7.40-7.32 (overlap, 3H), 7.16-
7.13 (overlap, 3H), 7.09 (dd, J = 8.7, 2.6 Hz, 1H), 6.85-6.83 (overlap, 2H), 6.76-6.74 
(overlap, 2H), 4.03 (dd, J = 10.3, 2.5 Hz, 1H), 3.91 (d, J = 5.3 Hz, 1H), 3.65 (ddd, J = 
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10.6, 7.7, 5.6 Hz, 1H), 3.55 (dt, J = 10.6, 7.4 Hz, 1H), 2.31 (m, 1H), 1.94-1.80 (overlap, 
2H), 1.32 (br s, 1H), 1.22 (m, 1H), 0.68 (d, J = 7.0 Hz, 3H), 0.47-0.46 (overlap, 6H) 
13
C NMR (125 MHz, CDCl3): 153.4, 141.6, 138.8, 134.0, 130.2, 130.0, 129.1, 128.0, 
127.9, 126.7, 126.6, 124.9, 117.6, 77.3, 62.6, 46.9, 32.2, 27.6, 24.1, 14.8, -2.4, -2.9; IR 
(thin film, cm
-1) νmax: 3358, 3067, 2960, 1579, 1481, 1452., 1427, 1412, 1299, 1245, 
1191, 1126, 1112, 1029, 998, 903, 813, 768, 736, 701, 644; HRMS (m/z): [M+H]
+
 
calculated for C27H31ClO2Si 451.1860, found 451.1880. 
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CHAPTER TWO. Progress Toward an Asymmetric Cyclopropanation of 
Allenylsilanes 
 
Introduction 
 Alkylidenecyclopropanes (ACPs) represent an important class of molecules 
containing a cyclopropyl ring and an exocyclic double bond. Despite their considerable 
inherent ring strain (about 12-13 kcal/mol greater than the parent cyclopropane ring),
73
 
ACP derivatives (JM-1) are notably stable at ambient conditions and are found in various 
biologically active products, including the DNA topisomerase 1 inhibitor amphimic acid 
A,
74
 the anti-human cytomegalovirus nucleoside analogue cyclopropavir,
75
 and the anti-
human immunodeficiency virus nucleoside analogue YQL-609 (Figure 2.1).
76
  
Figure 2.1 Alkylidenecyclopropane and derivatives with biological relevance 
 
Additionally, ACP derivatives have been utilized as important intermediates in a wide 
range of applications due to their general stability and unique reactivity imparted by the 
potential release of ring strain. In particular, many synthetically useful transformations 
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have successfully exploited selective cyclopropyl ring-opening reactions and addition 
reactions to the adjoining double bond.
77
 
 Since the 1970's, a multitude of transition metal-catalyzed processes employing 
ACP intermediates have been developed utilizing nickel, palladium, platinum, copper, 
rhodium, ruthenium, and gold-derived catalysts, and have been the subject of extensive 
reviews.
78,79,80,81,82
 One particularly interesting feature of transition metal catalysts in this 
respect is their ability to directly insert into the cyclopropyl moiety of ACPs at either the 
proximal or distal bond, providing the opportunity to selectively access a diverse set of 
products from a given ACP substrate through a slight modification of the reaction  
Figure 2.2 Transition metal-catalyzed reactions of alkylidenecyclopropanes 
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parameters or the catalyst system. For example, in the copper-catalyzed cyclization of 
cyclopropylideneacetic acid HZ-1, running the reaction at 60 C promoted the selective 
cleavage of the distal cyclopropyl bond to yield the iodo-substituted furanone HZ-3 in 
68% yield (Figure 2.2, Eq. 1).
83
 However, upon increasing the temperature to 85 C 
under the same conditions, pyranone HZ-5 was isolated through a proposed proximal 
cleavage of the cyclopropyl ring by copper. In the silaboration of the cyclohexyl-
substituted ACP YI-1, complete regioselectivity was achieved to yield either the vinyl 
borane YI-3 or allylborane YI-5 products by a simple switch in the catalytic metal system 
employed for the reaction (Figure 2.2, Eq.2).
84
 Though studies are ongoing to determine 
the precise role that each catalyst and ligand system may play in securing product 
selectivity, these studies nevertheless demonstrate the exciting potential of transition 
metal catalysis in harnessing the unique reactivity of ACP intermediates.   
 Within the past few decades, significant progress has also been made in utilizing 
Lewis and Brønsted acids to promote various ring-opening and annulation reactions of 
ACP intermediates.
85
 For example, in the presence of AlCl3, aryl-substituted ACP YY-1 
and acetyl chloride reacted to provide selective access to either the α,-unstaurated 
ketone YY-2 or the benzofulvene derivative YY-4 depending on the number of 
equivalents of Lewis acid used (Figure 2.3, Eqs. 1 and 2).
86
 The authors reasoned that 
initial acylation of YY-1 promoted by one equivalent of AlCl3 could generate a cationic 
intermediate (YY-3), which upon attack by a chloride ion would initiate cyclopropyl 
ring-opening to give product YY-2. However, when two equivalents of AlCl3 were used, 
the excess Lewis acid could coordinate to YY-2 to form another cationic intermediate 
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Figure 2.3 Lewis acid promoted reactions of alkylidenecyclopropanes 
 
 
(YY-5) and undergo a Fridel-Crafts reaction to form bicycle YY-4. To lend support to the 
possible intermediacy of the α,-unstaurated ketone in the one-pot procedure, a solution 
of YY-2 was heated in the presence of one equivalent of AlCl3 and gave the expected 
benzofulvene YY-4 in 92% yield (Figure 2.3, Eq. 3). 
 Alkylyidene cyclopropanes have also been utilized as key intermediates in the 
total synthesis of complex natural products. In 2017, the Takemoto laboratory reported 
the first total synthesis of Avenaol, which featured an all cis-cyclopropane ring that they 
envisioned could be accessed through an isomerization of alkylidenecyclopropane 
intermediate YT-2 (Figure 2.3, Eq. 1).
87
 Preparation of YT-2 commenced with the 
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Figure 2.4 Total synthesis of Avenaol utilizing an ACP intermediate 
 
intramolecular cyclopropanation of α-diazo--ketonitrile YT-3 catalyzed by rhodium(II) 
acetate, which selectively gave the (E)-isomer of ACP derivative YT-4 in 84% yield 
(Figure 2.3, Eq. 2). Subsequent reduction of the ketone and protection as the PMB ether, 
reduction of the nitrile, and silyl deprotection gave the isomerization precursor YT-2. 
Gratifyingly, when YT-2 was subjected to a modified Crabtree iridium-based catalyst 
system, stereoselective isomerization occured to give the desired all cis-cyclopropane 
product YT-1 in a 10:1 dr through a proposed coordination of the iridium catalyst to the 
directing hydroxyl group.
88
 Notably, this isomerization procedure of ACP derivative YT-
2 was found to be highly reproducible, allowing for the preparation of gram-scale 
quantities of the crucial all cis-cyclopropane product YT-1. 
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 The wide-ranging synthetic utility and prevalence of the ACP scaffold in 
biologically important compounds have motivated continual synthetic efforts toward their 
preparation. However, efficient stereoselective approaches toward the construction of 
chiral ACPs still remain scarce. In addition, the substrate scope of the previously 
developed asymmetric transformations remains limited due to reactivity issues associated 
with cyclopropanation reactions. In this context, the present work in this chapter aims to 
address these issues by developing the use of highly reactive, enantioenriched 
allenylsilane reagents in asymmetric cyclopropanation reactions to enable the synthesis of 
functionalized chiral ACP products. 
 
 
 
 
 
 
 
  
  
116 
Background 
 General Methods to Access Alkylidenecyclopropanes 
 The preparation of alkylidenecyclopropanes in a non-stereocontrolled fashion has 
been the subject of extensive reviews covering work reported over the past five 
decades.
89,90,91,92
 Despite the breadth of literature encompassing ACP generation, the 
majority of approaches can be divided into three categories which have focused on: the 
formation of the cyclopropane ring (Figure 2.5, Eq. 1), the use of preformed 
cyclopropanes (Figure 2.5, Eqs. 2-4), and the functionalization of preformed 
alkylidenecyclopropanes (Figure 2.5, Eq. 5).
89
 
Figure 2.5 General approaches toward the preparation of ACPs 
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 Methods involving the formation of the cyclopropane ring to prepare ACPs have 
typically utilized carbene or carbenoid intermediates in reactions with unsaturated 
compounds. Some of the first general approaches toward synthesizing the ACP moiety 
involved reactions of alkylidenecarbenes AB-1 with substituted alkenes AB-2 or the 
analogous reactions of carbenes AB-4 with allenes AB-3 (Figure 2.5, Eq. 1).
89
   
 One of the earliest examples of utilizing carbenes in the preparation of ACP 
products was reported in 1964 by Hartzler.
93
 The use of 1,1-dibromopropene (HH-1) in 
the presence of methylithium generated an alkylidenecarbene intermediate (HH-4), 
which underwent cyclopropanation reactions with various alkenes to generate ACP 
products (HH-3) in good yield (Figure 2.6, Eq. 1). More nucleophilic vinyl ether 
substrates, such as ethyl vinyl ether (70% yield), performed optimally under the reaction 
conditions compared to aliphatic alkenes such as trans-2-butene (23% yield). The Shioiri 
laboratory also utilized alkylidenecarbene intermediates to prepare ACP products, but  
Figure 2.6 Preparation of ACPs from reaction of alkylidenecarbenes and alkenes 
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sought to develop an alternative carbene precursor to the halides usually employed 
(Figure 2.6, Eq. 2).
94
 Reaction of the lithium salt of TMS-diazomethane with 1,3-
diphenyl-2-propanone (TS-1) was found to generate the alkylidenecarbene intermediate 
TS-4, which reacted with a variety of cyclic alkenes, styrenes, and vinyl ethers to furnish 
the dibenzyl-substituted ACP products TS-3. Both the model substrate cyclohexene (69% 
yield) as well as the more nucleophilic ethyl vinyl ether (67% yield) reacted to give the 
corresponding ACPs in good yield. 
 Allene substrates have also been widely implemented in cyclopropanation 
reactions to generate ACP scaffolds.
73
 A seminal report by the Kuivila laboratory in 1966 
described the use of allenes HK-1 in reactions with dibromocarbene (HK-3), which was 
generated in-situ from the reaction between carbon tetrabromide and potassium t-
butoxide (Figure 2.7, Eq. 1).
95
  Both allenes, 2,3-pentadiene (HK-1a) and 2-methyl-2,3-
pentadiene (HK-1b), reacted selectively to give the corresponding dibromo-substitued 
ACP products HK-2 in good yields of 87% and 78%, respectively.    
 In addition to the generation of halocarbenes, the use of metal carbenoids in 
cyclopropanation reactions of allenes represents an important class of transformations to 
synthesize ACP derivatives, particularly in the advancement of catalytic processes. As 
will be discussed further in the following background subsection, the use of metal-based 
carbenoid reagents has also enabled the development of asymmetric reactions of allenes 
by the introduction of chiral ligands to the metal centers. The metal carbenoids employed 
in these methods are commonly generated in-situ by the decomposition of a 
diazocarbonyl compound in the presence of a transition metal precursor.
96
 The 
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Figure 2.7 Preparation of ACPs from reaction of carbenes and allenes 
 
Somekawa laboratory utiilized the in-situ generated rhodium carbenoid intermediate KS-
4 in reaction with the bromo-substituted allene KS-2 (Figure 2.7, Eq. 2).
97
 In the presence 
of a catalytic amount of the rhodium(II) acetate dimer, ethyl diazoacetate (KS-1) 
decomposed to generate the requisite carbenoid and subsequent cyclopropanation 
furnished the bromo-substituted ACP derivative KS-3 in 63% yield. Subsequent 
mechanistic studies conducted by the Hengge and Wu laboratories suggested that 
formation of such rhodium carbenoid species (WW-4) would occur through an initial 
complexation of the negatively polarized carbon of the diazo compound (WW-2) 
followed by an irreversible extrusion of N2 from a diazonium intermediate (WW-3) 
(Figure 2.7, Eq. 3).
98
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 The use of preformed cyclopropane derivatives have also provided a versatile 
platform for developing approaches toward ACP scaffolds. One of the most simple 
methods to access ACP analogues from preformed cyclopropanes is through the formal 
elimination of a hydrohalic acid (Figure 2.5, Eq. 2). Though a majority of such 
transformations have focused on the preparation of the related methylene cyclopropane 
derivatives (R
1
 = R
2
 = H), several base-mediated elimination processes have selectively 
prepared ACPs. For example, the de Meijere laboratory synthesized the benzyl ether 
susbtituted-ACP AM-3 in 89% yield through an efficient two-step benzylation of 
Figure 2.8 Preparation of ACPs from elimination reaction 
 
bromocyclopropyl methanol AM-1 and subsequent base-mediated elimination reaction of 
the bromo-substituted intermediate AM-2 (Figure 2.8, Eq. 1).
99
  
 Wittig olefination reactions using preformed cyclopropanes provide another  
approach toward ACP products, though the scope of these reactions remain relatively 
limited due to the unavailability of cyclopropanone and the generally low reactivity of the 
related cyclopropanone hemiacetals (Figure 2.5, Eq. 3).
89
 A report by the Tokuda 
laboratory sought to address this issue by utilizing ring-fused N,O-hemiacetal 
cyclopropanes (MT-1) as imminium ion precursors in reactions with a variety of Wittig 
reagents (MT-2).
100
 The interesting bicyclo-[n.1.0]-ACP products (MT-4) were obtained 
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Figure 2.9 Preparation of ACPs from Wittig olefination 
 
in good yields when using the additive Kyowaad

 700 (Al2O39SiOxH2O) in 
combination with a catalytic amount of benzoic acid. 
 Double bond shifts of cyclopropane derviatives represent the last general set of 
reactions employing preformed cyclopropanes in the construction of ACP products 
(Figure 2.5, Eq. 4). The most commonly used substrates in such transformations are 
cyclopropenes, which generate ACP derivatives through an exocyclic shift of the double 
bond. In particular, cyclopropenes bearing allylic ethers or alcohols have been utilized in 
such transformations for their ability to promote the double bond isomerization.
77
 For 
example, the Marek laboratory utilized enantioenriched cyclopropenyl alcohols (IM-1) in 
directed copper-catalyzed reactions with various Grignard reagents, which furnished 
chiral ACP derivatives (IM-2) in good yield and excellent stereoselectivity (Figure 
2.10).
101
 A transition state model (IM-3) was proposed in which minimization of allylic 
1,3-strain and coordination of the copper-R
2
 species facilitated the highly selective 
addition to the cyclopropenyl ring and subsequent elimination process. 
Figure 2.10 Preparation of ACPs from double bond shift reaction 
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 The functionalization of preformed alkylidenecyclopropanes, while not 
technically a de novo synthesis of ACP products, has also enabled the preparation of a 
diverse range of ACP derivatives. Efforts to functionalize ACP products have typically 
taken advantage of the relatively acidic allylic cyclopropyl carbons to generate 
nucleophilic ACP species to participate in reactions with electrophiles. The Singleton 
laboratory used this strategy to construct disubstituted ACP derivatives (AS-3) in good 
yields from the reaction between alkyl iodides AS-2 and the lithium enolate derived from 
AS-1 (Figure 2.11, Eq. 1).
102
 Selective functionalization of the exocyclic double bond of 
ACPs has also been accomplished, particularly in cross coupling reactions. For example, 
the Chen laboratory sucessfully utilized tosyl-substituted ACPs (QC-1) in Heck reactions 
with electronically diverse aryl iodides (QC-2), providing access to a variety of densely 
functionalized ACP derivatives (QC-3) in moderate to good yield (Figure 2.11, Eq. 2).
103
 
Figure 2.11 Preparation of ACP derivatives from preformed 
alkylidenecyclopropanes 
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Stereoselective Approaches to Access Chiral Alkylidenecyclopropanes  
 Despite the multitude of methods to access ACP scaffolds, examples of highly 
stereoselective reactions to prepare chiral ACPs remain rare.
104
 In general, earlier 
approaches toward chiral ACPs relied on chiral resolutions of the racemic form of the 
ACP substrate, which reliably generated enantioenriched ACPs provided that the 
necessary functional handle was present.
89
  However, within the past decade, several 
important reports by the Gregg,
105,106
 Charette,
107
 and Iwasa
104
 laboratories have 
established the use of allenes in highly stereoselective cyclopropanation reactions as a 
general and effetive strategy to access chiral ACP products. 
 Initial studies in 2009 by the Gregg laboratory sought to develop an asymmetric 
cyclopropanation reaction between a variety of substituted allenes (TG-1) and the metal 
carbenoid generated from aryldiazoacetate ester TG-2 (Table 2.1).
105
 In the presence of a  
 
  
124 
Table 2.1 Preparation of chiral ACPs by Rh2(S-DOSP)4 catalyzed allene 
cyclopropanation 
 
catalytic amount of Rh2(S-DOSP), both aryl and alkyl mono-substituted allenes 
underwent cycloproponation to give the chiral ACP products TG-3 in good yields and 
enantioselectivities (Table 2.1, Entries 1-4). However, attempts to expand the scope to the 
more sterically demanding 1,1-disubstituted allenes resulted in comparable 
enantioselectivities to the mono-substituted allenes, but noticeable decreases in yield 
(Table 2.1, Entries 5 and 6). Interestingly, the 1,1-disubstituted TMS allene demonstrated 
a marked increase in product yield, which the authors attributed to the increased stability 
imparted by the silicon group (Table 2.1, Entry 7). Subsequent DFT calculations to 
investigate the transition state for the allene cyclopropanation revealed that both 
cyclopropane bonds formed simultaneously, though bonding at the terminal carbon of the 
allene was significantly more advanced (C-C bond distance of 2.3 Å) than at the adjacent 
center carbon (C-C bond distance of 2.8 Å) (Figure 2.12). The authors reasoned that the 
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asynchronicity in transition state TG-6 would place a partial positive charge at the central 
carbon of the allene, which could be stabilized by the adjacent coplanar silyl group 
through hyperconjugation and account for the increase in reactivity of the allenylsilane. 
Figure 2.12 DFT transition state model for allene cyclopropanation 
 
 In a followup study the next year, the Gregg laboratory probed the potential 
electronic and steric effects that allene substitutents would have on the rates of the 
established rhodium-catalyzed cyclopropanation reaction (Table 2.2).
106
 Competition 
experiments were devised in which a 1:1 mixture of phenylallene (TG-7) and a 
competing allene substrate (TG-8 or TG-9) were mixed with TG-2 under the rhodium-
catalyzed cyclopropanation conditions. The ratio of products obtained in the crude 
reaction mixture were then calculated by their respective 
1
H NMR signals, which were 
used as a direct measure of the relative rate of reaction between a given competing allene 
and phenylallene (kR,R'/kPh).  
 To test the potential electronic effects on the cyclopropanation process, a series of 
electron-rich and -poor aryl-substituted allenes were subjected to a competition 
experiment with phenylallene (Table 2.2, Entries 1-4). As predicted, an electron-rich 
alkoxy-substituted allene reacted faster than the model phenylallene, while electron-poor 
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Table 2.2 Substituent effects on rates of rhodium-catalyzed allene cyclopropanation 
 
allenes reacted slower with the electron-deficient carbenoid species. However, the 
magnitude of the observed electronic effects on the relative rates of reaction were 
significantly less than expected, which was attributed to the inability of the aryl rings to 
engage in conjugation with the reacting terminal allene π-system. To lend support to this 
conclusion, stryene (TG-9) was subjected to a competition study with phenylallene and 
resulted in a >20-fold rate increase, which demonstrate the rate enhancement expected 
from a conjugated π-system (Table 2.2, Entry 5). To probe the effects of sterics in the 
allene cyclopropanation, a sterically-demanding 1,1-disubstituted allene was reacted 
against phenylallene and led to an 8-fold decrease in reaction rate as predicted (Table 2.2, 
Entry 7). In addition, a competition reaction employing a silyl-substituted substrate  
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Figure 2.13 Competition experiment with allenylsilane in rhodium-catalyzed 
cyclopropanation 
 
demonstrated a remarkable enhancement in reactivity relative to the 1,1-dimethylallene, 
which was consistent with the observations in their previous study (Figure 2.13). 
 A few years later in 2013, the Charette laboratory expanded the scope of 
asymmetric allene cyclopropanations by developing the first reaction using a diacceptor 
diazo carbene precusor, which possessed two electron-withdrawing substituents.
107
 The 
use of one nitrile group in the diazo compound AC-2 was determined to be critical in 
order to achieve high yields in the cyclopropanation of allenes AC-1, which was 
attributed to the unique ability of the α-cyano group to create a more electron-deficient 
carbene (Table 2.3). Both electron-rich and -deficient aryl substituted allenes reacted to 
give excellent dr and %ee for chiral ACP products AC-3, though the electron-rich 
alkoxy-substitued allene (74% yield) showed diminished reactivity to the model phenyl- 
substituted allene (92% yield) (Table 2.3, Entry 1-4). These results were in constrast to 
the previously discussed electronic effects observed by the Gregg laboratory in their 
Rh2(S-DOSP)4 catalyzed cyclopropanation of allenes, highlighting the subtle effects that 
steric and electronic factors can play in arylallene cyclopropanation reactions. Alkyl and 
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Table 2.3 Preparation of chiral ACPs by Rh2(S-IBAZ)4 catalyzed allene 
cyclopropanation 
 
N-phthalamide-substituted allenes gave good yields for the corresponding ACP products 
(Table 2.3, Entries 5-7), while reaction of the electron-deficient ethyl ester allene led to a 
significant drop in yield to 29% (Table 2.3, Entry 8). As was observed by the Gregg 
laboratory, a significant boost in yield was achieved in the reaction of the sterically 
demanding 1,1-disubstitued allene bearing a silyl group (Table 2.3, Entry 10).  
  Most recently in 2015, the Iwasa group demonstrated a highly regio- and 
stereoselective cyclopropanation of substituted allenes utilizing a versatile chiral 
ruthenium (II) catalyst developed by their laboratory.
104
 In the presence of 1 mol% of 
Ru(S-Pheox) catalyst, succinimidyl diazoacetate SI-2 successfully underwent  
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Figure 2.14 Preparation of chiral ACPs by Ru(S-Pheox) catalyzed allene 
cyclopropanation 
 
intermolecular, asymmetric cyclopropanation reactions with both alkyl and aryl 
monosubstituted allenes  (SI-1) in good to excellent yields and stereoseletivity for the 
corresponding chiral ACP products (SI-3/SI-4) (Figure 2.14, Eq. 1). Gratifyingly, 
cyclopropanation of the sterically demanding 1,1-disubstituted cyclohexylallene (SI-5a) 
as well as dimethylallene (SI-5b) also gave good yields and enantioselectivity for ACP 
products SI-6/SI-7 (Figure 2.14, Eq. 2). Encouraged by the results of the intermolecular 
cyclopropanation process, a series of allenyl diazoacetates (SI-8) were also prepared and 
successfully underwent the analogous asymmetric, intramolecular cyclopropanation 
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reaction catalyzed by Ru(S-Pheox) (Figure 2.14, Eq. 3). In general, allenes bearing alkyl 
substitution produced the corresponding bicyclic ACP products (SI-9) efficiently, while 
aryl-substituted allenyl diazoacetates gave diminished yields and selectivities (8% ee for 
allene R
1
= R
2
= H, R
3
 = Ph). 
 The seminal work conducted by the Gregg, Charette, and Iwasa laboratories have 
set the foundation for the first catalytic and stereoselective preparations of chiral ACP 
derivatives through the asymmetric cyclopropanation of allenes. However, the substrate 
scope of the allenes employed in efficient asymmetric, intermolecular cyclopropanation 
reactions remains generally limited to only a few examples of the more sterically 
demanding di-substituted allenes. Herein, we report preliminary studies addressing this 
issue by developing the use of di- and tri-substituted allenylsilanes in highly 
stereoselective cyclopropanation reactions to furnish chiral ACP products.  
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Results and Discussion 
Optimization of the Asymmetric Cyclopropanation of Achiral Allenylsilanes 
 Preliminary experiments were inspired by the Iwasa laboratory's development and 
utilization of the versatile Ru(S-Pheox) catalyst (2.3) in selecvtive asymmetric 
cyclopropropanation reactions.
108
 We initiated the study by evaluating the reactivity of 
the achiral, 1,1-disubstituted trimethylsilylallene 2.1a with the metal carbenoid generated 
from the readily prepared benzyl diazoacetate 2.2 in the presence of a catalytic amount of 
2.3 (Table 2.4).
109
 Using a modified procedure from the Iwasa laboratory's report, 5 
equivalents of the allene (2.1a) were pre-stirred with the catalyst (2.3) at 0 C and the  
Table 2.4 Optimization of asymmetric cyclopropanation of achiral 
trimethysilylallene
a
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diazoacetate ester was added as a solution in DCM via syringe pump over a 10 minute 
period (Table 2.4, Entry 1). Gratifyingly, the ACP product (2.4) was isolated in 77% 
yield and 99:1 er. An attempt to lower the allene equivalents led to a decrease in yield, 
but it was noted that the color of the reaction was not consistent with the vibrant yellow 
reaction color observed for the first experiment (Table 2.4, Entry 2). After rechecking the 
purity of the reagents, it was determined that the Ru(S-pheox) sample had turned a 
slightly pale green color, indicating possible decomposition of the catalyst. Fortunately, 
simple repurification of the catalyst by column chromatography reproduced the yellow 
color of the original batch of catalyst. After repeating the reaction using 4 equivalents of 
allenylsilane and the newly purified Ru(S-pheox) catalyst, an optimal yield of 85% yield 
was achieved for the functionalized ACP product 2.4 (Table 2.4, Entry 3). 
 We next sought to extend the scope of the reaction to the achiral, 1,1-disubstituted 
dimethyphenylsilylallene 2.1b (Table 2.5). Using the optimized condition developed for  
the trimethysilylallene, reaction of the benzyl diazoacetate (2.2) and 4 equivalents of the 
allene (2.1b) in the presence of 2 mol% of the Ru(S-pheox) catalyst gave an 80% yield of 
the dimethylphenylsilyl-substituted ACP product 2.4b in >99:1 er (Table 2.5, Entry 1). 
Decreasing the catalyst loading to 1 mol% led to a relatively significant drop in yield to 
61% yield (Table 2.5 Entry 2). Interestingly, when attempting to lower the equivalents of 
allenylsilane needed for the reaction, a new byproduct was isolated and determined to be 
(E)-dibenzyl fumarate ((E)-2.5) (Table 2.5, Entry 3). Production of this byproduct was 
presumed to occur from the dimerization of the in-situ generated carbenoid. Thus, it was 
concluded that the use of a large excess of allenylsilane was necessary in order to  
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Table 2.5 Optimization of asymmetric cyclopropanation of achiral 
dimethylphenylsilylallene
a
 
 
 
promote the productive cyclopropanation reaction and to prevent the background 
dimerization of the ruthenium carbenoid. 
  
Extension to the Asymmetric Cyclopropanation of Chiral Allenylsilanes 
 With the optimized reaction conditions in hand for the cyclopropanation of 1,1-
disubstituted allenylsilanes, we next sought to extend the asymmetric cyclopropanation 
reaction to incorporate enantioenriched, 1,1,3-trisubstituted allenylsilanes. Given that the 
reactions were run with a chiral catalyst, it was predicted that the use of chiral 
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allenylsilane subtrates would proceed in a double stereodifferentiating fashion. To test 
this, both the (Ra)- and (Sa)-allenylsilanes were prepared and studied in the asymmetric 
cyclopropanation process.
110
 
 Optimization studies were initiated using the (Ra)-trimethylsilylallene (Ra)-2.6, 
which reacted with the carbenoid generated from 2.2 and Ru(S-Pheox) at 0 C to produce 
only 8% yield of the desired ACP product (2.7a) (Table 2.6, Entry 1). The (E)-alkene 
geometry of the ACP product was confirmed by 1D NOE and the trans-relative 
configuration of the cyclopropane ring was confirmed by the observed coupling constants  
Table 2.6 Effect of addition rate and temperature on asymmetric cyclopropanation 
of (Ra)-trimethylsilylallene
a
 
 
between the C-1 and C-3 methyne protons, but er determinations are still in progress (See 
Selected 1D NOE and Relative Stereochemistry of Cyclopropyl Ring subsections). 
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Unfortunately, both the (E)- and (Z)-dibenzyl fumarate products (2.5) were also isolated 
in 60% combined yield from the background carbenoid dimerization. To try to suppress 
the deleterious dimerization, the rate of addition of diazoacetate was decreased to 77 
L/min and led to a modest increase in yield to 18% (Table 2.6, Entry 2), while 
decreasing the rate even further to 36 L/min unfortunately led to a diminished yield 
(Table 2.6, Entry 3). The temperature of the reaction was also decreased to try and 
minimize the background dimerization, but resulted in almost exclusively dimerization 
products (Table 2.6, Entry 4). 
 Using the optimized 77 L/min  rate of addition, a brief catalyst study was 
conducted to try to improve on the currently achieved 18% yield of ACP product 2.7a 
(Table 2.7, Entry 1). The more sterically demanding Rh2(S-DOSP)4 was employed to try 
to suppress the dimerization process, but required a prolonged reaction time at room 
temperature and led to diminished yield and diastereoselectivity (Table 2.7, Entry 2). 
Given the excellent selectivities observed thus far with the Ru(S-pheox) catalyst system, 
we decided to focus future optimization efforts solely on reactions employing that 
catalyst. Increasing the Ru(S-pheox) catalyst loading to 10 mol% gave a slight increase in 
yield to 25% of ACP product with excellent dr (Table 2.7, Entry 3). Despite the excellent 
stereoselectivity achieved, it became clear that an alternative approach toward the 
reaction of the relatively unreactive tri-substituted allene was necessary in order to 
generate an appreciable improvement in yield.   
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Table 2.7 Brief catalyst study in asymmetric cyclopropanation of (Ra)-
trimethylsilylallene
a
 
 
  
 Fortunately, because the generated dibenzyl fumarate dimerization byproducts 
could be separated from the generated ACP product by column chromatrography, we 
decided to utilize the allenylsilane (Ra)-2.6 instead as the limiting reagent in the 
asymmetric cyclopropanation reaction. Gratifyingly, when using 2 equivalents of 
diazoacetate 2.2 and 10 mol% of catalyst 2.3, ACP product 2.7a was isolated in 50% 
yield as a single diastereomer (Table 2.8, Entry 1). Increasing to 3 equivalents of 2.2 led 
to a boost in yield to 62%, while using 4 equivalents of the diazoacetate led to an  
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Table 2.8 Allene as the limiting reagent in the asymmetric cyclopropanation of (Ra)-
trimethylsilylallene
a
 
 
optimized yield of 70% for the functionalized ACP product with excellent 
diastereoselectivity (Table 2.8, Entry 3). 
 The asymmetric cyclopropanation reaction was then extended to the (Sa)-
trimethylsilylallene ((Sa)-2.6) using the optimized conditions developed for the (Ra)-
trimethylsilylallene ((Ra)-2.6). As mentioned previously, it was predicted that the 
asymmetric cyclopropanation process utilizing both a chiral catalyst and chiral 
allenylsilane substrates should proceed in a double stereodifferentiating fashion. Namely, 
the relative yields and/or stereochemical outcomes of the respective reactions using the 
(Ra)-allenylsilane versus the (Sa)-allenylsilane should be dependent on whether the 
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Figure 2.15  Asymmetric cyclopropanation of  (Sa)-trimethylsilylallene 
  
 
chirality of the Ru(S-Pheox) catalyst (2.3) was matched or mis-matched with the given 
chirality of the allenylsilane subtrate. As predicted, reaction of (Sa)-2.6 resulted in a 
significant drop in yield to 15% for the ACP product 2.7b  and a slight decrease in 
diastereoselectivity to 21:1 dr for the favored cis-cyclopropane (Figure 2.15). Thus, the 
(Ra)-2.6 allenylsilane appeared to be a matched pair with the chirality of the Ru(S-pheox) 
catalyst system. 
 To further support the proposed double stereodifferentiation event, both the (Ra)- 
and (Sa)-dimethylphenylsilylallenes were prepared and subjected to the optimized Ru(S-
pheox)-catalyzed reaction conditions (Figure 2.16). As anticipated, reaction of the 
proposed matched (Ra)-2.8 allenysilane resulted in both a higher yield (40%) and 
diastereoselectivity (>30:1) for the trans-ACP product 2.9a compared to the mis-matched 
reaction using (Sa)-2.8 to produce the cis-ACP product 2.9b (13% yield, 9:1 dr) (Figure 
2.16, Eqs. 1 and 2). 
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Figure 2.16  Asymmetric cyclopropanation of (Ra)- and (Sa)-
dimethylphenylsilylallenes 
 
 
 
Proposed Stereochemical Model for Cyclopropanation of Chiral Allenes 
 A proposed mechanistic model was developed to rationalize the observed double 
stereodifferentiation event in the Ru(S-pheox)-catalyzed asymmetric cyclopropanation of 
both (Ra)- and (Sa)-silylallenes (Figure 2.17). Use of the (S)-pheox ligand was expected to 
orient the benzyl ester moiety of the carbenoid away from the phenyl chiral center. The 
ensuing cyclopropanation event should then occur such that the allene and carbneoid 
align in an "edge-on" aproach, where the more sterically demanding silyl group faces 
away from the catalyst/carbenoid complex as the allene approaches.
111,106
 In turn, this 
dictates the relative positioning of the teminal substitutents of the allene, either forcing 
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Figure 2.17  Proposed stereochemical model for asymmetric cyclopropanation of 
chiral silylallenes 
 
 
the smaller hydrogen substituent of the (Ra)-silylallenes and the benzyl ester of the 
carbenoid to align in the matched case (Figure 2.17, Eq. 1) or the larger methyl-
substitutent of the (Sa)-silylallenes and the benzyl ester to be aligned in the mis-matched 
case (Figure 2.17, Eq. 2). 
 The predicted approach of the allene such that the silyl moeity faced away from 
the metal-carbenoid complex was supported by the observed (E)-olefin geometry of the 
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isolated ACP products (See Selected 1D NOE subsection). In addition, the observed C1-
C3 trans-selectivity for the cyclopropyl rings of ACP products 2.7a and 2.9a obtained 
from the cyclopropanation of the (Ra)- silylallenes and the corresponding cis-selectivity 
for the cyclopropyl rings of ACP products 2.7b and 2.9b obtained from the (Sa)-
silylallenes also appeared to be in agreement with the proposed stereochemical model 
(see Relative Stereochemistry of Cyclopropyl Ring subsection). Unfortunately, 
determination of the absolute configuration of ACP products 2.7 and 2.9 is still in 
progress, but will hopefully be resolved in future studies. 
 
Selected 1D NOE Studies to Confirm (E)-Alkene Geometry of ACP products 
 In order to confirm the (E)-alkene geometry of the ACP products generated in the 
asymmetric cyclopropanation reactions, 1D NOE experiments were carried out on a 
representative group of ACP products (Table 2.9). Irradiation of one of the methylene 
proton peaks at the C3 carbon of ACP product 2.4a showed an NOE enhancement of 
0.95% of the TMS proton peak, demonstrating the (E)-configuration for an ACP product 
derived from an achiral silylallene (Table 2.9, Entry 1). Additionally, irradiation of the 
methyne proton peak at the C3 carbons of ACP products 2.7a, 2.7b, as well as 2.9b all 
showed an NOE enhancement to the respective silyl methyl proton peaks, demonstrating 
the overall general (E)-seletivity attained by the asymmetric cyclopropanation process 
catalyzed by Ru(S-pheox) (Table 2.9, Entries 2-4). 
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Table 2.9  Selected 1D NOE experiments to confirm (E)-alkene of ACP 
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Relative Stereochemistry of Cyclopropyl Ring in ACP products 2.7/2.9 
 Coupling constants between the C1 and C3 carbons of the cyclopropyl ring were 
calculated for each of the ACP products derived from the reaction of chiral allenylsilanes 
2.6 and 2.8 (Table 2.9). ACP products 2.7a and 2.9a, which were prepared from the  
cyclopropanation of (Ra)-silylallenes, showed coupling constants of 4.1 and 4.2 Hz 
respectively, which were consistent with a trans-substituted cyclopropane ring (Jtrans = 2-
7 Hz).
112
 Analogously, ACP products 2.7b and 2.9b, which were prepared from the  
Table 2.10 Cyclopropyl ring coupling constants for ACP products 2.7/2.9 
 
 
cyclopropanation of (Sa)-silylallenes, showed coupling constants of 9.5 and 9.7 Hz 
respectively, which were consistent with a generally larger cis-substituted cyclopropane 
ring coupling constant (Jcis = 7-13 Hz).  
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Exploring Reactivity of ACP Products: Unexpected Iodolactonization 
 With the densely functionalized ACP products in hand, the reactivity of the 
alkylidenecyclopropane core was explored. Studies utilized the TMS-ACP product 2.7a 
and were focused on the reactivity of the vinyl silane moiety. The possible vinyl 
iodination was investigated according to the procedure previously utilized in our 
laboratory using NIS.
113
  ACP product 2.7a was subjected to 2 equivalents of NIS in a 4:1 
mixture of acetonitrile and chloroacetonitrile and stirred overnight at room temperature 
overnight (Figure 2.18, Eq. 1). Interestingly, instead of isolating the expected vinyl iodide  
Figure 2.18 Unexpected iodolactonization of 2.7a in attempted vinyl iodination 
 
 
2.10,  mass spectral and 
1
H NMR analysis revealed that the 3-oxabicyclo[3.1.0]hexane-2-
one derivative 2.11 was isolated instead in 39% yield. Additionally, retention of the 
original C1-C3 trans-cyclopropyl ring relative configuration of the starting material 2.7a 
(JH1/H3 = 4.1 Hz) was observed in the C2-C6 trans-cyclopropyl ring of 2.11  (JH2/H6 = 3.6 
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Hz).  Increasing to 5 equivalents of NIS led to the optimized yield of 68% for the γ-
lactone product as a single diastereomer. After consulting the literature for precedent for 
this transformation, we found a study conducted by the Ma laboratory in which a similar 
methyl ester functionalized ACP derivative (SM-1) underwent an NIS-promoted 
iodolactonization to furnish γ-lactone product SM-2 (Figure 2.18, Eq. 2).114  
 A mechanism was proposed, in accordance with the Ma laboratory's findings, for 
the ioodolactonization process in which an initially formed iodonium ion intermediate 
2.12 is attacked and opened by the benzyl ester carbonyl to give oxocarbenium ion 2.13  
Figure 2.19 Proposed mechanism of iodolactonization of 2.7a 
 
 
(Figure 2.19). Subsequent isomerization and loss of a benzyl cation would give rise to the 
γ-lactone product 2.11. Given the biological relevance of the 3-oxabicyclo[3.1.0]hexane-
2-one scaffold, further expansion of the scope of the asymmetric allene cyclopropanation 
would be desirable in order to access a wide variety of chiral ACP substrates for the 
developed NIS-promoted iodolactonization reaction.
115,116
  
  
148 
Conclusion 
 In conclusion, chiral alkylidenecyclopropane (ACP) products have been 
successfully accessed via the asymmetric cyclopropanation of substituted allenylsilanes. 
In the presence of 2 mol% of the versatile Ru(S-pheox) catalyst system, 4 equivalents of 
1,1-disubstituted allenylsilanes reacted with the metal carbenoid derived from benzyl 
diazoacetate ester to yield the corresponding ACP products in excellent yields (up to 
85%) and stereoselectivities (>30:1 E:Z and >98:2 er).  
 The asymmetric cyclopropanation methodology was then extended to the use of 
chiral 1,1,3-trisubstituted allenylsilanes, which required a switch in the limiting reagent to 
the allenylsilane and use of 10 mol% of the Ru(S-pheox) catalyst system to give good 
yields (up to 70%) and stereoselectivities (>30:1 dr) for the corresponding ACP products.  
Reaction of both a chiral catalyst and chiral allenylsilane substrate was proposed to occur 
in a double stereodifferentiating fashion dependent on the chirality of the starting material 
allenylsilane employed. Indeed, (Ra)-allenylsilane substrates reacted to give the 
corresponding ACP products in higher yields and stereoselectivities relative to the (Sa)-
allenylsilane counterparts when using the Ru(S-pheox) catalyst. From these observations, 
a stereochemical model was devised which predicted the (Ra)-allenylsilanes and the 
Ru(S-pheox) catalyst to be a matched pair. To the best of our knowledge, this work 
demonstrates the first intermolecular, asymmetric cyclopropanation of sterically 
demanding tri-substituted allenes. 
 Subsequent studies utilizing the ACP products in further transformations led to 
the discovery of an unexpected iodolactonization process driven by the proposed loss of a 
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benzyl cation. The methodology provided access to the structurally interesting 3-
oxabicyclo[3.1.0]hexan-2-one scaffold in 68% yield as a single diastereomer. 
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Experimental 
General Information 
All 
1
H and 
13
C NMR spectra were taken in CDCl3 at 400 or 500 MHz (as indicated, 
respectively) using a Varian 400 or 500 MHz VNMR spectrometer at ambient 
temperature. Chemical shifts are reported as major diastereomer and/or alkene isomer, 
unless otherwise noted, in parts per million using the solvent internal standard 
(chloroform: 7.26 for 
1
H NMR and 
13
C NMR 77.2 ppm, benzene: 7.16 ppm for 
1
H 
NMR). Data are reported as follows: chemical shift, multiplicity (s = singlet, d = doublet, 
t = triplet, q = quartet, m = multiplet, br = broad), coupling constant, integration. Infrared 
resonance spectra were recorded on a Nexus 670 FT-IR spectrometer. Optical rotations 
were recorded on a Rudolph Autopol II digital polarimeter at 25 C and 589 nm and 
reported as follows:     
  (concentration in g/100 mL of CH2Cl2). High resolution mass-
spectra were obtained on a Waters Q-TOF Mass Spectrometer at Boston University 
Chemical Instrumentation Center (CIC). A Chiralpak AD-H (Chiral Technologies Inc., 
150 x 4.60 mm I.D.) column was used for enantiomeric ratio determination. All reactions 
were carried out in oven or flame-dried glassware under argon atmosphere, unless 
otherwise noted. Dichloromethane was obtained from a dry solvent system (alumina) and 
used without further drying. All other reagents were purchased from Sigma Aldrich, Alfa 
Aesar, Gelest, and Oakwood and used as supplied. Unless otherwise noted, reactions 
were magnetically stirred and monitored by thin layer chromatography with Macherey 
Nagel Polygram 0.20 mm silica gel 60 Å plates. Flash chromatography was performed 
using ZEOprep 60 ECO 32-63 μm ZEOCHEM silica gel 
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Preparation of Starting Materials and Catalyst 
 
A) Preparation of allenylsilanes 
 
Methyl 3-(trimethylsilyl)penta-3,4-dienoate (2.1a): 
Methyl 3-(dimethyl(phenyl)silyl)penta-3,4-dienoate (2.1b): 
Methyl (R)-3-(trimethylsilyl)hexa-3,4-dienoate ((Ra)-2.6): 
Methyl (R)-3-(dimethyl(phenyl)silyl)hexa-3,4-dienoate ((Ra)-2.8): 
Methyl (S)-3-(trimethylsilyl)hexa-3,4-dienoate ((Sa)-2.6): 
Methyl (S)-3-(dimethyl(phenyl)silyl)hexa-3,4-dienoate ((Sa)-2.8): 
Prepared according to the procedure by Panek, et. al.
110
 
 
B) Preparation of benzyl diazoacetate ester 
 
Benzyl 2-diazoacetate (2.2) 
Prepared according to the procedure by Fukuyama, et. al.
117
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C) Preparation of Ru(S-pheox) catalyst 
 
[(S)-(2-phenyl-4-pheox)Ru(CH3CN)4]PF6 complex (2.3): 
Prepared according to the procedure by Iwasa, et. al. 
108
 
 
General Procedure for Ru(S-pheox) Catalyzed Asymmetric Cyclopropanation of 
Achiral Allenylsilanes 2.1 
 
Achiral TMS allenylsilane (2.1) (2.00 mmol, 4.0 equiv) was dissolved in DCM (10 mL) 
and cooled to 0 °C. Ru(S-Pheox) complex (2.3) (0.0063 g, 0.01 mmol, 0.02 equiv) was 
added quickly to the mixture and the reaction was stirred for 20 min. Benzyl 2-
diazoacetate (2.2) (0.0881 g, 0.50 mmol, 1.0 equiv) was then added as a 0.2 M solution in 
DCM (2.5 mL) via a syringe pump over 15 min. After stirring for an additional 10 min at 
0 °C, the solvent was removed by rotary evaporation. Purification by silica gel 
chromatography yielded ACP product 2.4. 
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General Procedure for Ru(S-pheox) Catalyzed Asymmetric Cyclopropanation of Chiral 
Allenylsilanes 2.6 and 2.8 
 
 
Chiral allenylsilane (Ra or Sa -2.6 or -2.8) (0.50 mmol, 1.0 equiv) was dissolved in DCM 
(2.5 mL) and cooled to 0 °C. Ru(S-pheox) complex (2.3) (0.0316 g, 0.05 mmol, 0.1 
equiv) was added quickly to the mixture and the reaction was stirred for 20 min. Benzyl 
2-diazoacetate (2.2) (0.352 g, 2.00 mmol, 4.0 equiv) was then added slowly as a 0.2 M 
solution in DCM (10 mL) via a syringe pump over 2 h 10 min. After stirring for an 
additional 30 min at 0 °C, the solvent was removed by rotary evaporation. Purification by 
silica gel chromatography yield ACP product 2.7 or 2.9. 
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benzyl (R,E)-2-(3-methoxy-3-oxo-1-(trimethylsilyl)propylidene)cyclopropane-1-
carboxylate (2.4a): 
Prepared by the General Procedure for Ru(S-pheox) Catalyzed 
Asymmetric Cyclopropanation of Achiral Allenylsilanes 2.1. 
Purification by silica gel chromatography (19:1 hexanes:EtOAc) 
afforded 2.4a as a clear oil (141.9 mg, 85 % yield).     
   = -21.6 (c = 5.0, CH2Cl2). 
Enantiomeric Ratio: 98:2. HPLC Analysis: Chiralpak AD-H column, Hexanes:IPA = 
99:1, 1.0 ml/min, tr major: 6.0 min, tr minor: 5.2 min. 
1
H NMR (500 MHz, CDCl3): 
δ7.38-7.32 (overlap, 5H), 5.16 (d, J = 12.4 Hz, 1H), 5.09 (d, J = 12.4 Hz, 1H), 3.60 (s, 
3H), 3.20-3.12 (overlap, 2H), 2.28 (ddd, J = 8.4, 4.7, 1.2 Hz, 1H), 1.97 (m, 1H), 1.76 (m, 
1H), 0.16 (s, 9H); 
13
C NMR (125 MHz, CDCl3): 172.3, 171.8, 136.2, 134.5, 128.6, 
128.3, 128.2, 123.1, 66.6, 51.9, 39.6, 17.1, 12.8, 1.4; IR (thin film, cm
-1) νmax: 2954, 
1728, 1498, 1456, 1437, 1381, 1333, 1248, 1159, 1069, 1024, 914, 839, 753, 698; 
HRMS (m/z): [M+H]
+
 calculated for C18H24O4Si 333.1522, found 333.1509. 
 
benzyl (R,E)-2-(1-(dimethyl(phenyl)silyl)-3-methoxy-3-oxopropylidene) 
cyclopropane-1-carboxylate (2.4b): 
Prepared by the General Procedure for Ru(S-pheox) Catalyzed 
Asymmetric Cyclopropanation of Achiral Allenylsilanes 2.1. 
Purification by silica gel chromatography (16:1 hexanes:EtOAc)  
afforded 2.4b as a yellow oil (157.5 mg, 80 % yield).     
   = -12.9 
(c = 5.0, CH2Cl2). HPLC Analysis: Chiralpak AD-H column, Hexanes:IPA = 99:1, 1.0 
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ml/min, tr major: 6.8 min, tr minor: 5.8 min. 
1
H NMR (500 MHz, CDCl3): δ7.51-7.50 
(overlap, 2H), 7.38-7.31 (overlap, 8H), 5.17 (d, J = 12.4 Hz, 1H), 5.10 (d, J = 12.4 Hz, 
1H), 3.48 (s, 3H), 3.18-3.11 (overlap, 2H), 2.32 (m, 1H), 1.90 (m, 1H), 1.69 (m, 1H), 
0.46-0.45 (overlap, 6H); 
13
C NMR (125 MHz, CDCl3): 171.9, 171.6, 137.5, 136.4, 136.2, 
134.1, 129.3, 128.7, 128.3, 128.2, 127.9, 121.5, 66.6, 51.7, 39.7, 17.3, 13.1, 2.6, 2.8; IR 
(thin film, cm
-1) νmax: 2952, 1733, 1498, 1456, 1428, 1380, 1333, 1250, 1161, 1112, 
1067, 1024, 913, 836, 848, 779, 734, 699; HRMS (m/z): [M+H]
+
 calculated for 
C23H26O4Si 395.1679, found 395.1697. 
 
benzyl (1R,3R,E)-2-(3-methoxy-3-oxo-1-(trimethylsilyl)propylidene)-3-
methylcyclopropane-1-carboxylate (2.7a) 
Prepared by the General Procedure for Ru(S-pheox) Catalyzed 
Asymmetric Cyclopropanation of Chiral Allenylsilanes 2.6 and 
2.8. Purification by silica gel chromatography (20:1 to 18:1 to 
15:1 hexanes: EtOAc) afforded 2.7a as a clear oil (121.3 mg, 70 
% yield) and single diastereomer.     
   = -14.4 (c = 2.0, CH2Cl2). 
1
H NMR (500 MHz, 
CDCl3): δ7.38-7.30 (overlap, 5H), 5.14 (d, J = 12.5 Hz, 1H), 5.08 (d, J = 12.5 Hz, 1H), 
3.60 (s, 3H), 3.19-3.10 (overlap, 2H), 2.28 (m, 1H), 1.91 (d, J = 4.1 Hz, 1H), 1.25 (d, J = 
6.3 Hz, 1H), 0.16 (s, 9H); 
13
C NMR (125 MHz, CDCl3): 172.3, 171.7, 141.4, 136.3, 
128.6, 128.2, 128.1, 123.1, 66.4, 51.8, 39.8, 24.9, 21.3, 17.3, 1.1; IR (thin film, cm
-1
) 
νmax: 2955, 1726, 1498, 1456, 1435, 1380, 1295, 1247, 1155, 1092, 1040, 1028, 977, 913, 
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838, 755, 696; HRMS (m/z): [M+H]
+
 calculated for C19H26O4Si 347.1679, found 
347.1664. 
 
benzyl (1R,3S,E)-2-(3-methoxy-3-oxo-1-(trimethylsilyl)propylidene)-3-
methylcyclopropane-1-carboxylate (2.7b) 
Prepared by the General Procedure for Ru(S-pheox) Catalyzed 
Asymmetric Cyclopropanation of Chiral Allenylsilanes 2.6 and 
2.8. Purification by silica gel chromatography (20:1 to 18:1 to 
15:1 hexanes:EtOAc) afforded 2.7b as a clear oil (26.0 mg, 15 
% yield) and 21:1 dr.     
   = -15.2 (c = 0.5, CH2Cl2).
 1
H NMR (500 MHz, CDCl3): 
δ7.37-7.34 (overlap, 5H), 5.14 (d, J = 12.5 Hz, 1H), 5.10 (d, J = 12.5 Hz, 1H) 3.60 (s, 
3H), 3.20-3.13 (overlap, 2H), 2.35 (d, J = 9.5 Hz, 1H), 2.20 (m, 1H), 1.32 (d, J = 6.4 Hz, 
3H), 0.15 (s, 9H); 
13
C NMR (125 MHz, CDCl3): 172.4, 170.6, 140.3, 136.4, 128.6, 
128.2, 123.8, 66.3, 51.8, 39.6, 29.8, 21.5, 20.7, 12.5, 1.1; IR (thin film, cm
-1) νmax: 2954, 
1729, 1498, 1455, 1435, 1379, 1326, 1248, 1141, 1097, 1029, 942, 913, 754, 697; 
HRMS (m/z): [M+H]
+
 calculated for C19H26O4Si 347.1679, found 347.1674. 
 
benzyl (1R,3R,E)-2-(1-(dimethyl(phenyl)silyl)-3-methoxy-3-oxopropylidene)-3-
methylcyclopropane-1-carboxylate (2.9a) 
Prepared by the General Procedure for Ru(S-pheox) Catalyzed 
Asymmetric Cyclopropanation of Chiral Allenylsilanes 2.6 and 
2.8. Purification by silica gel chromatography (20:1 to 18:1 to 
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15:1 hexanes: EtOAc) afforded 2.9a as a light yellow oil (81.2 mg, 40 % yield) and 
single diastereomer. 
1
H NMR (500 MHz, CDCl3): δ7.51-7.49 (overlap, 2H), 7.38-7.30 
(overlap, 8H), 5.14 (d, J = 12.4 Hz, 1H), 5.08 (d, J = 12.4 Hz, 1H), 3.47 (s, 3H), 3.16-
3.08 (overlap, 2H), 2.18 (m, 1H), 1.93 (d, J = 4.2, 1H), 1.07 (d, J = 6.3 Hz, 3H), 0.44 (s, 
3H), 0.43 (s, 3H); 
13
C NMR (125 MHz, CDCl3): 172.0, 171.6, 143.4, 137.5, 136.3, 
134.2, 129.3, 128.6, 128.2, 128.2, 127.9, 121.4, 66.5, 51.7, 39.9, 25.2, 21.6, 17.0, 2.5; IR 
(thin film, cm
-1) νmax: 2955, 1727, 1498, 1456, 1428, 1379, 1296, 1249, 1158, 1111, 
1092, 1040, 913, 835, 820, 779, 734, 699; HRMS (m/z): [M+H]
+
 calculated for 
C24H28O4Si 409.1835, found 409.1841. 
 
benzyl (1R,3S,E)-2-(1-(dimethyl(phenyl)silyl)-3-methoxy-3-oxopropylidene)-3-
methylcyclopropane-1-carboxylate (2.9b) 
Prepared by the General Procedure for Ru(S-pheox) Catalyzed 
Asymmetric Cyclopropanation of Chiral Allenylsilanes 2.6 and 
2.8. Purification by silica gel chromatography (20:1 to 18:1 to 
15:1 hexanes:EtOAc) afforded 2.9b as a clear oil (29.5 g, 13 % 
yield) and 9:1 dr.     
   = -5.6 (c = 0.5, CH2Cl2).
1
H NMR (500 MHz, CDCl3): δ7.52-
7.50 (overlap, 2H), 7.37-7.32 (overlap, 8H), 5.14 (d, J = 12.5 Hz, 1H), 5.11 (d, J = 12.3 
Hz, 1H), 3.49 (s, 3H), 3.17-2.13 (overlap, 2H), 2.38 (d, J = 9.7, 1H), 2.10 (m, 1H), 1.14 
(d, J = 6.5 Hz, 3H), 0.45 (s, 3H), 0.43 (s, 3H); 
13
C NMR (125 MHz, CDCl3): 172.2, 
170.6, 142.2, 137.6, 136.3, 134.2, 129.3, 128.6, 128.2, 127.9, 122.1, 66.4, 51.7, 39.7, 
21.8, 20.9, 12.2, 2.3, 2.7; IR (thin film, cm
-1) νmax: 2955, 1730, 1455, 1428, 1379, 1325, 
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1248, 1142, 1111, 1028, 778, 733, 698; HRMS (m/z): [M+H]
+
 calculated for C24H28O4Si 
409.1835, found 409.1836. 
 
Procedure for the NIS-promoted Iodolactonization of ACP Product 2.7a 
 
 
benzyl (1R,3S,E)-2-(1-(dimethyl(phenyl)silyl)-3-methoxy-3-oxopropylidene)-3-
methylcyclopropane-1-carboxylate (2.11) 
TMS ACP product 2.7a (0.0347 g, 0.10 mmol, 1.0 equiv) was dissolved in a 4:1 mixture 
of CH3CN and ClCH2CN (0.8 mL:0.2 mL) and N-iodosuccinimide (0.112 g, 0.50 mmol, 
5.0 equiv) was added in one portion. The reaction mixture was shielded from light and 
stirred at room temperature for 30 hours. The reaction was then quenched with sodium 
thiosulfate solution (5 mL). It was then extracted with DCM (3 x 10 mL), and the 
combined organic layers were washed with brine, dried over MgSO4, filtered, and 
concentrated. Purification by silica gel chromatography (20:1 to 15:1 to 10:1 
hexanes:EtOAc) afforded iodolactonization product 2.11 as a white residue (26 mg, 68 % 
yield) and single diastereomer.     
   = 24.0 (c = 1.0, CH2Cl2). 
1
H NMR (500 MHz, 
CDCl3): δ3.71 (s, 3H), 3.05 (d, J = 17.4 Hz, 1H), 2.96 (d, J = 17.4 Hz, 1H), 2.05 (d, J = 
3.6 Hz, 1H), 1.31 (d, J = 6.2 Hz, 3H), 1.12 (qd, J = 6.1, 3.6 Hz, 1H), 0.24 (s, 9H); 
13
C 
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NMR (125 MHz, CDCl3): 175.2, 170.1, 82.4, 52.0, 43.8, 35.2, 25.1 20.5, 19.4, 1.3; IR 
(thin film, cm
-1) νmax: 2954, 2924, 2850, 1770, 1739, 1436, 1356, 1251, 1201, 1170, 
1141, 1055, 1000, 958, 926, 874, 846, 819, 759, 697; HRMS (m/z): [M+H]
+
 calculated 
for C12H19IO4Si 383.0176, found 383.0178. 
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